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Abstract 
Numerical and structural chromosome abnormalities are common in the 
human population and cause infertility associated with germ cell losses 
during meiotic prophase I. The precise trigger of germ cell loss in response 
to chromosome abnormalities in mammals is still unclear, but several 
models have been postulated, including a DNA damage checkpoint, an 
asynapsis checkpoint, and meiotic silencing of asynapsed chromosomes. 
Here, I investigate the contribution of these mechanisms to oocyte loss in 
mice with chromosome abnormalities, such as X chromosome monosomy 
(XO). First, I show that asynapsed chromosomes trigger oocyte elimination 
during diplonema of meiotic prophase I, later than predicted by the 
pachytene checkpoint model that has been characterized in other 
organisms. Markers of DNA double-strand break repair disappear from 
asynapsed chromosomes during pachynema, suggesting that persistent DNA 
damage is unlikely to be the proximal cause of diplotene oocyte losses in 
chromosomally abnormal mice. I also show that oocytes with asynapsed 
accessory (i.e. supernumerary) chromosomes are not eliminated during 
diplonema, suggesting that asynapsis per se is not sufficient to cause germ 
cell loss. In support of the meiotic silencing model of germ cell loss, I find 
that deletion of the meiotic silencing factor H2afx prevents diplotene oocyte 
elimination in XO females. I show that meiotic silencing is less robust in 
oocytes compared to spermatocytes, and that this may be associated with 
sex-specific differences in the epigenetics of meiotic silencing. Finally, I 
report on the meiotic characterization of Brca1 and Hormad2 mutant mouse 
models, and in doing so ascribe critical roles for them in the meiotic 
silencing pathway. Together, these studies inform a meiotic silencing-based 
mechanism of prophase I surveillance against asynapsis. 
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1 Introduction 
Aneuploidy is a common chromosome abnormality in humans, affecting 
7-10% of clinically recognized pregnancies (Hunt and Hassold, 2008). Many 
aneuploid conditions, such as Turner syndrome (chromosome X monosomy; 
XO), are associated with germ cell loss and infertility (Burgoyne et al., 2009). 
The underlying molecular basis for germ cell loss associated with 
chromosome abnormalities is still not well understood (Hall et al., 2006). 
The primary goal of this thesis is to examine and characterize the 
mechanisms that respond to chromosome abnormalities and lead to germ 
cell losses.  
1.1 Mammalian meiosis: an overview 
Meiosis is an integral step of gametogenesis, the process of forming 
mature eggs and sperm for reproduction (Handel and Schimenti, 2010). 
Meiosis is characterized by one round of DNA replication, an extended 
prophase I stage, and two successive cell divisions (Intro Figure 1). Meiotic 
prophase I consists of several meiosis-specific events that are essential for 
the production of viable gametes. Two such events are the physical pairing 
of maternal and paternal homologous chromosomes, called synapsis, and 
the reshuffling of genetic material between them by meiotic recombination 
(Bolcun-Filas and Schimenti, 2012). Together, these events result in the 
establishment of crossovers (CO) between homologs, which are required for 
accurate chromosome segregation (Bolcun-Filas and Schimenti, 2012). 
Additionally, meiotic recombination creates new genetic combinations from 
maternal and paternal genomes.  
During metaphase I, homologous chromosomes align at the 
equatorial plate in a bi-oriented fashion (Handel and Schimenti, 2010). 
Chromosome bi-orientation ensures that homologs are segregated faithfully 
into different daughter cells during the first meiotic division (Wang and Sun, 
2006). The first division yields two daughter cells, each with one 
chromosome (two chromatids) from every homologous pair. These 
daughter cells then undergo meiosis II, which involves the alignment of 
 12 
paired sister chromatids, followed by their separation into two more 
daughter cells. At the end of one cycle of meiosis, genetically unique haploid 
gametes are produced (Handel and Schimenti, 2010). 
1.1.1 Developmental timing and duration of meiosis 
The timing and duration of meiosis vary widely between different 
species and even between sexes (Intro Figure 1). In mammals, male 
meiosis occurs in a series of uninterrupted steps beginning during early 
post-natal life. In juvenile male mice, the first subset of germ cells enters 
meiosis at 10.5 dpp and completes meiotic prophase I at 21 dpp (Cohen et 
al., 2006). At 21 dpp, spermatocytes enter metaphase I and subsequently 
progress through meiosis I and meiosis II. Following the second meiotic 
division, male germ cells undergo significant morphological changes in a 
process called spermiogenesis (for review see (Jan et al., 2012)). By 27 dpp, 
mature sperm (i.e. spermatozoa) are formed, and continuous cycles of 
meiosis ensue thereafter (Cohen et al., 2006). Therefore, at the end of each 
cycle each germ cell produces four haploid spermatozoa.  
By contrast, female meiosis – the main focus of this thesis – takes 
place predominantly during embryonic development and occurs over a 
significantly longer timeframe (Intro Figure 1). Meiotic prophase I begins 
at 13 days post coitum (dpc), and germ cells reach pachynema by 17 dpc 
(Speed, 1982). Oocytes complete prophase I by 21 dpc (i.e. 1-2 days post 
partum (dpp)), and soon after enter an extended arrest period called the 
dictyate stage (Pepling and Spradling, 2001; Speed, 1986). Dictyate oocytes 
remain quiescent until sexual maturation (6-8 weeks old in mouse), after 
which point a subset of arrested oocytes re-enter meiosis at each estrus 
cycle (Morelli and Cohen, 2005). These ovulated oocytes undergo the first 
meiotic division, extruding a polar body in the process, and then temporarily 
arrest again before metaphase II (Morelli and Cohen, 2005). Upon 
fertilization, these oocytes resume meiosis and complete the final meiotic 
division, extruding another polar body. In contrast to male meiosis, female 
meiosis produces only one haploid oocyte per cycle.   
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Introduction Figure 1: Meiosis in male and female mice.  
(a) Overview of male mouse meiosis. In mice, the first wave of male meiosis 
occurs at 10.5 days post partum (dpp), when a spermatogonium duplicates 
its DNA. Prophase I, subdivided into leptonema, zygonema, pachynema, and 
diplonema, occurs over the subsequent 10 days. From leptonema to 
zygonema, components of the synaptonemal complex begin to form, leading 
to synapsis of paternal (blue) and maternal (orange) homologs at 
pachynema. The heterologous X and Y chromosomes achieve only partial 
synapsis at the pseudoautosomal region (PAR). Recombination between 
homologs during pachynema leads new genetic combinations. 
Chromosomes desynapse at diplonema, remaining physically attached at 
sites of crossing over, called chiasmata. Metaphase I (MI) is achieved by 21 
dpp and results in separation of homologs into two secondary 
spermatocytes. The second meiotic division divides the sister chromatids to 
form four haploid spermatids. Spermatids then undergo spermiogenesis to 
produce spermatozoa. This process occurs continuously throughout male 
reproductive lifespan. (b) Overview of female mouse meiosis. In mice, all 
oogonia enter prophase I at 13.5 dpc. Prophase I occurs in one synchronous 
wave over the next 7-8 days, at which point primary oocytes arrest at the 
dictyate growth stage. Cohorts of arrested oocytes re-enter meiosis I at each 
estrus cycle, leading to the first meiotic division and the formation of a 
secondary oocyte and one polar body. This secondary oocyte arrests at 
metaphase II and only resumes meiosis II at fertilization, if such should 
occur. Fertilization triggers the second meiotic division and formation of 
another polar body. The fertilized egg then gives rise to a diploid embryo.   
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Unlike in mouse, where meiosis progression is synchronous, 
initiation of female meiotic prophase I in humans occurs over a broader 
period of time (Gondos et al., 1971). The first cohort of oocytes enter 
prophase I at week 12 of gestation, while the remaining oocytes enter 
prophase I over the subsequent 18 weeks (Gondos et al., 1971).  By birth, 
most oocytes have completed prophase I and entered the dictyate stage 
(Gondos et al., 1971). Compared to the mouse, female meiosis in humans is 
less synchronous and much more challenging to study. The mouse, 
therefore, is a commonly used experimental model for studying mammalian 
meiosis.    
1.1.2 Meiotic prophase I events: an overview 
One goal of meiotic prophase I is to form physical connections, called 
chiasmata, between maternal and paternal homologous chromosomes. 
Chiasmata are formed from COs made during meiotic recombination, and 
they are a prerequisite for faithful chromosome segregation at metaphase I 
(Cohen et al., 2006). Another important consequence of meiotic 
recombination is the creation of new allelic combinations from parental 
genomes, leading to genetic diversity (Bolcun-Filas and Schimenti, 2012).  
Prophase I is divided into four sub-stages: leptonema, zygonema, 
pachynema, and diplonema (Intro Figure 1). First, DNA is replicated during 
meiotic S phase (Lima-de-Faria and Borum, 1962). Then, at leptonema, 
programmed DNA double-strand breaks (DSBs) are introduced throughout 
the germ cell genome (Cohen and Pollard, 2001). These DNA DSBs are the 
substrates for meiotic recombination and are essential for prophase I 
progression (Baudat et al., 2000; Romanienko and Camerini-Otero, 2000).  
During zygonema, the second stage of prophase I, homologous 
chromosomes begin to physically pair in a process called synapsis (Handel 
and Schimenti, 2010). Synapsis is mediated by a multi-partite proteinaceous 
structure called the synaptonemal complex (SC) (Fraune et al., 2012). 
During this process of synapsis, the intimate association of homologs allows 
for DNA DSBs to be repaired via homologous recombination (Handel and 
Schimenti, 2010). At pachynema, homologous chromosomes are fully 
 15 
synapsed along their lengths. At diplonema, the SC breaks down in a process 
called desynapsis, but homologs remain physically connected at chiasmata.  
1.1.3 Aneuploidy and meiotic errors 
Aneuploidy is the state of having an abnormal number of 
chromosomes, such as an extra chromosome or a missing chromosome. It 
does not, however, include states in which an organism or cell has a change 
in the number of complete sets of chromosomes. Aneuploidy can result from 
non-disjunction of chromosomes during meiosis I or meiosis II (Intro 
Figure 2a-e).  
In humans, the most prevalent class of aneuploidies involves the sex 
chromosomes (Hall et al., 2006). In males, the most common sex 
chromosome aneuploidies are 47,XXY (Klinefelter syndrome; 0.1%) and 
47,XYY (Double Y syndrome; 0.1%) (Heard and Turner, 2011). In females, 
the most common sex chromosome abnormality is 46,XO (Turner 
syndrome; 0.04%) (Heard and Turner, 2011). Sex chromosome aneuploidies 
more commonly arise from XY non-disjunction occurring in the paternal 
germ line (Hall et al., 2006). For example, sex chromosome non-disjunction 
can produce sperm harboring both the X and Y chromosomes or no sex 
chromosomes, which can result in several different sex chromosome 
aneuploidy conditions (Intro Figure 2d,e).    
On the other hand, most autosomal trisomies, such as Trisomy 21 
(i.e. Down syndrome; 47,XX/XY+21; 0.1%) result from non-disjunction 
occurring in the maternal germ line (Hassold and Hunt, 2001; Shin et al., 
2009). Trisomy 21 arises due to non-disjunction related to improper 
crossover positioning and/or loss of sister chromatid cohesion. 
Chromosome crossovers that form too proximal or too distal to the 
centromere are thought predispose germ cells to non-disjunction (Lynn et 
al., 2004). Increasing maternal age also predisposes to chromosome non-
disjunction due to progressive deterioration of the cohesin complex that 
maintains sister chromatids cohesion (Herbert et al., 2015). This mechanism 
is thought to be responsible for the majority of human trisomy 21 
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conceptions from older women however there is likely interaction between 
the advancing age and crossover positioning risk factors (Oliver et al., 2008). 
Aneuploidy in germ cells presents major challenges during meiosis 
(Jones and Lane, 2013). For example, if one chromosome is missing, as in 
Turner syndrome (46,XO), there is no homolog for the univalent 
chromosome to synapse with or repair its DNA DSBs from during prophase 
I. An unpaired chromosome, therefore, cannot generate chiasmata, leading 
to non-disjunction and the subsequent development of aneuploid gametes 
(Intro Figure 2) (Hodges et al., 2001). Similarly, meiotic events can be 
disrupted if one chromosome exists in too many copies, as in Down 
syndrome (47,XX/XY+21) (Hall et al., 2006).  In summary, meiotic errors 
and aneuploidies are intimately related (Hall et al., 2006; Hassold and Hunt, 
2001). 
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Introduction Figure 2: Meiotic non-disjunction and aneuploidy. 
(a) Normal disjunction during meiosis I and II. Each meiosis product has one 
copy of each chromosome, which can generate euploid embryos. (b) 
Autosomal non-disjunction at meiosis I. Half the products have two 
complements of one autosome, which leads to trisomic embryos. The other 
half are missing this autosome, resulting in monosomic embryos. (c) 
Autosomal non-disjunction at meiosis II. One product contains two copies of 
an autosome, leading to trisomies. Another product is missing the autosome, 
leading to monosomies. (d) Meiosis I non-disjunction of the XY 
chromosomes. Half of the products contain both X and Y chromosomes, 
leading to XXY embryos, and the other half contain no sex chromosome, 
leading to XO embryos. (e) Two cases of XY non-disjunction during MII. In 
the first case, there is non-disjunction of the X chromosomes, resulting in 
XXX and XO embryos. In the second case, there is non-disjunction of the Y 
chromosomes, leading to XYY and XO embryos. Red indicates aneuploid 
conditions.   
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1.1.4 Meiotic surveillance mechanisms: an overview 
In order to minimize potentially deleterious meiotic errors that could 
lead to aneuploidies, germ cells have developed a system of checks and 
balances, called meiotic surveillance mechanisms. These are cellular 
pathways that actively monitor the fidelity of meiotic events (MacQueen and 
Hochwagen, 2011). Meiotic quality control mechanisms are triggered by 
specific meiotic defects, such as asynapsed chromosomes (Burgoyne et al., 
2009), persistent unrepaired DNA DSBs (Di Giacomo et al., 2005), and 
improper meiotic spindle tension (Sun and Kim, 2012). By eliminating 
defective germ cells, surveillance mechanisms prevent the formation of 
aneuploid gametes and offspring. However, these mechanisms can also have 
deleterious reproductive consequences, including infertility, if they cause 
total germ cell elimination. Therefore, studying the surveillance mechanisms 
that operate in mammals has important implications for our understanding 
of aneuploidy and infertility.  
Surveillance mechanisms operate at several different developmental 
points during meiosis. One important quality control mechanism, called the 
spindle assembly checkpoint (SAC), operates at metaphase I and monitors 
the tension of microtubule attachments to kinetochores of homologous 
chromosomes (Sun and Kim, 2012). The SAC is activated when a 
kinetochore is unattached or when there is loss of tension, and it arrests the 
germ cell until chromosomes are properly aligned (Sun and Kim, 2012).  
Interestingly, in mammals, the stringency of the SAC is sexually 
dimorphic, being more sensitive to tension defects in males than in females 
(Hunt and Hassold, 2002; Nagaoka et al., 2011). The reduced stringency of 
the SAC in oocytes may explain why autosomal trisomies are predominately 
maternally derived (Hall et al., 2006; Hunt and Hassold, 2002). The precise 
reason for the SAC sexual dimorphism remains unclear.   
In addition to the SAC, other important surveillance mechanisms 
operate earlier in germ cell development, particularly during meiotic 
prophase I. While the details of these mechanisms remain to be worked out 
in mammals, they are believed to monitor important prophase I events, 
including chromosome synapsis and meiotic DNA repair (Burgoyne et al., 
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2009; Di Giacomo et al., 2005), similar to what has been described in other 
organisms (MacQueen and Hochwagen, 2011).  
Like the SAC, there is some evidence that the prophase I surveillance 
mechanism is less stringent in females than males (Di Giacomo et al., 2005). 
Despite the importance of meiotic prophase I surveillance mechanisms, the 
molecular details of these pathways remain poorly understood. Identifying 
and characterizing prophase I surveillance mechanisms in mammals is a 
major aim of this thesis. 
1.2 Meiotic DNA double-strand breaks and repair 
One of the earliest events in mammalian meiosis is the formation of 
programmed DNA DSBs throughout the genome (Baudat et al., 2013). This 
process initiates meiotic recombination, facilitates homologous 
chromosome synapsis, and helps create new genetic combinations from 
parental genomes. However, persistent unrepaired meiotic DSBs are 
deleterious, and have been implicated as a trigger of a prophase I 
surveillance mechanism (Di Giacomo et al., 2005). Therefore, a detailed 
discussion of meiotic DNA DSB metabolism is important for understanding 
prophase I quality control.  
1.2.1 Meiotic DNA DSBs initiation 
During leptonema of prophase I, programmed DNA DSBs are 
generated by the topoisomerase II-like enzyme sporulation-specific 11 
(SPO11) (Baudat et al., 2000; Keeney et al., 1997; Romanienko and 
Camerini-Otero, 2000). SPO11 is a highly evolutionarily conserved protein 
(Keeney, 2008) that is expressed predominantly in germ cells (Metzler-
Guillemain and de Massy, 2000; Shannon et al., 1999).  
In mice, Spo11 has two primary alternative splice transcripts, Spo11 
and Spo11 (Bellani et al., 2010). In spermatocytes, SPO11β is expressed in 
early prophase I, implicating it as the major isoform for DNA DSB formation 
at leptonema (Bellani et al., 2010; Kauppi et al., 2011). By contrast, the 
smaller SPO11 isoform, SPO11α (exon 2 skipped), is expressed later in 
prophase I, during pachynema and diplonema, and recent work suggests 
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that SPO11α may be involved in DNA DSB formation on the small region of 
homology shared between the X and Y chromosomes, called the 
pseudoautosomal region (PAR) (Kauppi et al., 2011). Mice that express only 
the Spo11β isoform have normal numbers of nuclear DNA DSBs at 
leptonema, but reduced numbers of X-Y PAR-associated DNA DSBs (Kauppi 
et al., 2011). This suggests that Spo11α and Spo11β have temporally and 
functionally distinct roles during meiosis.      
Deletion of Spo11 in mice leads to infertility in both sexes (Baudat et 
al., 2000; Romanienko and Camerini-Otero, 2000). Phenotypically, Spo11-/- 
mice do not form programmed DNA DSBs at leptonema, and consequently 
have severe chromosome asynapsis at late zygonema-pachynema (Baudat et 
al., 2000; Romanienko and Camerini-Otero, 2000). Therefore, SPO11-
dependent DNA DSBs are required for homologous chromosome synapsis in 
mouse.  
In mice, Spo11-/- spermatocytes fail to progress beyond the mid-
pachytene stage (Baudat et al., 2000; Romanienko and Camerini-Otero, 
2000). By contrast, in Spo11-/- females, oocyte arrest occur later, with some 
oocytes reaching diplonema (Baudat et al., 2000). Nevertheless, at birth 
Spo11-/- females have 40% fewer oocytes than wildtype females (Di 
Giacomo et al., 2005), indicating that a substantial wave of oocytes are 
eliminated during prophase I. The remaining oocytes in Spo11-/- females 
are subsequently eliminated over several weeks after birth, resulting in 
infertility (Baudat et al., 2000; Di Giacomo et al., 2005).   
1.2.2 Distribution of meiotic DNA DSBs 
SPO11-induced DNA DSBs are non-randomly distributed, occurring 
at higher frequencies in specific regions of the genome called “hot spots” 
(Paigen and Petkov, 2010). In mice, hotspots are defined by PR domain-
containing 9 (PRDM9) (Baudat et al., 2010; Mihola et al., 2009; Parvanov et 
al., 2010; Smagulova et al., 2011). PRDM9 is a meiosis-specific histone H3 
methyltransferase, which adds methyl moieties to histone H3. Consistent 
with PRDM9’s role in designating DNA DSB locations, studies using 
chromatin immunoprecipitation with sequencing (ChIP-seq) have shown 
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that hotspot co-localize with sites of histone H3 trimethylation at lysine 4 
(H3K4me3) (Smagulova et al., 2011).  
The zinc finger domain of Prdm9 is critical for determining hotspot 
location (Grey et al., 2011). Mutating the zinc finger array alters the genomic 
location of DNA DSB hotspots and H3K9me3 marks (Grey et al., 2011). The 
current model for meiotic DNA DSB initiation posits that PRDM9 first binds 
to specific regions of the genome determined by its zinc finger domain 
where it then generates H3K4me3 marks, which in turn recruit SPO11 to 
generate DNA DSBs (Brick et al., 2012).  
1.2.3 Regulation of meiotic DNA DSB formation 
Faithful segregation of chromosomes requires that at least one CO be 
generated on each homologous chromosome pair.  Regulating the number of 
DNA DSBs introduced in the genome is referred to as DSB homeostasis. The 
goal of DSB homeostasis is to ensure that neither too few nor too many DNA 
DSBs are generated, both of which could have deleterious outcomes (Lange 
et al., 2011).  
In mouse, on average 200-300 DNA DSBs per nucleus are generated 
during early prophase I (Cole et al., 2012). This is 10x in excess the number 
of crossovers formed (20-25 CO events per nucleus) (Moens et al., 2002). 
This indicates that the vast majority of meiotic DNA DSBs resolve as non-
crossover (NCO) products rather than CO products (Cole et al., 2012). 
Furthermore, while individual germ cells show variability in the number of 
DNA DSBs, the number of COs is held constant (Cole et al., 2012). A high 
ratio of meiotic DNA DSBs to COs is also observed in other organisms, 
including humans (150 DSBs), Saccharomyces cerevisiae (140-170 DSBs), 
and Arabidopsis thaliana (230 DSBs) (Cole et al., 2012). Therefore, DNA DSB 
homeostasis is highly conserved.  
What factors are involved in meiotic DSB homeostasis? Recently, the 
kinase ataxia telangiectasia mutated (ATM) was implicated in inhibiting 
DNA DSB formation in the vicinity of existing DNA DSBs (Lange et al., 2011). 
This model is consistent with the phenotype of Atm-deficient mice, which 
show higher than normal numbers of meiotic DNA DSBs (Lange et al., 2011). 
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A similar role for ATM has been described in S. cerevisiae (Zhang et al., 
2011) and Drosophila melangastor (Joyce et al., 2011), suggesting an 
evolutionarily conserved function for ATM in limiting DNA DSB numbers. 
While the mechanism of ATM-dependent homeostasis is unclear mammals, 
a recent study in yeast has shown that ATM promotes phosphorylation of 
Rec114 meiotic recombination protein (Rec114), which in turn inhibits 
further DNA DSB formation (Carballo et al., 2013). This mechanism is likely 
important because having too many DNA DSBs can create genomic damage. 
There also appear to be mechanisms that promote DNA DSB 
formation during meiosis. In the case of the X and Y chromosomes in 
mammals, crossing over is limited to a small region of X-Y homology, the 
PAR (Burgoyne, 1982). Insufficient DNA DSBs within the PAR can result in 
failed CO formation and X-Y non-disjunction. Spo11is thought to induce 
DNA DSBs on the PARs of the X and Y chromosomes, thereby ensuring that 
sufficient breaks are generated for CO formation (Kauppi et al., 2013). 
Furthermore, in S. cerevisiae a group of factors called ZMM proteins are 
involved in complex feedback loops that coordinate homolog engagement 
with meiotic DNA DSB formation (Thacker et al., 2014). In summary, meiotic 
DNA DSBs are tightly controlled temporally, quantitatively, and spatially.  
1.2.4 Repair of DNA DSBs by homologous recombination 
In somatic cells, DNA DSBs are repaired predominantly via non-
homologous end-joining (NHEJ). During meiosis, however, DNA DSBs are 
repaired via homologous recombination (HR) (Andersen and Sekelsky, 
2010). Components of the NHEJ pathway are down-regulated during 
meiosis, leaving HR as the default repair pathway (Goedecke et al., 1999). 
HR is the preferred repair mechanism in meiosis because it is less error 
prone than NHEJ and it generates the necessary COs between homologs 
(Andersen and Sekelsky, 2010).  
Meiotic DNA DSBs are catalyzed by SPO11 via endonuclease cleavage 
of DNA (Keeney et al., 1997). This results in SPO11 covalently bound to the 
break site (Intro Figure 3). Processing first involves cleavage of SPO11-
DNA complex (Neale et al., 2005). This reaction is mediated by the MRN 
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complex, composed of MRE11 meiotic recombination 11 (MRE11), RAD50 
homolog (RAD50), and Nibrin (NBS1), as well as other factors such as the 
nuclease retinoblastoma binding protein 8 (RBBP8, CTIP) (Farah et al., 
2009; Hartsuiker et al., 2009; Milman et al., 2009).  
After SPO11 removal, the 5’-end of the break is resected by 
exonucleases, including CTIP and exonuclease 1 (EXO1), to form 3’ single-
stranded DNA (ssDNA) overhangs (Intro Figure 3) (Farah et al., 2009; Sun 
et al., 1991). These ssDNA ends then invade the neighboring intact DNA 
molecule on the homologous chromosome, catalyzed by DNA strand 
exchange proteins RAD51 and disrupted meiotic cDNA1 (DMC1) (Neale and 
Keeney, 2006). RAD51/DMC1-ssDNA nucleoprotein filaments support DNA 
homology search and strand invasion of the intact homolog, and results in 
the formation a heteroduplex intermediate called the displacement loop (D-
loop) (Hunter and Kleckner, 2001). 
After D-loop formation, the resected DNA strand is then 
resynthesized using the homolog as a template (Intro Figure 3) (Neale and 
Keeney, 2006). Finally, the DNA DSB is resolved into either a CO or NCO 
(Neale and Keeney, 2006). Resolution into a CO involves formation of an 
intermediate structure called the double Holliday junction (dHJ) (Collins and 
Newlon, 1994; Schwacha and Kleckner, 1994, 1995). By contrast, NCOs are 
generated through synthesis-dependent strand annealing (SDSA) (McMahill 
et al., 2007), where the re-synthesized strand is displaced from the intact 
homolog and re-anneals with the complementary end of its original 
homolog (Andersen and Sekelsky, 2010). The factors that control the 
decision to resolve DNA DSBs as COs or NCOs are not well understood 
(Guillon et al., 2005).  
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Introduction Figure 3: Meiotic homologous recombination. 
Meiotic homologous recombination begins with introduction of DNA DSBs 
on a parental molecule by the enzyme SPO11. The SPO11-DNA complex is 
cleaved by the MRN complex and CTIP, and the free DNA ends are then 
resected 5’-to-3’ by exonucleases, leaving 3’ overhangs. With the aid of 
single stranded DNA binding proteins DMC1 and RAD51, the 3’ overhang 
then invades the neighboring molecule, forming a D loop. In the canonical 
recombination pathway, the second end is captured leading to the formation 
of a double Holliday junction, which is processed to a crossover or a non-
crossover. In an alternative recombination pathway, called synthesis-
dependent strand annealing, the extended D loop is dissolved and the newly 
synthesized strand reanneals with the second end of the DSB, resulting in 
non-crossover product.  
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1.2.5 DNA DSB cytological analysis by chromosome spreads 
In yeast, meiotic DNA DSB events such as initiation and repair can be 
analyzed directly using established biochemical assays (Murakami and 
Keeney, 2008). However, these techniques are less feasible in mouse due to 
low bioavailability of meiotic tissue and higher cellular heterogeneity. More 
commonly, meiotic DNA DSBs are studied indirectly in mice using surrogate 
markers of DNA DSBs, such as DNA repair proteins (Moens et al., 2002). A 
common method to visualize meiotic events, such as DNA DSB repair, is 
called meiotic chromosome spreads (Peters et al., 1997). This involves 
permeablizing and fixing germ cell nuclei onto glass slides, followed by 
antibody-mediated immunofluorescence to detect meiotic proteins (Peters 
et al., 1997). Fluorescence microscopy is then used to visualize the staining 
pattern of immunofluorescently-labeled proteins within individual germ cell 
nuclei (see Materials and Methods for more details).  
Meiotic chromosome spreads have greatly advanced our 
understanding of mouse meiosis. For example, chromosome spreads have 
allowed for estimation of DNA DSB numbers, by quantifying foci of DNA 
repair proteins, especially RAD51 and DMC1 (Tarsounas et al., 1999). This 
approach has also provided a wealth of information about the timing of 
events and proteins involved in meiotic processes. In this thesis, I used 
meiotic chromosome spreads to answer important questions about meiotic 
DNA DSB repair and meiotic prophase I surveillance. 
1.2.6 Meiotic DNA DSB repair proteins 
H2AFX and its interacting proteins 
One of the earliest markers of DNA DSBs in meiotic and mitotic cells 
is the serine-139 phosphorylated histone H2A family member X (H2AFX) 
(Mahadevaiah et al., 2001; Rogakou et al., 1998) (Table 1). H2AFX is a 
ubiquitously expressed histone variant, making up approximately 25% of 
histone H2A (Redon et al., 2002), and it is enriched in germ cell nuclei 
compared to other tissues (Mahadevaiah et al., 2001).  
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Early studies have shown that upon induction of DNA DSBs by laser, 
H2AFX becomes rapidly phosphorylated at serine-139 within the carboxy-
terminal SQ motif (Rogakou et al., 1998). Immunocytologically, this appears 
as discreet foci of H2AFX (Pilch et al., 2003; Rogakou et al., 1999). In 
mammalian cells, H2AFX accumulates in the nearby chromatin up to a 
megabase around DNA DSBs, forming large domains (Rogakou et al., 1999; 
Shroff et al., 2004). H2AFX domains have been hypothesized to create a 
chromatin microenvironment suitable for DNA DSB repair (Srivastava et al., 
2009).  
In eukaryotes, ATM is involved in phosphorylation of histone protein 
H2AFX at serine-139 in response to DNA DSBs (Burma et al., 2001). 
However, H2AFX can also be phosphorylated by other kinases, including 
ataxia telangiectasia and Rad3-related (ATR) and DNA-dependent protein 
kinase (DNA-PKcs) (Wang et al., 2005a).  
 Much of our understanding of H2AFX in the context of DNA DSB 
repair has been gained from studies of mitotic mammalian cells and yeast 
cells. Such studies have shown that H2AFX recruits a downstream DNA 
damage response (DDR) protein called mediator of checkpoint signaling 1 
(MDC1) (Stucki et al., 2005). H2AFX-MDC1 complexes promote retention 
and amplification of additional downstream DDR factors at DNA DSB sites. 
These DDR proteins include ATM, NBS1, breast cancer 1 (BRCA1), and p53 
binding protein 1 (53BP1) (Bekker-Jensen et al., 2005; Lukas et al., 2004; 
Paull et al., 2000; Stucki et al., 2005).  
 Other studies have implicated H2AFX in the recruitment of cohesion 
to DNA DSBs (Unal et al., 2004) and maintenance of checkpoint arrest until 
DNA DSB repair is complete (Fillingham et al., 2006). In yeast, H2AFX is 
involved in recruitment of chromatin modifiers (Downs et al., 2004). In 
summary, H2AFX has multiple roles in DNA DSB repair, including 
modifying chromatin structure and promoting the recruitment, retention, 
and amplification of downstream DNA DSB repair proteins.   
 In mitotic cells, upon completion of DNA DSB repair H2AFX is 
dephosphorylated by protein phosphatase 2A (Chowdhury et al., 2005). This 
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dephosphorylation event is necessary for recovery from the checkpoint 
arrest established by H2AFX (Keogh et al., 2006).  
Despite its myriad roles in DDR, H2afx is not necessary for viability of 
cells or animals (Bassing et al., 2002; Celeste et al., 2002). Nevertheless, 
H2afx-/- mice show growth retardation, immune deficiencies, cancer 
predisposition, and male-specific sterility (Celeste et al., 2002). H2afx-/- 
cells have genomic instability and DNA repair defects (Bassing et al., 2002; 
Celeste et al., 2003b), including impaired recruitment of NBS1, 53BP1, and 
BRCA1, but not RAD51, to irradiation-induced DNA DSBs (Bassing et al., 
2002; Celeste et al., 2002).  
H2afx heterozygous mice also have a phenotype, specifically genomic 
instability and increased predisposition to cancer in a p53-deficient 
background (Celeste et al., 2003a; Srivastava et al., 2009). Furthermore, 
H2afx mutations and copy number variations are implicated in human 
cancers (Parikh et al., 2007; Srivastava et al., 2008). In summary, H2AFX is 
critical for a proper DDR in mitotic cells and mutations in H2afx have 
deleterious genomic consequences. 
Despite these studies, the role of H2AFX in meiosis is less well 
understood. Importantly, H2afx-/- male mice are sterile and experience a 
germ cell arrest at mid-pachynema (Celeste et al., 2002), suggesting that 
H2AFX has an important meiotic function. By contrast, H2afx-/- female mice 
are fertile, but have reduced litter sizes (Celeste et al., 2002). This suggests 
that H2AFX’s essential meiotic role is limited to spermatogenesis. A reduced 
litter size in H2afx-/- females may reflect embryo loss during pregnancy or a 
reduction in oocytes ovulated, but this has yet to be worked out.  
In leptotene-staged germ cells, H2AFX diffusely stains the chromatin 
of germ cell nuclei (Mahadevaiah et al., 2001). This staining pattern 
disappears in Spo11-/- spermatocytes, indicating that leptotene H2AFX is a 
direct response to SPO11-induced DNA DSB formation (Mahadevaiah et al., 
2001). Leptotene H2AFX-staining is also disrupted in Atm-/- mice (Bellani 
et al., 2005), implicating ATM as the primary kinase involved in H2AFX 
phosphorylation in response to meiotic DNA DSB formation (Burma et al., 
2001).  
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This diffuse nuclear H2AFX staining disappears with chromosome 
synapsis, when meiotic DNA DSBs are repaired, during zygonema 
(Mahadevaiah et al., 2001). In spermatocytes, however, there is a second 
wave of H2AFX, which occurs during pachynema to late diplonema. During 
this period, H2AFX accumulates throughout the chromatin of the X and Y 
chromosomes (Mahadevaiah et al., 2001). Unlike the first wave, which is 
driven by ATM, this second wave of H2AFX formation is predominately 
mediated by the kinase ATR (Royo et al., 2013). As discussed later, this sex 
chromosome-associated H2AFX is necessary for meiotic silencing of the sex 
chromosomes, called meiotic sex chromosome inactivation (MSCI) 
(Fernandez-Capetillo et al., 2003). 
Despite its role in DNA DSB repair in somatic cells, H2AFX does not 
appear to be essential for meiotic DNA DSB repair. H2afx-/- females are 
fertile (Celeste et al., 2002), which would not be expected if H2AFX had an 
essential role in meiotic DNA DSB repair. For example, DNA DSB repair 
proteins such as RAD51 are not affected by H2afx deletion (Fernandez-
Capetillo et al., 2003). Furthermore, autosomal synapsis, which is often 
disrupted when DNA DSB is compromised, is not defective in H2afx-/- 
spermatocytes (Fernandez-Capetillo et al., 2003). By contrast, the X and Y 
chromosomes frequently fail to synapse at the PAR (Fernandez-Capetillo et 
al., 2003), again suggestive of a role for H2AFX in sex chromosome events.  
RAD51, DMC1, and RPA 
The recombinases RAD51 and DMC1 are highly conserved proteins 
involved in meiotic DNA DSB repair (Handel and Schimenti, 2010) (Table 
1). RAD51 and DMC1 together form ssDNA-protein filaments that facilitate 
strand invasion during homologous recombination (Neale and Keeney, 
2006). Since they represent early intermediates in homologous 
recombination, RAD51 and DMC1 are frequently used as surrogate markers 
to monitor the DNA DSB repair process (Tarsounas et al., 1999). 
Immunocytologically, RAD51 and DMC1 form distinct foci on asynapsed 
chromosome axes in germ cell nuclei at zygonema, and foci on asynapsed 
chromosomes during pachynema (Moens et al., 2002). Furthermore, ChIP-
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seq using anti-RAD51 antibodies has been performed to map meiotic 
hotspots throughout the genome in germ cells (Smagulova et al., 2011).   
Unlike RAD51, which is expressed in both somatic and germ cells 
(Lim and Hasty, 1996), DMC1 is a meiosis-specific recombinase (Bishop et 
al., 1992). In mouse, DMC1 is required for proficient repair of DNA DSBs 
during meiosis (Pittman et al., 1998; Yoshida et al., 1998). Dmc1-/- 
spermatocytes have persistent RAD51 foci (Pittman et al., 1998) and 
persistent diffuse H2AFX staining at early/mid-pachynema (Mahadevaiah 
et al., 2008), indicating stalled DNA DSB repair. Dmc1-/- mice also have 
extensive chromosome asynapsis, germ cell apoptosis, and infertility in both 
sexes (Pittman et al., 1998; Yoshida et al., 1998). By contrast, Rad51 deletion 
is embryonic lethal in mice, challenging efforts to understand its precise 
meiotic function (Lim and Hasty, 1996). 
The ssDNA-binding protein replication protein A (RPA) also forms 
foci in close proximity to RAD51 and DMC1 (Moens et al., 2002). RPA is a 
three-protein complex comprising the subunits RPA1, RPA2 and RPA3 
(Wold, 1997). During homologous recombination, RPA loads onto newly 
formed 3’ ssDNA tails before RAD51 and DMC1, where it also helps stabilize 
the ssDNA tails and remove secondary structure (Wang and Haber, 2004). 
This event may also facilitate subsequent RAD51 and DMC1 loading to 
ssDNA ends (Wang and Haber, 2004).  
During meiosis, RAD51 and DMC1 foci reach maximum numbers 
between late leptonema and early zygonema (Burgoyne et al., 2007; Moens 
et al., 2002). While RAD51 and DMC1 foci are rapidly depleted from 
chromosome cores following synapsis, RPA foci are also observed on 
synapsed chromosomes (Burgoyne et al., 2007; Moens et al., 2002; Plug et 
al., 1997). In fact, RPA numbers peak between zygonema and pachynema, 
when chromosomes are becoming increasingly synapsed (Moens et al., 
2002; Plug et al., 1997). This post-synaptic localization is thought to 
represent RPA bound to the D-loop intermediate of DNA molecules engaging 
in meiotic homologous recombination (Burgoyne et al., 2007). RPA is 
usually depleted from chromosomes by mid-pachynema (Moens et al., 
2002).  
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BRCA1 
Breast cancer susceptibility gene 1 (BRCA1) is a tumor suppressor 
protein involved DDR and homologous recombination (Moynahan et al., 
1999) (Table 1). Brca1 was first described as a gene that is associated with 
an increased risk to breast cancer (Hall et al., 1990). BRCA1’s role in DNA 
repair is thought to be critical for genomic stability and cancer (Caestecker 
and Van de Walle, 2013).  
Immunocytologically, BRCA1 forms foci at DNA DSB sites in both 
mitotic and meiotic cells (Scully et al., 1997). Similar to RAD51 and DMC1, 
BRCA1 only localizes to pre-synaptic (i.e. asynapsed) chromosomes 
(Mahadevaiah et al., 2008). At leptonema and early zygonema, BRCA1 foci 
co-localize with RAD51 (Mahadevaiah et al., 2008), consistent with a role for 
BRCA1 in DNA DSB repair events. BRCA1 foci disappear once chromosomes 
synapse (Turner et al., 2004).  
In spermatocytes, there is a second wave of BRCA1 staining during 
pachynema to diplonema. At this time, BRCA1 accumulates along the cores 
of asynapsed X and Y chromosome (Turner et al., 2004). Furthermore, if 
autosomal regions are abnormally asynapsed at pachynema, as in 
translocation carriers, they also accumulate BRCA1 (Turner et al., 2005). As 
discussed later, this BRCA1 localization pattern is consistent with a role for 
BRCA1 in meiotic silencing (Turner et al., 2004).  
Mouse embryonic stem cells with mutations in Brca1 show genomic 
instability and defects in homologous recombination (Moynahan et al., 
1999). Single Brca1 null mutations are not compatible with mouse survival 
(Xu et al., 2001).  However, embryo viability can be restored by combining 
Brca1 mutations with mutations in either tumor protein p53 (Tp53, or p53) 
(Xu et al., 2001) or tumor protein p53 binding protein 1 (Tp53bp1, or 53bp1) 
(Bunting et al., 2012). Deletion of exon 11 of Brca1 on a p53+/- background 
(i.e. Brca111 p53+/-) produces viable mice with an increased risk for 
development of mammary tumors (Xu et al., 2001). Exon 11 of Brca1 is 
3.4kb and encodes protein-binding sites for RAD51 and other interacting 
proteins (Deng and Brodie, 2000). Interestingly, Brca111 p53+/- mice have 
male-specific infertility associated with pachytene-stage germ cell arrest (Xu 
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et al., 2003). By contrast, Brca111 p53+/- females are fertile and have no 
germ cell arrest phenotype (Xu et al., 2003).  
According to the original characterization study (Xu et al., 2003), 
Brca111 p53+/- spermatocytes fail to load RAD51 to asynapsed 
chromosomes at leptonema-zygonema, but have normal DMC1 loading (Xu 
et al., 2003). A recent study, however, reported normal localization of 
RAD51 in a Brca1 conditionally deleted mouse model (Brca1cKO) (Broering 
et al., 2014). At early and mid pachynema, when RAD51 is restricted to the X 
and Y chromosomes, there was a slight but significant reduction in RAD51 
foci numbers in Brca1cKO mice and Brca111 53bp1-/- mice (Broering et al., 
2014). Proteins involved in later stages of meiotic DSB repair, including 
MutS homolog 4 (MSH4), which promotes crossover formation at late 
zygonema and pachynema (Kneitz et al., 2000), and MutL homolog 1 
(MLH1), which labels crossovers at pachynema (Edelmann et al., 1996), 
show minor perturbations in Brca1 mutants (Broering et al., 2014). MSH4 
numbers are normal in Brca111 53bp1-/- mice, but somewhat reduced in 
Brca1cKO mice, and MLH1 levels are normal (Broering et al., 2014). 
Together, these data suggest that BRCA1 probably has a minor role in 
meiotic DNA DSB repair events. 
Other DNA repair proteins 
After homologous chromosomes have synapsed, early recombination 
proteins RAD51 and DMC1 are displaced by post-synaptic recombination 
proteins (Moens et al., 2002). These post-synaptic proteins include RPA, as 
discussed above, and others, such as MSH4 and mutS homolog 5 (MSH5) 
(Moens et al., 2002), testis expressed 11 (TEX11) (Adelman and Petrini, 
2008; Yang et al., 2008), and the pro-crossover factor ring finger protein 
212 (RNF212) (Reynolds et al., 2013) (Table 1). MSH4 and MSH5 are 
mismatch repair proteins that are required for chromosome synapsis, 
crossing over, and progression through prophase I (de Vries et al., 1999; 
Edelmann et al., 1999; Kneitz et al., 2000; Tsubouchi et al., 2006). TEX11 is 
required for timely DNA DSB repair, proper synapsis, and CO formation in 
mice (Adelman and Petrini, 2008; Yang et al., 2008). RNF212, while 
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dispensable for chromosome synapsis, is essential for CO formation, 
presumably by stabilizing other CO factors such as MSH4 and MSH5 
(Reynolds et al., 2013). 
In addition to these factors, there are even later recombination 
nodule proteins, including as MLH1 and MutL homolog 3 (MLH3), which 
form complexes on synapsed chromosome cores during mid-pachynema 
(Kolas et al., 2005; Plug et al., 1998), where they are thought to promote CO 
formation (Baker et al., 1996; Lipkin et al., 2002). Mlh1 and Mlh3 deficient 
mice show sterility in both sexes (Baker et al., 1996; Lipkin et al., 2002). 
While synapsis occurs normally at pachynema in Mlh1-/- and Mlh3-/- mice, 
chromosomes desynapse prematurely owing to failed CO formation, leading 
to univalents at diplonema (Baker et al., 1996; Lipkin et al., 2002).  
1.2.7 Meiotic DNA DSBs on the X and Y chromosomes 
In mammalian males, the X and Y chromosomes are largely non-
homologous and remain asynapsed during meiosis except at the PAR 
(Burgoyne, 1982). Both the PAR and the asynapsed regions of the X and Y 
chromosomes are subject to DNA DSBs (Kauppi et al., 2011). Germ cells, 
therefore, must have mechanisms to repair DNA DSBs on asynapsed cores.  
Based on immunocytology, the asynapsed X chromosome 
accumulates RAD51, DMC1, and RPA foci in mouse spermatocytes (Ashley et 
al., 1995; Barlow et al., 1997; Mahadevaiah et al., 2001; Moens et al., 1997; 
Plug et al., 1998; Tarsounas et al., 1999). RAD51 and DMC1 foci are observed 
on the asynapsed X chromosome at zygonema and persist into mid-
pachynema, when RAD51 is no longer present on synapsed autosomes 
(Barlow et al., 1997; Moens et al., 1997; Plug et al., 1998). Interestingly, 
RAD51 and DMC1 foci are rarely observed on the asynapsed region of the Y 
chromosome, but are restricted to the PAR (Kauppi et al., 2011). RPA foci 
persist on the asynapsed X chromosome into mid-late pachynema, i.e. later 
than RAD51 and DMC1 (Plug et al., 1998). By the end of pachynema, 
however, RPA is depleted from asynapsed X chromosome (Plug et al., 1998).  
Therefore, DNA DSB repair is protracted on the asynapsed X 
chromosome compared to autosomes. These delayed kinetics of DNA DSB 
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repair are not limited to the asynapsed X chromosome, but are observed on 
asynapsed autosomes as well. In Tc1 mouse model of Down syndrome 
(O'Doherty et al., 2005), RAD51 persists on the asynapsed human 
chromosome 21 into late pachynema (Mahadevaiah et al., 2008). The reason 
for delayed repair on asynapsed chromosomes is unclear, but may be linked 
to the fact that asynapsed chromosomes are heterochromatic and 
transcriptionally silenced at pachynema (Turner, 2007), since DNA repair is 
influenced by chromatin environment (van Attikum and Gasser, 2009). 
Two different mechanisms have been proposed to facilitate DNA DSB 
repair on asynapsed chromosomes: (1) homologous recombination, using 
the sister chromatid as a template; (2) non-homologous end joining (Inagaki 
et al., 2010). Since components of the NHEJ pathway are suppressed during 
mammalian meiosis (Goedecke et al., 1999), however, it is believed that 
sister chromatid-mediated HR is a key mechanism acting on asynapsed 
chromosomes (Kauppi et al., 2011). However, recent work in C. elegan males 
has shown that DNA DSBs on the hemizygous (i.e. asynapsed) X 
chromosome can be repaired in the absence of HR machinery, indicating 
that other mechanisms, such as an error-prone single-strand annealing 
(SSA) pathway may also operate (Checchi et al., 2014).  
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Table 1. Proteins involved in meiotic DNA DSB events 
 
Protein Function(s) Mouse mutant 
meiotic phenotype 
Reference 
53BP1 Tumor suppressor protein, 
interacts with p53, involved 
in the DNA damage 
response 
Normal fertility (Ward et al., 
2003) 
ATM Kinase involved in 
phosphorylation of H2AFX 
at DNA DSBs, and DNA DSB 
homeostasis 
Asynapsis, 
persistent 
unrepaired DNA 
DSBs 
(Burma et al., 
2001; Lange et 
al., 2011) 
ATR Kinase involved in DNA DSB 
repair, cell cycle 
progression/checkpoints, 
and meiotic silencing 
MSCI defects (Royo et al., 
2013; Traven 
and Heierhorst, 
2005) 
BRCA1 Tumor suppressor protein 
involved in DNA repair, cell 
cycle, and meiotic silencing. 
MSCI defects (Boulton, 2006; 
Turner et al., 
2004) 
DMC1 Meiosis-specific 
recombinase, HR strand 
exchange 
Persistent 
unrepaired DNA 
DSBs, asynapsis 
(Pittman et al., 
1998; Yoshida 
et al., 1998) 
H2AFX Phosphorylated H2AFX 
modification (H2AFX) 
involved in somatic DNA 
DSB repair and meiotic 
silencing 
MSCI failure (Fernandez-
Capetillo et al., 
2003; 
Fillingham et al., 
2006) 
MDC1 DNA repair protein, 
interacts with H2AFX at 
DNA DSBs, necessary for 
meiotic silencing. 
MSCI defects (Ichijima et al., 
2011; Stucki et 
al., 2005) 
MLH1/3 MutL homolog mismatch 
repair proteins, marks 
crossover sites at 
pachynema 
Failed crossover/ 
chiasmata formation 
and premature 
separation of 
homologs, 
metaphase I 
univalents 
(Baker et al., 
1996; Lipkin et 
al., 2002)  
MSH4/5 MutS homolog mismatch 
repair protein  
Aberrant 
chromosome 
synapsis and 
crossing over, 
persistent 
unrepaired DNA 
DSBs 
(de Vries et al., 
1999; Edelmann 
et al., 1999; 
Kneitz et al., 
2000) 
PRDM9 H3 methyltransferase, 
dictates DNA DSB location 
Altered hotspot 
locations, asynapsis, 
unrepaired DNA 
DSBs 
(Baudat et al., 
2010) 
RAD51 Recombinase, HR strand 
exchange 
Not viable (Cloud et al., 
2012) 
RNF212 Pro-crossover protein DNA DSB repair and (Reynolds et al., 
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crossover defects 2013) 
RPA Single-stranded DNA 
binding protein involved in 
DNA repair and strand 
exchange 
Not viable (Sakaguchi et 
al., 2009) 
SPO11 Generates DNA DSBs at 
leptonema 
Failed programmed 
DNA DSB formation, 
asynapsis, MSCI 
failure 
(Keeney et al., 
1997) 
TEX11 MRE11-interacting protein 
required for DNA DSB 
repair and crossing over 
Asynapsis, 
persistant 
unrepaired DNA 
DSBs, MSCI defects 
(Hartsuiker et 
al., 2009) 
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1.3 Meiotic chromosome synapsis 
1.3.1 Synapsis: an overview 
Homologous chromosome synapsis is a critical and highly conserved 
meiotic event during which homologs become physical paired via a 
proteinaceous structure called the synaptonemal complex (SC) (Cohen et al., 
2006). Synapsis begins during zygonema and is completed upon entry into 
pachynema, defined as the stage when homologous chromosomes have 
synapsed along their lengths (Cohen et al., 2006). The SC is composed of 
several meiosis-specific proteins that come together in a zipper-like fashion 
to stabilize homologous chromosomes as one unit, called a bivalent. 
Synapsis is essential for meiotic progression through meiosis and for 
faithful chromosome segregation (Fraune et al., 2012). Defects in synapsis 
result in aneuploid gametes, germ cell arrest, and infertility (Burgoyne et al., 
2009; Wang and Hoog, 2006). In mammals, synapsis and meiotic 
recombination are intimately linked processes: synapsis requires meiotic 
DNA DSBs (Baudat et al., 2000), and efficient repair of DNA DSBs requires 
homologous chromosome synapsis (Fraune et al., 2012). The SC is thought 
to facilitate the formation of COs by keeping homologs in close proximity (de 
Vries et al., 2005; Wang and Hoog, 2006; Yuan et al., 2002).  
Given the importance of the SC, the faithful completion of synapsis is 
monitored by specific, yet currently undefined meiotic surveillance 
mechanisms. In the following section, I will introduce SC morphogenesis and 
homologous chromosome recognition, alignment, and synapsis. My results 
presented later in this thesis sheds important new insight into how synaptic 
defects are monitored in germ cells.  
1.3.2 Components of the synaptonemal complex 
Components of the SC begin forming at leptonema of prophase I 
(Intro Figure 4). At this stage, axial elements (AEs) begin to assemble along 
the length of each chromosome (Fraune et al., 2012). At zygonema, 
homologous chromosomes start to align along their AEs, and gradually 
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synapse via a central region (CR) composed of transverse filaments (TFs) 
and the central elements (CE) (Fraune et al., 2012). At this stage, AEs are 
termed lateral elements (LEs). The mature SC is assembled at pachynema 
when two LEs are connected along their entire lengths by TFs and the CE. 
Chromosomes that have completed SC assembly are considered to have 
synapsed.  
In mammals, the SC is composed of at least seven meiosis-specific 
protein components (Fraune et al., 2012) (Table 2). These components are: 
synaptonemal complex protein 1 (SYCP1), synaptonemal complex protein 2 
(SYCP2), synaptonemal complex protein 3 (SYCP3), synaptonemal complex 
central element protein 1 (SYCE1), synaptonemal complex central element 
protein 2 (SYCE2), synaptonemal complex central element protein 3 
(SYCE3), and testis expressed 12 (TEX12) (Fraune et al., 2012). The AE/LE 
portion of the SC is composed of SYCP3 (Lammers et al., 1994) and SYCP2 
(Offenberg et al., 1998; Yang et al., 2006). The TF is made of SYCP1 
(Meuwissen et al., 1992). The remaining SC components, including SYCE1 
(Costa et al., 2005), SYCE2 (Costa et al., 2005), SYCE3 (Schramm et al., 
2011), and TEX12 (Hamer et al., 2006), are part of the CE. 
1.3.3 Synaptonemal complex assembly and dynamics 
Synapsis entails the pairing of AEs, comprised of SYCP3 and SYCP2, 
and the loading of SYCP1 between them (Handel and Schimenti, 2010). 
Structurally, SYCP1 contains two globular domains separated by a coiled-
coil segment (Ollinger et al., 2005). One globular domains of SYCP1 binds 
the SYCP2-portion of the AE, while the other binds the CE (Liu et al., 1996; 
Tarsounas et al., 1997). In mice, deletion of Sycp1 results in defective 
synapsis and infertility in both sexes (de Vries et al., 2005). Sycp3-/- mice 
have severe defects in SC morphogenesis, meiotic arrest, and male-specific 
infertility (Yuan et al., 2002; Yuan et al., 2000).  
Components of the CE are also critical for SC morphogenesis. SYCE1, 
SYCE2, and SYCE3 interact to form complexes (Costa et al., 2005; Schramm 
et al., 2011), and each component of the CE is required for stability of SYCP1 
(Bolcun-Filas et al., 2007; Bolcun-Filas et al., 2009; Hamer et al., 2008; 
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Schramm et al., 2011). Therefore, components of the SC are highly 
interdependent. 
Unlike AEs, which are visible during all stages of prophase I, the CE 
part of the SC is only present when chromosomes are synapsed (de Vries et 
al., 2005; Yuan et al., 2000). Desynapsis of homologues during diplonema is 
associated with loss of CR proteins, but retention of AE components (Handel 
and Schimenti, 2010). Since SYCP3 is present throughout prophase I, it is a 
commonly used marker to visualize meiotic chromosomes and substage 
germ cells (Cohen et al., 2006).  
In addition to the SC structural components, there is a cohort of 
proteins that localize to the SC in a stage-specific manner. In mouse, two 
such proteins are HORMA-domain containing 1 (HORMAD1) and HORMA-
domain containing 2 (HORMAD2) (Wojtasz et al., 2009). In early prophase I, 
HORMAD1 and HORMAD2 preferentially associate with pre-synaptic 
chromosome axes (Wojtasz et al., 2009). At pachynema, HORMAD1 and 
HORMAD2 are restricted to asynapsed chromosomes, i.e. the asynapsed 
regions of the X and Y chromosomes (Fukuda et al., 2009; Wojtasz et al., 
2009). By contrast, in normal females, since all chromosomes have 
homologs for synapsis at pachynema, HORMAD1 and HORMAD2 are only 
found on pre-synaptic axes (Wojtasz et al., 2009). 
During diplonema, the localization pattern of HORMAD1 and 
HORMAD2 diverge (Wojtasz et al., 2009). At this stage, HORMAD1 
accumulates along the asynapsed regions of the desynapsing chromosomes 
and is retained on the X and Y chromosomes (Fukuda et al., 2009; Wojtasz et 
al., 2009). By contrast, HORMAD2 remains preferentially bound to the X and 
Y chromosomes, but does not label desynapsed axes at diplonema (Wojtasz 
et al., 2009). Therefore, HORMAD2 is a marker that is retained on 
chromosomes that were previously asynapsed at pachynema, whereas 
HORMAD1 localizes to all unsynapsed axes (Wojtasz et al., 2009). 
Deletion of Hormad1 in mice disrupts several meiotic processes and 
results in infertility in both sexes (Daniel et al., 2011; Shin et al., 2010). 
Hormad1-/- mice show defects in synapsis and SC formation, suggesting that 
it is required for SC assembly (Daniel et al., 2011; Shin et al., 2010). 
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Hormad1-/- mice also have reduced numbers of DNA DSBs and lower 
numbers of meiotic recombination protein foci compared to wildtype 
(Daniel et al., 2011; Shin et al., 2010). It is believed that HORMAD1 helps 
coordinate the progression of chromosome synapsis with meiotic 
recombination (Daniel et al., 2011). Under this model, HORMAD1 might 
ensure that there are sufficient numbers of DNA DSBs to engage in 
homology search and synapsis. With homolog engagement, HORMAD1 is 
displaced from the chromosome cores, permitting progression through 
prophase I (Daniel et al., 2011).  By contrast, the role of HORMAD2 is not 
clear. Dissecting the role of HORMAD2 in mammalian meiosis is an objective 
of this thesis.  
In summary, the SC is composed of a variety of proteins that together 
facilitate synapsis of homologous chromosomes and the repair of meiotic 
DNA DSBs. Understanding the interplay between components of the SC and 
the meiotic recombination pathway and how they are regulated remains an 
important challenge in the field of meiosis. 
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Introduction Figure 4: Synaptonemal complex dynamics. 
During meiotic S phase, the DNA of each parental chromosome is replicated 
(not shown), forming two sister chromatids per chromosome which are held 
together by cohesins. At leptonema, each pair of sister chromatids begins to 
assemble a proteinaceous axis, called axial elements. At zygonema the axes 
of each homolog begin to synapse via transverse filaments. At pachynema, 
the synaptonemal complex is complete, with lateral elements, transverse 
filaments, and a central element. During diplonema, the synaptonemal 
complex disassembles, but the axial elements and asynapsis axial proteins 
(i.e. HORMAD1) remain. Between diakenesis and the first meiotic 
metaphase (MI) the axial elements are disassembled and cohesins are 
removed, separating the sister chromatids. 
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Table 2. Proteins involved in the meiotic synaptonemal complex  
 
Protein Function(s) Mouse mutant 
meiotic phenotype 
Reference 
HORMAD1 SC morphogenesis, 
DNA DSB 
processing, meiotic 
silencing, and 
meiotic surveillance 
SC defects, reduced 
DNA DSB 
formation/intermediat
es, meiotic silencing 
failure 
(Daniel et al., 
2011; Shin et 
al., 2010) 
SYCE1 Central element 
component of SC 
SC and recombination 
defects 
(Bolcun-Filas 
et al., 2009; 
Costa et al., 
2005; Hamer 
et al., 2006) 
SYCE2 Central element 
component of SC 
SC, recombination, and 
MSCI defects 
(Bolcun-Filas 
et al., 2007) 
SYCE3 Central element 
component of SC 
SC and recombination 
defects 
(Schramm et 
al., 2011) 
SYCP1 Transverse filament 
component of SC 
SC and recombination 
defects 
(de Vries et 
al., 2005) 
SYCP2 Axial/lateral 
element component 
of SC 
SC defects (Yang et al., 
2006) 
SYCP3 Axial/lateral 
element component 
of SC 
SC and recombination 
defects 
(Yuan et al., 
2000) 
TEX12 Central element 
component of SC 
SC and recombination 
defects 
(Hamer et al., 
2006) 
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1.4 Meiotic silencing  
In this section, I will introduce meiotic silencing, another critical 
event of mammalian meiotic prophase I. In mammals, meiotic silencing 
refers to the transcriptional inactivation of genes on asynapsed 
chromosomes (Turner, 2007). In the following section, the process of 
meiotic silencing in mammals will be introduced in the context of the X and 
Y chromosomes, and then examined as a more general mechanism affecting 
any asynapsed chromosome. Then, the epigenetics of the meiotic silencing 
response will be discussed, building off the previous sections of DDR and 
chromosome synapsis. Finally, various theories will be addressed to explain 
the role of meiotic silencing in germ cell development and fertility. 
1.4.1 Meiotic Sex Chromosome Inactivation (MSCI) 
In mammals, the X and Y chromosomes are unique in that they are 
largely heteromorphic and have only a small region of genetic homology, the 
PAR (Burgoyne, 1982; Ellis and Goodfellow, 1989). The PAR is where the X 
and Y chromosomes form a requisite CO that is necessary for proper 
segregation of homologs at metaphase I. In mouse, the PAR spans less than 
1Mb (Perry et al., 2001), which is short relative to the full length of the X 
chromosome (171 Mb) and Y chromosome (91 Mb). In mice, the PAR has 
several unique properties, including a higher than expected frequency of 
DNA DSBs and a distinct chromatin loop size (Kauppi et al., 2011). 
Furthermore, one particular isoform of Spo11, namely Spo11, is thought to 
be important for the formation of DNA DSBs at the PAR and the subsequent 
pairing of the X and Y chromosomes (Kauppi et al., 2013). Together, these 
properties of the PAR ensure that an obligatory crossover forms between 
the X and Y chromosomes (Kauppi et al., 2011).  
In addition to these distinct features of the PAR, the non-PAR regions 
of the X and Y chromosomes have unique properties during prophase I of 
meiosis. Given that they are non-homologous, the non-PAR X-Y regions do 
not synapse during pachynema. In other words, the vast majority of the X 
and Y chromosomes remains asynapsed during pachynema. Very early 
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studies showed that the X-Y chromosomes form a dense staining structure 
in pachytene nuclei, and this was originally termed the “sex vesicle” (Sachs, 
1954; Solari, 1964). Later cytological work revealed that rather than being 
enveloped in a vesicular compartment, the X-Y chromosomes instead attain 
a dense chromatin structure during pachynema (Solari, 1974). This lead to 
the renaming of the X-Y chromosomes at pachynema as the “sex body” 
(Solari, 1974).  
Early studies of transcription in germ cells revealed that the sex body 
does not incorporate [3H]uridine at pachynema, indicating that the X and Y 
chromosomes are transcriptionally inactive (Henderson, 1964 ; 
Kierszenbaum and Tres, 1974; Monesi, 1965). This inactivity of the X and Y 
chromosomes during male meiotic prophase I was later termed meiotic sex 
chromosome inactivation (MSCI) (McKee and Handel, 1993). Since these 
early studies, MSCI has been confirmed using several other methods, 
including RNA fluorescent in situ hybridization (RNA FISH) (Turner et al., 
2005), micro-arrays (Ichijima et al., 2011), RNA polymerase II 
immunostaining (Baarends et al., 2005), and high throughput sequencing 
(Modzelewski et al., 2012). 
MSCI initiates during the zygonema to pachynema transition (McKee 
and Handel, 1993; Turner, 2007), and this is associated with the 
accumulation of repressive chromatin marks and meiotic silencing proteins 
within the chromatin of the sex chromosomes (Baarends et al., 2005; Turner 
et al., 2004). This results in the complete suppression of X- and Y-linked 
genes at mid-pachynema (Turner et al., 2006). In spermatocytes, the 
repressive effects of MSCI are maintained to the end of prophase I and also 
to a substantial degree into spermatid development (Greaves et al., 2006; 
Namekawa et al., 2006; Turner et al., 2006).   
In contrast to X chromosome inactivation (XCI) in female somatic 
cells, where 25-30% of X-linked genes escape silencing (Carrel and Willard, 
2005), previous studies using RNA microarrays (Namekawa et al., 2006), 
reverse transcriptase polymerase chain reaction (RT-PCR) (Wang et al., 
2005b), and RNA FISH (Mueller et al., 2008) have failed to identify any X- or 
Y-linked gene that escapes MSCI in the male germ line. Therefore, MSCI 
 44 
causes the complete silencing all of X- and Y-linked protein-coding genes at 
pachynema (Turner, 2007). 
According to a recent study, however, the majority of miRNAs on the 
X chromosome are expressed throughout prophase I (Song et al., 2009). By 
RT-PCR, RNA FISH, and RNA polymerase II ChIP followed by quantitative 
PCR (ChIP-qPCR), Song et al. detected de novo transcription of X-linked 
miRNAs in samples enriched for pachytene spermatocytes. This was the first 
report of transcription occurring from the X chromosome during 
pachynema in mice. Based on these findings, it was suggested that X-linked 
miRNAs may function in MSCI itself, by promoting gene repression, or may 
have a role in autosomal gene regulation (Song et al., 2009). 
Another recent analysis (Mueller et al., 2008) revealed that not all X-
linked genes are subject to the same level of repression in post-meiotic cells. 
Using both RNA FISH and microarrays, it was discovered that many X-genes, 
particularly multicopy genes, are re-activated in spermatids (Mueller et al., 
2008). Indeed, an estimated 18% of X-linked genes are expressed in 
spermatids, and the majority of these are multicopy genes (Mueller et al., 
2008). Gene amplification is believed to be a mechanism by which important 
post-meiotic X-linked genes escape the repressive effects imposed by MSCI 
(Mueller et al., 2008).  
In summary, MSCI initiates at pachynema and causes the inactivation 
of all protein-coding genes in spermatocytes. After pachynema, the majority 
of genes remain repressed into diplonema, but a subset of X-linked genes, 
particularly multicopy genes, is reactivated in round spermatids. 
1.4.2 Meiotic silencing of unsynapsed chromatin (MSUC) 
Meiotic silencing is a response that is not limited to the asynapsed X 
and Y chromosomes, but also occurs on asynapsed autosomes (Baarends et 
al., 2005; Turner et al., 2005). This more general silencing response is called 
meiotic silencing of unsynapsed chromatin (MSUC), or simply meiotic 
silencing. Evidence for MSUC came from analysis of T(X;16)16H 
translocation mice (Turner et al., 2005), which have a translocation 
involving chromosomes X and 16 that creates a X;16 fusion chromosome 
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(Ford and Evands, 1964). During meiosis, the X;16 translocation disrupts 
synapsis, leaving segments of chromosome 16 asynapsed at pachynema 
(Turner et al., 2005). This asynapsed autosomal region is enriched in 
silencing factors and transcriptionally silent in pachytene spermatocytes 
(Turner et al., 2005). 
An independent group analyzed T(1;13)70H/T(1;13)1Wa mice, 
which have a translocation involving chromosomes 1 and 13 that disrupts 
synapsis at pachynema (Baarends et al., 2005). These asynapsed autosomal 
regions are subject to transcriptional inactivation and are enriched in 
silencing proteins (Baarends et al., 2005). Together, these studies revealed 
that meiotic silencing occurs in response to asynapsis in general, not just X 
and Y asynapsis. MSCI was thereafter recognized as the manifestation of a 
general meiotic silencing response specifically affecting the X and Y 
chromosomes (Schimenti, 2005). 
Importantly, meiotic silencing is not restricted to the male germ, but 
also can occur in females. While normal XX oocytes contain fully 
homologous chromosomes, if a chromosome is missing, in excess, or 
structurally abnormal, asynapsis can be present (Burgoyne et al., 2009). In 
such circumstances, asynapsed chromosomes accumulate meiotic silencing 
proteins and are subject to transcriptional inactivation at pachynema 
(Turner et al., 2005).  
Evidence for MSUC in females came from analysis of female mice 
carrying a single X chromosome, called XO mice (Evans and Phillips, 1975). 
The asynapsed X chromosome in XO pachytene oocytes was shown to be 
transcriptionally repressed, as measured by Cot-1 RNA FISH (Turner et al., 
2005) and RNA polymerase II immunostaining (Baarends et al., 2005). 
Furthermore, the asynapsed X chromosome in XO pachytene oocytes is 
enriched in silencing factors, such as H2AFX and ubiquitinated histone H2A 
(ubi-H2A) (Baarends et al., 2005; Turner et al., 2005). In summary, meiotic 
silencing is a general response to asynapsis that operates in both sexes. 
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1.4.2 Epigenetics of meiotic silencing in mice 
γH2AFX 
One of the earliest meiotic silencing factors discovered in mammals 
was S-139 phosphorylated H2AFX (H2AFX) (Celeste et al., 2002; 
Fernandez-Capetillo et al., 2003) (Table 3, Intro Figure 5). As mentioned 
above, γH2AFX has two temporally distinct patterns of localization during 
prophase I in spermatocytes (Mahadevaiah et al., 2001). The first wave 
occurs at early prophase during leptonema, when γH2AFX diffusely stains 
chromatin, consistent with a response to meiotic DNA DSBs (Mahadevaiah 
et al., 2001). As meiotic prophase I continues, γH2AFX disappears in a 
manner that is temporally linked to chromosome synapsis and DSB repair 
(Mahadevaiah et al., 2001).  
The second wave of γH2AFX staining in spermatocytes occurs at 
pachynema, when it forms a chromatin domain around asynapsed X and Y 
chromosomes (Mahadevaiah et al., 2001). This X-Y chromosome γH2AFX-
domain persists from pachynema until late diplonema, and disappears upon 
entry into metaphase I (Mahadevaiah et al., 2001). Importantly, these 
γH2AFX-domains also form on asynapsed autosomes, and on the asynapsed 
X chromosome in XO pachytene oocytes, suggesting that this is a general 
response to asynapsis in both male and female germ cells (Turner et al., 
2005). This localization pattern of H2AFX is consistent with a role in 
meiotic silencing.  
Genetic evidence supporting that H2AFX is involved in meiotic 
silencing came from studies of mice carrying a null mutation of H2afx 
(Fernandez-Capetillo et al., 2003). H2afx-/- male mice have defective X-Y 
chromatin compaction and over expression of X- and Y-linked genes, 
indicative of MSCI failure (Celeste et al., 2002; Fernandez-Capetillo et al., 
2003). Therefore, H2afx is essential for meiotic silencing in mice.  
As described above, H2afx-/- male mice are infertile, but female 
mutants are fertile (Celeste et al., 2002). This sexually dimorphic infertility 
phenotype indicates that H2afx has an essential role in a male-specific 
process. It is now believed that abnormal MSCI is the underlying cause of 
 47 
infertility in H2afx-/- male mice, and in many other mouse mutants that 
have MSCI defects (Mahadevaiah et al., 2008; Royo et al., 2010). In support 
of this, there are no obvious meiotic defects outside of MSCI failure in H2afx-
/- mice (Celeste et al., 2002; Fernandez-Capetillo et al., 2003).  
Additional support for the MSCI-failure model of male-specific 
infertility comes from recent transgenic mouse experiments (Royo et al., 
2010). XY male mice carrying autosomal transgenes for two Y-linked genes, 
namely Zfy1 and Zfy2, experience a pachytene germ cell arrest similar to that 
observed in H2afx-/- mice (Royo et al., 2010). This suggests that mis-
expression of two Y-linked genes alone is sufficient to trigger pachytene 
germ cell arrest. Indeed, several mutant mouse models with defective 
H2AFX domains show mis-expression of Zfy1/2 (Royo et al., 2010). 
Therefore, H2AFX accumulation and MSCI are intimately linked, and 
defects in either can result in germ cell arrest and infertility. 
ATR 
Like H2AFX, ATR has two distinct localization patterns during 
meiotic prophase I (Keegan et al., 1996; Moens et al., 1999). During 
zygonema, ATR localizes as foci to asynapsed chromosome cores (Keegan et 
al., 1996; Moens et al., 1999). These ATR foci overlap with H2AFX staining 
(Moens et al., 1999) and RPA (Burgoyne et al., 2007), suggesting that ATR 
accumulates near DNA DSB repair sites. At early pachynema, ATR foci are no 
longer present, but instead ATR accumulates within the chromatin of the 
asynapsed X and Y chromosomes (Moens et al., 1999), where it co-localizes 
with γH2AFX (Intro Figure 5) (Turner et al., 2004). These ATR chromatin 
domains also occur on the asynapsed X chromosome in XO oocytes (Turner 
et al., 2005). In addition to ATR, the ATR co-factors ATR interacting protein 
(ATRIP) and topoisomerase II binding protein 1 (TOPBP1) are enriched in 
the sex body in spermatocytes (Perera et al., 2004; Refolio et al., 2011; Reini 
et al., 2004). (Table 3) 
ATR-enrichment in the chromatin of the X and Y chromosomes is 
suggestive of a role in H2AFX phosphorylation and meiotic silencing. Recent 
genetic studies have confirmed that ATR is the key meiotic silencing kinase 
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(Table 3). Conditional deletion of Atr during early meiotic prophase I 
disrupts γH2AFX domain formation and meiotic silencing (Royo et al., 
2013). However, ablation of Atr after meiotic silencing initiates does not 
affect γH2AFX, indicating that once the γH2AFX domain and silencing are 
established it is stable and irreversible (Royo et al., 2013).  
BRCA1 
Like ATR and H2AFX, BRCA1 has two distinct localization patterns 
during meiotic prophase I in mice. At zygonema, BRCA1 forms distinct foci 
on pre-synaptic chromosome axes (Scully et al., 1997; Turner et al., 2004), 
and these foci overlap with RAD51, indicating an association with meiotic 
DNA DSBs (Mahadevaiah et al., 2008; Scully et al., 1997). Interestingly, 
however, similar BRCA1 foci are also observed in Spo11-/- DNA DSB-
deficient mice (Mahadevaiah et al., 2008). The presence of BRCA1 in Spo11-
/- spermatocytes suggests a role for BRCA1 outside of meiotic DNA DSB 
events.  
At pachynema, BRCA1 localizes along the length of asynapsed 
chromosome axes (Intro Figure 5) (Scully et al., 1997; Turner et al., 2004; 
Turner et al., 2005). In spermatocytes, BRCA1 is restricted to the asynapsed 
axes of the X and Y chromosomes, suggestive of a role in meiotic silencing 
(Turner et al., 2004). Several mutant mouse models of Brca1 have been 
developed to understand BRCA1’s role in meiosis. Brca1 p53+/- 
mutant mice, which have a deletion in exon 11 of Brca1, show defective 
targeting of ATR to the asynapsed X and Y chromosomes (Broering et al., 
2014; Turner et al., 2004). This is associated with absence of H2AFX and 
failed meiotic silencing (Broering et al., 2014; Turner et al., 2004). Similar 
meiotic silencing defects were also observed in a conditional deletion 
mutant of Brca1 (Broering et al., 2014). 
Based upon these findings, it was postulated that BRCA1 is necessary 
for recruitment and retention of ATR to asynapsed chromosome axes (Table 
3). Interestingly, recent work has also shown that loss of Atr compromises 
the loading of BRCA1 on asynapsed axes, indicating an interdependence of 
ATR and BRCA1 in meiotic silencing (Royo et al., 2013). Additionally, 
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BRCA1, ATR, and H2AFX accumulation on asynapsed chromosomes is 
dependent on the SC component SYCP3 (Fukuda et al., 2012; Kouznetsova et 
al., 2009). This indicates that SYCP3 is upstream of BRCA1 in the meiotic 
silencing cascade.   
HORMAD1  
In addition to BRCA1 and ATR, several other proteins have been 
recently implicated in meiotic silencing, including the HORMA-domain 
protein HORMAD1 (Daniel et al., 2011; Shin et al., 2010) (Table 3, Intro 
Figure 5). As discussed above, HORMAD1 associates with pre-synapsed, 
asynapsed, and desynapsed chromosome axes in both spermatocytes and 
oocytes (Fukuda et al., 2009; Shin et al., 2010; Wojtasz et al., 2009). 
HORMAD1 likely has multiple functions in mammalian meiosis, including 
regulation of synapsis, DNA DSB formation and/or repair, and meiotic 
silencing (Daniel et al., 2011). 
Mice with a deletion of Hormad1 have meiotic silencing defects. In 
Hormad1-/- spermatocytes, BRCA1 and ATR does not localize properly to 
asynapsed chromosome axes (Daniel et al., 2011; Shin et al., 2010). This 
leads to disrupted γH2AFX domains and failed X- and Y-linked gene 
silencing (Daniel et al., 2011; Shin et al., 2010). In wildtype spermatocytes, 
HORMAD1 associated with asynapsed axes becomes phosphorylated at 
serine-375 (Fukuda et al., 2012). Reduced phosphorylation leads to an 
impaired meiotic silencing response (Fukuda et al., 2012). Therefore, 
HORMAD1 recruitment to asynapsed axes and HORMAD1 post-translational 
modifications are critical for meiotic silencing.   
Another related HORMA-domain protein, HORMAD2, also 
accumulates on asynapsed chromosome axes in mouse spermatocytes and 
oocytes (Wojtasz et al., 2009). The function of HORMAD2 in mammalian 
meiosis remains unclear. As part of my goal to better understand the meiotic 
silencing pathway in mammals, I will present novel data on the meiotic 
silencing phenotype of Hormad2-/- mice (see below).  
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MDC1 
Another protein involved in meiotic silencing in mammals is MDC1 
(Table 3). MDC1 directly interacts with H2AFX and mediates the DDR in 
mammals (Stewart et al., 2003; Stucki et al., 2005). Like many factors 
involved in meiotic silencing, MDC1 labels the chromatin over the asynapsed 
X and Y chromosomes (Intro Figure 5), which overlaps H2AFX and other 
sex body-associated proteins (Ichijima et al., 2011; Lu et al., 2013).  
Deletion of Mdc1 in mice results in male-specific infertility, 
suggesting an essential role for MDC1 in male-specific events (Lou et al., 
2006). Mdc1-/- males have defects in the meiotic silencing pathway, 
including reduced spreading of the silencing factors ATR, TOPBP1, and 
H2AFX throughout the X-Y chromatin (Ichijima et al., 2011). This is 
associated with mis-expression of X- and Y-linked genes, indicating that 
MDC1 is essential for meiotic silencing (Ichijima et al., 2011). H2AFX, ATR, 
and MDC1 are interdependent in meiotic silencing – genetic ablation of any 
of these factors leads to defective loading of the others (Ichijima et al., 2011; 
Royo et al., 2013). 
AGO4 
Recent work implicated a component of the RNAi pathway, 
argonaute4 (AGO4), in meiotic silencing in mammals (Table 3) 
(Modzelewski et al., 2012). AGO4 is highly expressed in the male germ line 
(González-González et al., 2008), and AGO4 localizes to chromatin of the 
asynapsed X and Y chromosomes and asynapsed autosomes, suggestive of a 
role in silencing (Modzelewski et al., 2012). While Ago4-/- males are fertile, 
they have increased spermatocyte apoptosis, reduced testis weight, and 
reduced spermatozoa counts (Modzelewski et al., 2012). Pachytene 
spermatocytes from Ago4-/- mice show defects in ATR and H2AFX staining, 
and loss of silencing of sex-linked genes (Modzelewski et al., 2012). In the 
absence of Ago4, there is also a general down-regulation of X-linked miRNAs 
(Modzelewski et al., 2012), many of which have been previously reported to 
escape MSCI (Song et al., 2009). Based on these data, the authors speculate 
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that AGO4 may help coordinate silencing in conjunction with X-linked 
miRNAs, by promoting their production and/or stability (Song et al., 2009). 
SETX 
Another protein recently implicated in silencing in mice is senataxin 
(SETX) (Table 3). SETX has multiple biological functions, including 
regulation of DDR, transcription, and DNA replication (Becherel et al., 2013). 
In mouse spermatocytes, SETX co-localizes with ATR, MDC1, and H2AFX in 
the X-Y chromatin (Becherel et al., 2013). Setx-/- mice have defective 
accumulation of several silencing proteins, including ATR, MDC1, and 
H2AFX (Becherel et al., 2013). These sex body abnormalities are associated 
with upregulation of X- and Y-linked genes and male-specific infertility 
(Becherel et al., 2013). SETX’s role in MSCI is still unclear, but it maybe 
linked to its action on transcription, RNA processing, or DDR (Becherel et al., 
2013). 
SUMO 
Sumoylation is a post-translational modification associated with 
transcriptional regulation (Gill, 2005). Several small ubiquitin-like modifier 
(SUMO) proteins are enriched in the sex body in spermatocytes (La Salle et 
al., 2008; Rogers et al., 2004; Vigodner and Morris, 2005) (Table 3). Like 
many meiotic silencing components, SUMO also localizes to meiotic DNA 
DSBs in spermatocytes (Shrivastava et al., 2010). One study reported that 
SUMO localizes to the sex chromatin even before H2AFX (Vigodner, 2009), 
however subsequent studies refuted this claim (Ichijima et al., 2011; Royo et 
al., 2013). 
Other sex body associated factors  
As described above, specific epigenetic marks and histone 
modifications associate with the sex body in spermatocytes. Additional 
marks that localize to the sex body in mice include: di- and tri-methylation 
of histone H3 at lysine-9 (H3K9me2 and H3K9me3, respectively) (Khalil et 
al., 2004; van der Heijden et al., 2007); phosphorylated cyclin dependent 
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kinase 2 (p-CDK2) isoform 1 at threonine 160 (Wang et al., 2014); 
heterochromatin protein 1 beta and gamma isoforms (HP1and HP1) 
(Metzler-Guillemain et al., 2003)(Metzler-Guillemain et al., 2003)(Metzler-
Guillemain et al., 2003)(Metzler-Guillemain et al., 2003)(Metzler-Guillemain 
et al., 2003)(Metzler-Guillemain et al., 2003)(Metzler-Guillemain et al., 
2003)(Metzler-Guillemain et al., 2003)(Metzler-Guillemain et al., 
2003)(Metzler-Guillemain et al., 2003)(Metzler-Guillemain et al., 2003); 
histone macroH2A1.2 (Hoyer-Fender et al., 2000); histone H2A.Z (Greaves 
et al., 2006); ubiquitin conjugates (FK2) (Baarends et al., 2005; Ichijima et 
al., 2011); and, ubiquitinated histone H2A (uH2A) (Baarends et al., 1999; 
Baarends et al., 2005), formed by the action of ubiquitin protein ligase E3 
component n-recognin 2 (UBR2) (An et al., 2010) (Table 3). Additionally, 
the histone H3 variants, H3.1 and H3.2, are removed and replaced by 
histone H3.3 in the sex body of pachytene spermatocytes (van der Heijden et 
al., 2007) (Table 3). Deletion of one gene encoding H3.3 results in male 
specific infertility associated with spermatocyte loss (Yuen et al., 2014). The 
function of these sex body-associated chromatin modifications and proteins 
remain largely unclear.  
In summary, a multitude of factors interact with the sex 
chromosomes during late prophase I to establish a unique chromatin 
environment to facilitate the transcriptional silencing of X- and Y-linked 
genes (Intro Figure 5).  
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Table 3. Description of factors involved in meiotic silencing 
 
Protein Function(s) Mouse mutant 
phenotype 
Reference 
AGO4 Argonaute RNAi processing 
protein, enriched in sex 
body, meiotic silencing. 
Premature meiotic 
entry, sex body 
defects, MSCI failure, 
reduced X-linked 
miRNAs. 
(Modzelewski 
et al., 2012) 
ATR Kinase involved DNA DSB 
repair, cell cycle 
progression/checkpoints, 
and meiotic silencing. 
Enriched in the sex body. 
Defective 
accumulation of 
BRCA1, H2AFX, 
MDC1, SUMO, ATRIP, 
and TOPBP1; MSCI 
failure. 
(Royo et al., 
2013; Traven 
and 
Heierhorst, 
2005) 
ATRIP ATR interacting protein. 
Enriched on asynapsed sex 
chromosome axes. 
- (Royo et al., 
2013; Zou 
and Elledge, 
2003) 
BRCA1 Tumor suppressor protein 
involved in DNA repair, 
cell cycle, and meiotic 
silencing. 
Defective 
accumulation of ATR 
and H2AFX; MSCI 
failure. 
(Boulton, 
2006; Turner 
et al., 2004) 
CDK2 Kinase involved in cell cycle 
progression. 
Phosphorylated CDK2 at 
threonine 160 enriched in 
sex body. CDK2 also 
localized to crossovers. 
Synaptic defects, 
unrepaired DNA 
DSBs, sex body 
defects, including 
impaired loading of 
BRCA1 and ATR. 
 
(Viera et al., 
2009; Wang 
et al., 2014) 
 
 
FK2 Ubiquitin conjugate 
enriched in sex body. 
- (Ichijima et 
al., 2011) 
H2A.Z Histone variant enriched in 
sex body. Implicated in 
chromosome segregation 
and heterochromatin 
formation. 
- (Greaves et 
al., 2006) 
H2AFX H2AFX involved in 
somatic DNA DSB repair 
and meiotic silencing. 
Enriched in sex body. 
Failed accumulation 
of MDC1 and ATR, 
MSCI failure. 
(Celeste et al., 
2002; Royo et 
al., 2013) 
H3.3 Histone variant involved in 
transcriptional 
reprogramming, enriched 
in sex body. 
Deletion of one gene 
encoding H3.3 results 
in spermatocyte 
arrest. 
(van der 
Heijden et al., 
2007; Yuen et 
al., 2014) 
H3K9me2/3 Repressive methylation 
modification on histone H3. 
Enriched in sex body. 
- (Khalil et al., 
2004; van der 
Heijden et al., 
2007) 
HORMAD1 SC morphogenesis, DNA 
DSB processing, meiotic 
silencing, and meiotic 
SC defects, reduced 
DNA DSB 
formation/intermedi
(Daniel et al., 
2011; Shin et 
al., 2010) 
 54 
surveillance. ates, meiotic 
silencing failure. 
HP1/ Heterochromatin protein 1 
isoforms associated with 
sex body.  
Deletion of 
Hp1leads to 
reduction in number 
of primordial germ 
cells. 
(Abe, 2011; 
Metzler-
Guillemain et 
al., 2003) 
MacroH2A1.
2 
Histone variant enriched in 
sex body. 
- (Hoyer-Fender 
et al., 2000) 
MDC1 DNA repair protein, 
interacts with H2AFX at 
DNA DSBs, necessary for 
meiotic silencing. 
Defective 
accumulation of ATR 
and H2AFX. 
(Ichijima et 
al., 2011; 
Stucki et al., 
2005) 
SETX DDR, transcriptional 
regulation, and replication; 
enriched in sex body. 
Defective 
accumulation of ATR, 
MDC1, H2AFX, and 
MSCI failure. 
(Becherel et 
al., 2013) 
SUMO Transcriptional regulation, 
enriched in sex body and 
meiotic DNA DSBs. 
- (La Salle et al., 
2008; Royo et 
al., 2013; 
Vigodner and 
Morris, 2005) 
TOPBP1 ATR co-factor. Enriched on 
asynapsed sex 
chromosome axes. 
- (Perera et al., 
2004) 
uH2A Ubiquitylated H2A 
modification, formed by 
UBR2, involved in 
transcriptional regulation. 
Enriched in sex body. 
Deletion of Ubr2 
results in impaired 
meiotic silencing. 
(An et al., 
2010; 
Baarends et 
al., 1999) 
- indicates that mutant is not viable, available, or information unknown 
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Introduction Figure 5: Factors involved in meiotic silencing in 
mice. 
During zygonema, SYCP3, HORMAD1 (H1), HORMAD1 (H2), BRCA1, and 
ATR accumulate along the asynapsed chromosome axis. At this stage genes 
remain transcriptionally active. During pachynema, ATR spreads into the 
chromatin loops, where it phosphorylates H2AFX in a positive feedback loop 
involving H2AFX and MCD1. The resultant chromatin-wide H2AFX domain, 
in concert with other silencing factors, leads to chromosome-wide gene 
inactivation.  
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1.4.3 Meiotic silencing from an evolutionary perspective 
Meiotic silencing is conserved across many taxa, including eutherian 
mammals (Baarends et al., 2005; de Vries et al., 2012; Turner et al., 2005), 
metatherian mammals (Hornecker et al., 2007), fungi (Shiu et al., 2001), 
nematodes (Kelly et al., 2002), and insects (Cabrero et al., 2007b).   
The first report of meiotic silencing was described in the fungus 
Neurospora crassa (Shiu et al., 2001). Any unpaired DNA during meiosis in 
N. crassa becomes transcriptionally inactivated, along with any sequences of 
DNA that are homologous to it (Shiu et al., 2001). Meiotic silencing in N. 
crassa has been termed meiotic silencing by unpaired DNA (MSUD). In 
contrast to meiotic silencing in mammals, MSUD is mediated by post-
transcriptional mechanisms, which involves components of the RNA 
interference pathway (Alexander et al., 2008; Lee et al., 2003; Shiu et al., 
2001). MSUD has been proposed to function in genome defense, by silencing 
potentially mutagenic transposable elements (Shiu et al., 2001). 
 A mechanistically and functionally distinct form of meiotic silencing 
has been reported in the nematode Caenorhabditis elegans. In C. elegans, 
males have a single X chromosome (XO), compared to their hermaphroditic 
XX counterparts. Early immunostaining experiments reveled that the 
asynapsed X chromosome in XO males is devoid of RNA polymerase, 
suggesting gene inactivation (Kelly et al., 2002).  
Like in mammals, meiotic silencing in C. elegans is mediated in large 
part by chromatin modifications (Maine, 2010). The asynapsed X 
chromosome in XO males is deficient in active transcription histone marks 
and enriched in repressive histone marks, including tri-methylation of 
histone H3 at lysine 27 (H3K27me3) and H3K9me2 (Bean et al., 2004; 
Bender et al., 2004; Kelly et al., 2002). In C. elegans, silencing and 
heterochromatin formation have been proposed to shield the asynapsed X 
chromosome from a checkpoint. Indeed, mutants lacking met-2, which 
encodes the histone methyltransferase responsible for generating the 
repressive H2K9me2 mark, results in increased apoptosis and activation of 
a recombination checkpoint (Checchi and Engebrecht, 2011).  Thus, meiotic 
silencing may have evolved distinct functions in different organisms. 
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 Meiotic silencing may also operate in the grasshopper Eyprepocnemis 
plorans (Cabrero et al., 2007a). The asynapsed X chromosome in E. plorans 
accumulates H2AFX at pachynema (Cabrero et al., 2007a). However, the X 
chromosome in E. plorans is already heterochromatic and silenced at 
leptonema, even before the presence of H2AFX at pachynema (Cabrero et 
al., 2007b). This suggests that H2AFX in insects may help maintain a 
silenced state established in early prophase I, rather than initiating 
silencing.  
In addition to mammals, worms, and insects, MSCI has also been 
previously reported in birds (Schoenmakers et al., 2009; Schoenmakers et 
al., 2010). In avian species, females are the heterogametic sex, carrying the Z 
and W sex chromosomes, and males are ZZ. The Z and W chromosomes are 
largely non-homologous, but nevertheless achieve transient, near complete 
synapsis at mid-pachynema (Schoenmakers et al., 2009). An early gene 
expression study reported that the Z and W chromosome pair are 
transiently silenced from early pachynema to early diplonema 
(Schoenmakers et al., 2009). However, a more recent analysis involving 
epigenetic profiling and RNA FISH found no evidence for MSCI in chickens 
(Guioli et al., 2012). Therefore, MSCI may not be conserved in avian species.    
The status of the sex chromosomes in the germ line of Drosophila 
melanogaster is less well understood. While early genetic studies (Hoyle et 
al., 1995) and expression analyses (Vibranovski et al., 2009) suggested that 
meiotic silencing operates in Drosophila melanogaster, the latest work 
supports that it does not occur (Meiklejohn et al., 2011; Mikhaylova and 
Nurminsky, 2011). The earlier studies are thought to have been confounded 
by germ cell contamination (Vibranovski, 2014). Owing to the limitations of 
the methods used to study MSCI in Drosophila, more sophisticated 
approaches are needed to settle these conflicting results.  
Surprisingly, meiotic silencing has not been well characterized in 
humans. Like in mouse, the human X and Y chromosomes are condensed 
(Solari, 1974) and stain for H2AFX, BRCA1 (Sciurano et al., 2007), and ATR 
(de Boer et al., 2004). These meiotic silencing components also localize to 
asynapsed regions in human oocytes, e.g. the asynapsed chromosome 21 in 
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trisomy 21 oocytes (Garcia-Cruz et al., 2009). Therefore, the meiotic 
silencing pathway appears to be active in human germ cells with asynapsis.  
A recent study reported a high degree of variation in the meiotic 
silencing response in human males (de Vries et al., 2012). 
Immunofluorescent analyses of H2AFX, histone H3.1/3.2, RNA polymerase 
II, and Cot-1 RNA FISH in human spermatocytes showed significant 
heterogeneity in localization and intensity of these silencing components 
compared to mouse (de Vries et al., 2012). While this suggests that meiotic 
silencing may be less stringent in humans, this should be verified by direct 
analysis of transcription using gene-specific RNA FISH, a sensitive method to 
detect nascent transcription (Mahadevaiah et al., 2009a).  
In addition to eutherian mammals (e.g. mouse, humans, etc.), meiotic 
silencing has also been described in metatherian mammals (e.g. marsupials) 
(Hornecker et al., 2007; Namekawa et al., 2007). In the marsupial 
Monodelphis domestica, the X and Y chromosomes in pachytene 
spermatocytes are enriched in H2AFX and other silencing factors 
(Namekawa et al., 2007). Like in mouse, the sex chromosomes in M. 
domestica are robustly silenced during pachynema (Hornecker et al., 2007; 
Mahadevaiah et al., 2009b; Namekawa et al., 2007). While MSCI was 
previously believed to persist into spermiogenesis in M. domestica 
(Hornecker et al., 2007; Namekawa et al., 2007), a recent RNA FISH analysis 
debunked this claim, showing that many X-linked genes are reactivated 
during spermiogenesis (Mahadevaiah et al., 2009b). In summary, meiotic 
silencing operates in mammals and several other organisms, but there 
appear to be significant mechanistic differences between species. 
1.4.4 Role of meiotic silencing in mammalian germ cells 
In mammals, MSCI has an essential role in spermatogenesis 
(Burgoyne et al., 2009). Chromosome translocations that disrupt MSCI are 
associated with spermatocyte losses and infertility (Lifschytz and Lindsley, 
1972). For example, T43(16;17)H (T43H) mice, which have a translocation 
involving chromosomes 17 and 16, have incomplete MSCI and are sterile 
(Homolka et al., 2007; Homolka et al., 2012). Furthermore, deletion of genes 
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necessary for meiotic silencing, including Brca1 (Xu et al., 2003), Atr (Royo 
et al., 2013), Hormad1 (Daniel et al., 2011; Kogo et al., 2012b; Shin et al., 
2010), H2afx (Celeste et al., 2002), and Mdc1 (Ichijima et al., 2011; Lou et al., 
2006), also cause spermatocyte losses and male infertility. In all of these 
mutants, germ cell arrest occurs around mid-pachynema of meiotic 
prophase I. 
MSCI is also disrupted in other meiotic mutants that arrest at mid-
pachynema (Mahadevaiah et al., 2008; Royo et al., 2010). For example, in 
meiotic recombination mutants Dmc1-/- and Msh5-/- mice, the MSCI factors 
BRCA1 and ATR are abnormally retained at unrepaired DNA DSBs, and fail 
to accumulate on the asynapsed X and Y chromosomes, leading to disrupted 
MSCI (Mahadevaiah et al., 2008). In DNA DSB initiation mutants, e.g. Spo11-
/- mice, MSCI is also disrupted, for reasons that are still unclear (Bellani et 
al., 2005; Mahadevaiah et al., 2008). Given the overwhelming association 
between MSCI defects and spermatocyte arrest, it has been speculated that 
disruption in XY silencing is an underlying mechanism of male infertility 
(Royo et al., 2010).  
A recent study of male mice with an extra Y chromosome, i.e. XYY 
males, revealed that the X and Y chromosomes harbor genes that are toxic 
when expressed at pachynema (Royo et al., 2010). XXY mice have a 
pachytene stage spermatocyte arrest, similar to that observed in the 
aforementioned meiotic mutants (Burgoyne and Baker, 1984; Burgoyne and 
Biddle, 1980; Mahadevaiah et al., 2000). In a subset of XYY germ cells, the 
two Y chromosomes achieve homologous synapsis and are not subject to 
MSCI, resulting in Y-linked gene expression (Royo et al., 2010). These germ 
cells are eliminated during pachynema, suggesting that Y-gene expression is 
toxic. In support of this, transgenic mice mis-expressing the Y-linked genes 
zinc finger protein Y-linked 1 (Zfy1) and Zfy2 have pachytene germ cell losses 
(Royo et al., 2010). Therefore, mis-expression of sex-linked genes can cause 
spermatocyte losses.  
While these studies highlight the importance of MSCI in mice, its 
raison d’être remains a mystery. Several theories have been postulated to 
explain the role of MSCI during meiosis. One of the earliest theories 
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suggested that MSCI prevents recombination from occurring between the 
non-homologous regions of the X and Y chromosomes (McKee and Handel, 
1993). However, genetically ablating MSCI in mice, e.g. disrupting H2afx 
(Fernandez-Capetillo et al., 2003), Brca1 (Xu et al., 2003), Atr (Royo et al., 
2013), Hormad1 (Daniel et al., 2011), or Mdc1 (Ichijima et al., 2011), does 
not result in recombination between the X and Y heterologous regions. On 
the contrary, disrupting MSCI genes commonly result in failure of crossing 
over at the PAR and sex chromosome asynapsis (Fernandez-Capetillo et al., 
2003; Turner et al., 2004; Wojtasz et al., 2012). This indicates that MSCI may 
actually promote proper pairing and recombination of the sex 
chromosomes.  
Another proposed function of MSCI in mammals is to prevent 
transcription from DNA templates which have unrepaired meiotic DNA 
DSBs (Inagaki et al., 2010). As discussed above, DNA DSB repair proteins 
persist longer on the asynapsed X chromosome in spermatocytes than on 
synapsed autosomes (Moens et al., 2002). Perhaps MSCI evolved to suppress 
transcription from these damaged chromosomes. Support for this theory 
comes from the recent finding that HU-induced DNA DSBs in somatic cells 
results in local transcriptional repression (Ichijima et al., 2011). However, 
this theory does not explain why MSCI continues long after DNA DSBs on the 
asynapsed X chromosome are repaired (i.e. mid-pachynema).  
The recent discovery of meiotic silencing (i.e. MSUC) as a general 
mechanism of silencing asynapsed chromosomes has led to new ideas about 
the role of silencing (Turner et al., 2005). It is possible that MSUC existed 
before the emergence of the modern heteromorphic X and Y chromosomes. 
If this is true, then upon divergence of the proto-X-Y chromosomes into their 
modern day heteromorphic counterparts, MSCI would have become a 
permanent feature of spermatogenesis (Cloutier and Turner, 2010). This 
model would suggest that there was a selective advantage to a general 
meiotic silencing response even before the heteromorphic sex 
chromosomes existed.  
One theory is that MSUC evolved as an important surveillance 
mechanism to monitor the synaptic process (Burgoyne et al., 2009; Turner 
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et al., 2005). Under this model, MSUC would drive the elimination of germ 
cells with potentially deleterious errors in synapsis (Burgoyne et al., 2009; 
Schimenti, 2005; Turner et al., 2005). Mechanistically, MSUC could achieve 
this by silencing critical genes on asynapsed chromosomes (Burgoyne et al., 
2009). To date, however, there is very little known about the surveillance 
mechanisms that operate in mammalian germ cells. The potential role for 
meiotic silencing in surveillance of the synaptic process will be expanded 
upon in the following section.  
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1.5 Meiotic surveillance mechanisms 
Meiotic surveillance mechanisms monitor the integrity of meiotic 
processes to ensure that they are completed successfully before proceeding 
to cell division (Hochwagen and Amon, 2006). These quality control 
mechanisms prevent germ cells with defects from progressing through 
meiosis to produce abnormal gametes. In the absence of such surveillance 
mechanisms, germ cells with defects could generate aneuploid gametes and 
embryos.  
In contrast to mitosis, meiosis involves several unique steps, namely 
programmed DNA DSB formation and homologous chromosome synapsis. 
Ensuring the fidelity of these meiosis-specific processes requires specialized 
surveillance mechanisms. In mammals, the mechanisms that monitor these 
meiosis-specific processes are not well understood. This is particularly true 
in the female germ line, which has been historically less extensively studied. 
Four specific mechanisms have been proposed to operate in mammalian 
germ cells: asynapsis checkpoint, DNA damage (recombination) checkpoint, 
meiotic silencing based mechanism, and the SAC (Intro Figure 4). The first 
three are thought to specifically operate during meiotic prophase I, and they 
will be discussed more extensively in this section.  
1.5.1 The eukaryotic cell cycle  
In eukaryotes, the mitotic cell cycle consists of four stages: gap phase 
1 (G1), S phase, gap phase 2 (G2), and mitosis (M) (Futcher, 1996). During 
G1, cells grow and activate genes in preparation for the subsequent S phase 
(Bähler, 2005). Once the cells have reached a sufficient size, they proceed to 
S phase, when DNA is replicated (Futcher, 1996).  Following S phase, cells 
enter the G2 phase, a period of cell growth and protein synthesis during 
which the cell prepares for division (Futcher, 1996). The G2 phase ends with 
the onset of prophase I, when cells enter into mitosis. Progression through 
each of these phases of the cell cycle is coordinated by the spatial and 
temporal activity of cyclins and cyclin dependent kinase (CDK) proteins 
(Futcher, 1996).  
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Introduction Figure 6: Meiotic surveillance mechanisms in mice. 
In male mice, several different surveillance mechanisms operate to monitor 
the fidelity of meiotic processes. Three putative mechanisms, namely a DNA 
damage checkpoint, an asynapsis checkpoint, and a meiotic silencing based 
mechanism of surveillance, are thought to operate to prevent progression 
beyond pachynema. In females, the timing and activity of these prophase I 
mechanisms is not well understood. The spindle assembly checkpoint (SAC) 
operates in both male and female germ cells to prevent cells from 
progressing beyond metaphase I if improper spindle tension is detected. For 
simplicity, only one daughter cell is shown after each meiotic division. The 
chromosomes/chromatids boxed are those in the subsequent daughter cell.   
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  Similar to mitosis, the meiotic cell cycle begins with commitment 
into G1, followed by a round of DNA replication during meiotic S phase 
(Marston and Amon, 2004).  Following S phase, germ cells enter prophase I, 
which is akin to meiotic G2 (Marston and Amon, 2004). This begins with 
meiotic DNA DSBs being generated throughout the genome by SPO11 
(Borde et al., 2000). During meiotic G2, chromosomes synapse and meiotic 
recombination occurs. After completion of prophase I, the first meiotic 
division takes place, which segregates homologs, followed by the second 
meiotic division, which segregates sister chromatids. 
1.5.2 The DNA damage checkpoint: a mitotic perspective  
Several distinct meiotic surveillance mechanisms are believed to 
operate in germ cells. One of the first-described models, the pachytene 
checkpoint model, has been well characterized in yeast meiosis (Roeder and 
Bailis, 2000). A “checkpoint” is a point in the cell cycle where the integrity of 
chromosomal processes are monitored (Hartwell and Weinert, 1989). One 
such checkpoint, called the DNA damage checkpoint, monitors for DNA 
damage during the G2/M phase of the cell cycle (O'Connell and Cimprich, 
2005). When DNA damage is present, it sets off a series of biochemical 
events that triggers cell cycle delay or arrest until DNA lesions are repaired. 
If the lesion is too severe or irreparable, cells will undergo senescence or 
apoptosis (Harper and Elledge, 2007).  
DNA DSBs are one of the most hazardous forms of DNA damage, and 
pose a significant threat to cell viability, survival, and normal cellular 
processes (Finn et al., 2012). DNA DSBs are capable of inducing gross 
chromosomal rearrangements and potentially deleterious mutations (Finn 
et al., 2012). In mitosis, a DNA damage checkpoint operates to delay cell 
division until DNA DSBs are fully repaired (Hartwell and Weinert, 1989; 
O'Connell and Cimprich, 2005), thereby preventing the propagation of 
hazardous lesions (Weinert and Hartwell, 1988).  
The DNA damage checkpoint is best understood in the context of 
mitosis (O'Connell and Cimprich, 2005). During mitosis, DNA damage, such 
as DNA DSBs, can be made during S phase at replication forks, and these 
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lesions are subsequently repaired in G2, prior to cell division (Cuddihy and 
O'Connell, 2003). In the event that DNA DSBs persist at end of the G2 phase, 
the mitotic G2/M DNA damage checkpoint is triggered, and this delays entry 
into M phase, allowing more time for DNA repair (Harrison and Haber, 
2006).  
This mitotic DNA damage checkpoint is mediated by a number of 
highly conserved proteins that sense DNA damage and signal the cell cycle 
“effector” machinery (Finn et al., 2012). The first step in the DNA damage 
checkpoint is sensing the DNA lesion. The phosphoinositide three-kinase-
related kinase (PIKK) family proteins ATM, ATR, and DNA-PKcs are the 
primary sensors in the G2/M DNA damage checkpoint (Lovejoy and Cortez, 
2009). These kinases are activated by different DNA lesions: ATM and DNA 
PKcs are activated predominately by DNA DSBs, while ATR can be activated 
by a variety of DNA lesions, especially single-strand DNA gaps (Lovejoy and 
Cortez, 2009).  
Each kinase is recruited to DNA lesions by different factors. ATM is 
recruited by the MRN complex, specifically by the Nbs1 component (Horejsí 
et al., 2004); ATR is recruited by ATRIP (Zou and Elledge, 2003); and DNA-
PKc is recruited by the Ku70/80 heterodimer (Gottlieb and Jackson, 1993), 
which is composed of X-ray repair complementing defective repair in 
Chinese hamster cells 6 (XRCC6, or Ku70) and X-ray repair complementing 
defective repair in Chinese hamster cells 5 (XRCC5, or Ku80) (Falck et al., 
2005).  
Once recruited to DNA DSBs, ATR and ATM activate and recruit 
several downstream DDR proteins (Finn et al., 2012). Two important 
downstream effector kinases involved in the DNA damage checkpoint are 
checkpoint kinase 1 (CHK1) and checkpoint kinase 2 (CHK2), which are 
activated by ATR and ATM, respectively (Stracker et al., 2009). Functionally, 
CHK1 and CHK2 recruit additional downstream DDR factors, amplify the 
DDR signal, and activate the checkpoint (Stracker et al., 2009).  
In eukaryotes, the G2/M DNA damage checkpoint ultimately prevents 
entry into mitosis by inhibiting the activity of CDK proteins (Finn et al., 
2012). In the presence of DNA damage, activated CHK1 and CHK2 trigger a 
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cascade of events that inactivates CDK1 and CDK2 (Zhou and Bartek, 2004). 
Specifically, CHK1 phosphorylates the protein phosphatase cell division 
cycle 25A (CDC25A), leading to its degradation and thereby preventing it 
from activating CDK1/2 (Zhao et al., 2002). When CDK1/2 is inactivated, the 
cell cycle is halted at G2, providing additional time for DNA repair (Finn et 
al., 2012). Upon completion of DNA repair, cells exit the G2 arrest and 
resume to mitosis (Bartek and Lukas, 2007). Recovery from the checkpoint 
involves degradation of checkpoint mediator proteins, and activation of cell 
cycle promoting cyclin-CDK complexes (Bartek and Lukas, 2007). 
1.5.3 Meiotic DNA damage checkpoint: insight from other organisms 
An analogous DNA damage checkpoint is believed to operate in 
meiotic cells (Roeder and Bailis, 2000). Studies in the budding yeast S. 
cerevisiae have shown that the ATR and ATM orthologs, mitosis entry 
checkpoint 1 (Mec1; denoted Mec1ATR) and telomere maintenance 1 (Tel1; 
denoted Tel1ATM), respectively, are essential for arresting cells at 
pachynema in the presence of persistent DNA DSBs (Hochwagen and Amon, 
2006).  
In S. cerevisiae, two distinct DNA damage checkpoints operate during 
meiosis. The first pathway depends upon Tel1ATM and is activated by DNA 
DSBs with unprocessed DNA ends (Harrison and Haber, 2006). The second 
pathway, called the recombination checkpoint, is mediated by Mec1ATR and 
is activated by DNA DSBs with resected ends (Hong and Roeder, 2002; 
Lydall et al., 1996). Once activated, Mec1ATR phosphorylates the yeast 
ortholog of HORMAD1/2, called homolog pairing 1 (Hop1), which 
subsequently activates the CHK2-related effector kinase meiotic kinase 1 
(Mek1; denoted Mek1CHK2) (Carballo et al., 2008). Activated Mek1CHK2 then 
phosphorylates and activates saccharomyces wee1 (Swe1). In turn, Swe1 
inactivates the yeast ortholog of CDK1, cell division cycle 28 (Cdc28), 
resulting in meiotic arrest cells at pachynema (Leu and Roeder, 1999).  
Following DSB repair, checkpoint recovery is mediated by the 
transcription factor non-dityrosine 1 (Ndt80). While inactive in the presence 
of DNA damage, Ndt80 becomes activated once DNA lesions are repaired, 
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thereby allowing re-entry into meiosis (Chu and Herskowitz, 1998; Tung et 
al., 2000).  
This meiotic DNA damage checkpoint is thought to operate in other 
organisms. For example, persistent meiotic DSBs also trigger oocyte arrest 
in C. elegans, suggesting that a DNA damage checkpoint is active (Gartner et 
al., 2000). This checkpoint triggers oocyte death at pachynema and is 
mediated by the C. elegan orthologs of ATR (ATM like 1; ATL-1), HORMAD1 
(high incidence of males 3; HIM-3) and CHK2 (CHK-2), among other proteins 
(Gartner et al., 2000; Jaramillo-Lambert et al., 2010; MacQueen and 
Villeneuve, 2001; Stergiou and Hengartner, 2004).  
A DNA damage checkpoint has also been reported in the fission yeast 
Schizosaccharomyces pombe. This DNA damage checkpoint is dependent on 
the S. pombe orthologs of ATR (Rad3) and CHK2 (Cds1) (Perera et al., 2004; 
Pérez-Hidalgo et al., 2003; Shimada et al., 2002). Interestingly, some but not 
all S. pombe meiotic mutants with persistent DNA DSBs are subject to 
checkpoint arrest (Catlett and Forsburg, 2003; Pérez-Hidalgo et al., 2003). 
This suggests that the meiotic DNA damage checkpoint is less stringent, or 
more specific to only certain types of DNA lesions, in S. pombe.  
A DNA damage checkpoint has also been suggested in Drosophila 
melanogaster. Mutant flies with persistent unrepaired DSBs exhibit oocyte 
arrest (Ghabrial and Schüpbach, 1999; Jang et al., 2003). This arrest is 
mediated by ATR, indicating a highly conserved role for ATR in the meiotic 
DNA damage checkpoint (Joyce et al., 2011).  
1.5.4 DNA damage checkpoint model in mice 
Compelling evidence for a existence of DNA damage checkpoint in 
mammals comes from studies of mice with persistent unrepaired DNA DSBs. 
Deletion of genes involved in DNA DSB repair and meiotic recombination, 
such as Dmc1, Atm, and Msh5, result in persistent unrepaired DNA DSBs and 
significant germ cell losses and infertility (Intro Figure 7) (Barchi et al., 
2005; Di Giacomo et al., 2005). In female mice, these germ cell losses are 
partially reversed when DNA DSBs are abolished, i.e. by mutating Spo11 or 
meiosis 1 (Mei1) (Di Giacomo et al., 2005; Reinholdt and Schimenti, 2005). 
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These experiments provide strong genetic evidence that persistent 
unrepaired DNA DSBs can trigger oocyte losses in mice. 
The role of DNA damage checkpoint proteins in mice is not very well 
understood. This is in part because deletion of putative checkpoint genes, 
such as Atr, Rad9, Rad1 and Hus1, are incompatible with life (Brown and 
Baltimore, 2000; Han et al., 2010; Hopkins et al., 2004; Weiss et al., 2000). 
However, a recent study has provided evidence that ATM has a role in the 
meiotic DNA checkpoint in mice (Pacheco et al., 2015). Deletion of Atm in 
mice with recombination defects, i.e. Trip13 mutants, allows spermatocyte 
progression to a later stage in pachynema (Pacheco et al., 2015). This 
implicates ATM in a DNA damage/recombination checkpoint that operates 
during early pachynema.  
Recently, a conserved role for CHK2 in the meiotic DNA damage 
checkpoint has also been described in mice (Bolcun-Filas et al., 2014; 
Pacheco et al., 2015). Chk2 is dispensable for viability and fertility in mice 
(Takai et al., 2002). Deleting Chk2 in mouse mutants with persistent 
unrepaired DNA DSBS, such as Dmc1-/- females (Pittman et al., 1998) and  
thyroid hormone receptor interactor 13 (Trip13) mutant females (Li and 
Schimenti, 2007), enables prolonged survival of oocytes (Bolcun-Filas et al., 
2014). However, while Chk2-/- Trip13-/- mutants are fertile for several 
months, they only have a fraction (~25%) of the normal number of oocytes 
after birth (Bolcun-Filas et al., 2014), suggesting that the rescue is 
incomplete. CHK2-dependent oocyte losses are hypothesized to be mediated 
by the upstream kinase ATR and the downstream effectors p53 and p63 
(Bolcun-Filas et al., 2014). CHK2 is also thought to mediate the activation of 
the DNA damage/recombination checkpoint that occurs in Trip13 mutant 
spermatocytes (Pacheco et al., 2015).  
 In mice, the timing and kinetics of germ cell arrest in response to 
DNA damage is sexually dimorphic. Atm-/-, Dmc1-/-, and Msh5-/- mutant 
males experience a complete germ cell arrest at early pachynema (Barchi et 
al., 2005), with no cells progressing beyond. By contrast, in the female germ 
line, half of the mutant oocytes are eliminated by birth, corresponding to 
late diplonema/dicytate (Di Giacomo et al., 2005). The remaining oocytes 
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are eliminated over the next 2-3 postnatal weeks of development (Di 
Giacomo et al., 2005). This suggests that the meiotic DNA damage 
checkpoint is less stringent, delayed, and/or operates over a longer 
developmental period in females compared to males (Nagaoka et al., 2012).  
 The meiotic DNA damage checkpoint in mammals can also be 
triggered by other sources of DNA DSBs, such as those derived from 
retrotransposons. Retrotransposons are mobile genetic elements that utilize 
an RNA intermediate to facilitate insertion into new sites in the genome 
(Goodier and Kazazian, 2008). In addition to being an insertional mutagen, 
retrotransposons can produce hazardous DNA DSBs during the process of 
retrotransposition (Soper et al., 2008). Therefore, in mice, developing germ 
cells have mechanisms to suppress the expression of potentially mutagenic 
retrotransposons (Ollinger et al., 2010). These mechanisms involve DNA 
methylation (Bourc'his and Bestor, 2004; De La Fuente et al., 2006), Piwi-
like proteins (Aravin et al., 2007; Kuramochi-Miyagawa et al., 2008), and 
other components such as Maelstrom (Mael) (Soper et al., 2008) and testis 
expressed gene 19.1 (Tex19.1) (Ollinger et al., 2008). Mice lacking any of 
these factors have increased expression of retrotransposons and defects in 
meiosis which compromise fertility (Ollinger et al., 2010). For example, 
Mael-/- mutants accumulate retrotransposon-derived DNA DSBs and fail to 
complete meiotic prophase I (Soper et al., 2008). This highlights that 
misexpression of retrotransposons can lead to DNA damage checkpoint 
activation.  
Interestingly, retrotransposon-derived DNA DSBs may be important 
for fetal oocyte attrition (FOA) in wildtype females (Malki et al., 2014). FOA 
is a normal developmental process in mammals in which ~80% of the initial 
pool of oocytes are eliminated by birth (Burgoyne and Baker, 1985; Pepling 
and Spradling, 2001). While the molecular basis of FOA has been long 
debated (Pepling and Spradling, 2001), recent work showed that 
widespread derepression of retrotransposons in developing oocytes causes 
DNA DSBs (Malki et al., 2014). As repressive DNA methylation marks are 
erased in fetal oocytes during epigenetic reprogramming, retrotransposons 
are transiently reactivated (Lees-Murdock and Walsh, 2008). This opens up 
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a period of time in which oocytes are prone to the DNA damaging effects of 
retrotransposons. A critical role for retrotransposons in FOA is supported 
by experiments showing that FOA losses increase when LINE-1 
retrotransposons are upregulated, and decreased by the reverse 
transcriptase inhibitor AZT (Malki et al., 2014). In summary, the DNA 
damage checkpoint is an important process in normal and defective oocytes.  
  
 71 
 
 
Introduction Figure 7: Meiotic DNA damage checkpoint model of 
germ cell loss in mice. 
Under the DNA damage checkpoint model, endogenous or exogenous DNA 
DSBs that remain persistently unrepaired activates a signaling cascade that 
results in cell elimination at pachynema and/or diplonema. This model has 
been proposed to explain the oocyte losses experienced by female meiotic 
mutants with persistent unrepaired DNA DSBs (e.g. Dmc1-/-, Msh5-/-, Atm-
/-).   
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1.5.5 Asynapsis checkpoint model 
In addition to the DNA damage checkpoint, some organisms also have 
an asynapsis checkpoint, which monitors the fidelity of synapsis in a DNA 
damage-independent manner (MacQueen and Hochwagen, 2011). Under the 
asynapsis checkpoint, defects in chromosome axis structure and/or 
synaptonemal complex formation trigger germ cell arrest and elimination 
(Intro Figure 8).  
In mice, synapsis and meiotic recombination are intimately coupled, 
such that failed synapsis can result in delayed or defective DNA DSB repair 
(de Vries et al., 2005). This makes it difficult to determine the precise 
mechanism responsible for germ cell losses in cells with asynapsis. For 
example, asynapsed chromosomes could cause germ cell losses through a 
DNA damage checkpoint that is triggered by persistent unrepaired DNA 
DSBs. Alternatively, asynapsed chromosomes could directly trigger a DNA 
damage-independent asynapsis checkpoint. Owing to the difficulties of 
dissecting the asynapsis checkpoint in mammals, most of our understanding 
of the asynapsis checkpoint comes from studies of other organisms, such as 
C. elegans. 
In C. elegans, synapsis and meiotic recombination are mechanistically 
separable, such that synapsis can occur in the absence of meiotic DNA DSBs 
(Dernburg et al., 1998). Synapsis in C. elegans is mediated by distinct genetic 
regions called pairing centers (PCs) (MacQueen et al., 2005). If chromosome 
PCs are asynapsed at pachynema, a checkpoint is elicited and the defective 
oocytes are eliminated (Bhalla and Dernburg, 2005). These oocyte losses 
occur via a DNA DSB-independent pathway that involves CHK1 (Jaramillo-
Lambert and Engebrecht, 2010; MacQueen and Hochwagen, 2011) and 
pachytene checkpoint 2 (PCH-2) (Bhalla and Dernburg, 2005).  
Interestingly, the normally asynapsed X chromosome in XO C. elegans 
males does not trigger the asynapsis checkpoint (Jaramillo-Lambert and 
Engebrecht, 2010). Repressive chromatin marks, including H3K9me2, are 
thought to shield the asynapsed X chromosome from triggering the 
asynapsis checkpoint (Checchi and Engebrecht, 2011). However, 
accumulation of H3K9me2 on asynapsed autosomes does not prevent 
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checkpoint activation, suggesting that there are different functional 
responses on different chromosomes (Checchi and Engebrecht, 2011). 
An asynapsis checkpoint is also suspected to operate in yeast. In S. 
cerevisiae, the checkpoint protein PCH2 is required for germ cell arrest in 
certain mutants with SC formation defects (San-Segundo and Roeder, 1999; 
Wu and Burgess, 2006). However, these SC mutations also have meiotic 
recombination defects, making it difficult to determine the proximal cause of 
PCH2-dependent arrest in yeast (MacQueen and Hochwagen, 2011).  
In mice, evidence for an asynapsis checkpoint comes from studies of 
mutants lacking meiotic DNA DSBs, i.e. Spo11-/- and Mei1-/- animals. Both 
Spo11-/- (Baudat et al., 2000; Romanienko and Camerini-Otero, 2000) and 
Mei1-/- mice (Libby et al., 2002) lack programmed meiotic DNA DSBs, have 
extensive asynapsis, and experience profound germ cell losses resulting in 
infertility (Baudat et al., 2000; Di Giacomo et al., 2005; Libby et al., 2002; 
Romanienko and Camerini-Otero, 2000). This suggests a DNA DSB-
independent surveillance mechanism operates in mice.  
The molecular details of this DNA DSB-independent pathway remain 
largely unclear. However, recent work has shown that deletion of Hormad1 
rescues oocyte losses in Spo11-/- females (Daniel et al., 2011; Kogo et al., 
2012b). This implicates HORMAD1 in the meiotic surveillance response to 
asynapsis. One possibility is that HORMAD1 recruits important asynapsis 
signaling proteins, such as ATR, which triggers an asynapsis checkpoint 
(Daniel et al., 2011). Alternatively, since HORMAD1 is necessary for meiotic 
silencing, it may trigger germ cell losses through meiotic silencing of critical 
genes (Daniel et al., 2011).  The role of the mouse ortholog of the checkpoint 
protein PCH2, called TRIP13, is not fully understood. However, Trip13 
deficiency in mice does not rescue germ cell arrest in recombination- and 
synapsis-defective germ cells, suggesting that TRIP13 does not function in 
an asynapsis checkpoint in mice (Li and Schimenti, 2007; Roig et al., 2010).  
The timing of germ cell arrest in Spo11-/- and Mei1-/- mice is 
sexually dimorphic. In mutant males, spermatocytes arrest at mid-
pachynema, while in mutant females, oocytes are eliminated over a longer 
time period (Baudat et al., 2000; Di Giacomo et al., 2005; Libby et al., 2002). 
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Spo11-/- females lose 50% of their total oocyte pool by birth, and the 
remaining are lost over the next 2-3 weeks, when oocytes are arrested in 
dictyate (Di Giacomo et al., 2005). Differences in the timing of germ cell 
arrest imply that the DNA DSB-independent, asynapsis checkpoint is less 
efficient in females than males, or that different mechanisms operate in each 
sex.  
It is also possible that an asynapsis checkpoint operates in response 
to chromosome abnormalities, such as monosomies, inversions, and 
translocations. These chromosome abnormalities disrupt synapsis during 
meiosis, and thus are useful models for dissecting the asynapsis surveillance 
mechanisms in mammals. Furthermore, since these models do not have 
mutations in key meiotic genes, they are valuable for understanding the 
response to asynapsis in the context of normal biology.    
One useful chromosomally abnormal mouse model is the XO female 
mouse, which has a single X chromosome (Burgoyne and Baker, 1981, 
1985). The XO condition in humans leads to Turner syndrome. XO female 
mice are subfertile, defined as having a shortened reproductive lifespan 
compared to XX females (Burgoyne and Baker, 1981, 1985). XO subfertility 
has been linked to a wave of oocyte losses occurring during late prophase I 
(Burgoyne and Baker, 1985). This wave of oocyte losses correlates with an 
increased number of atretic or degenerating cells at 19.5 dpc, when oocytes 
are at late pachynema and early diplonema (Burgoyne and Baker, 1985).  
Interestingly, electron microscopy analysis of XO oocytes revealed 
that the single X chromosome in subset of XO oocytes forms a self-synapsed 
“hairpin” (Speed, 1986). This hairpin represents non-homologous synapsis 
and is mediated by the synapsis protein SYCP1 (Hodges et al., 2001). The 
percentage of pachytene XO oocytes with self-synapsed X chromosome 
increases during the period from 16.5 to 19.5 dpc, and the percentage of 
oocytes with an asynapsed X chromosome decreases (Hodges et al., 2001; 
Speed, 1986). This suggests that XO oocytes with an asynapsed X 
chromosome are eliminated during prophase I. It is possible that these 
oocytes with X chromosome asynapsis are eliminated by an asynapsis 
checkpoint. However, there are several other possible mechanisms that 
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could be responsible for XO oocyte losses, including a DNA damage 
checkpoint and a meiotic silencing-based mechanism (discussed in the next 
section). Therefore, there are still many unresolved questions concerning 
the molecular players involved in the asynapsis checkpoint and its 
contribution to germ cell losses in mice with chromosome abnormalities.  
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Introduction Figure 8: Asynapsis checkpoint model of germ cell 
loss in mice. 
Under the asynapsis checkpoint model, germ cells with asynapsed 
chromosomes at pachynema trigger a checkpoint and subsequent germ cell 
losses. This pathway functions independent of meiotic DNA DSBs. Such a 
checkpoint may contribute to the oocyte losses observed in Spo11-/- 
females, which lack meiotic DNA DSBs, but have extensive asynapsis. The 
precise timing and the molecular machinery of this putative checkpoint 
remain largely unclear. The pathway may involve HORMAD1 and/or ATR 
(Daniel et al., 2011).  
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1.5.6 Meiotic silencing model of meiotic surveillance 
The discovery of meiotic silencing of asynapsed chromosome in 
mammals (Baarends et al., 2005; Turner et al., 2005) has lead to another 
model of synaptic surveillance based on gene silencing (Schimenti, 2005). 
Under this model, meiotic silencing leads to the elimination of germ cells 
with asynapsis by inactivating critical genes on asynapsed chromosomes 
(Intro Figure 9) (Burgoyne et al., 2009; Schimenti, 2005). 
The meiotic silencing model of germ cell arrest was first proposed 
based upon studies of XO female mice (Baarends et al., 2005; Turner et al., 
2005). These studies showed that the asynapsed X chromosome in XO 
oocytes accumulates silencing factors, including BRCA1, ATR, H2AFX, and 
ubi-H2A (Baarends et al., 2005; Turner et al., 2005). They also provided 
evidence based on Cot-1 RNA FISH (Turner et al., 2005) and RNA PolII 
staining (Baarends et al., 2005) that the asynapsed X chromosome in XO 
oocytes is transcriptional repressed. Since the X chromosome is enriched in 
genes involved in oogenesis (Khil et al., 2004), silencing of the X 
chromosome in XO females is likely incompatible with oocyte survival. 
Therefore, meiotic silencing may be a cause of XO oocyte losses by starving 
developing oocytes of important gene products (Intro Figure 9) (Burgoyne 
et al., 2009). 
Genetics support for the meiotic silencing model comes from an 
analysis of meiotic mutant female mice (Kouznetsova et al., 2009). Females 
deficient in the gene structural maintenance of chromosomes 1B (Smc1) 
have variable levels of asynapsis, and experience oocyte losses and 
infertility (Revenkova et al., 2004). In 30% of Smc1-/- pachytene oocytes, 
up to 2-3 pairs of chromosomes are asynapsed, and they accumulate the 
silencing factors BRCA1 and H2AFX (Kouznetsova et al., 2009). However, 
when more than 2-3 pairs of asynapsed chromosomes are present, BRCA1 
accumulation on asynapsed axes is reduced, suggesting that the BRCA1 pool 
is limited and that silencing breaks down in oocytes with extensive 
asynapsis (Kouznetsova et al., 2009). Another study showed that 
spermatocytes also have limited pool of BRCA1, and suggested that BRCA1 
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is sequestered at unrepaired DNA DSBs in mutants with extensive asynapsis 
and recombination defects (Mahadevaiah et al., 2008). 
To address whether meiotic silencing or BRCA1/H2AFX signaling is 
involved in Smc1 oocyte losses, Kouznetsova and colleagues tested 
whether disrupting Sycp3, which is required for silencing (Fukuda et al., 
2012), improves survival of Smc1-/- oocytes (Kouznetsova et al., 2009). 
Indeed, Sycp3-/- Smc1-/- females have 25% more oocytes than Smc1-/- 
females at birth (Kouznetsova et al., 2009). They concluded that the 
silencing machinery, SYCP3/BRCA1/H2AFX, is required for a subset 
Smc1-/- oocyte losses (Kouznetsova et al., 2009). However, Sycp3-/- 
mutants have numerous meiotic defects, including meiotic recombination 
and synaptonemal complex defects (Yuan et al., 2000), and there is evidence 
that Sycp3 may also influence the DNA damage checkpoint in oocytes (Wang 
and Hoog, 2006). More research is therefore required to clarify the 
contribution of meiotic silencing and other checkpoints to oocyte losses. 
Meiotic silencing has also been invoked as a mechanism responsible 
for the elimination of synapsis-defective Spo11-/- oocytes (Burgoyne et al., 
2009). Traditionally, Spo11-/- oocyte losses were hypothesized to be driven 
by an asynapsis checkpoint (Di Giacomo et al., 2005). However, recent 
studies have revealed that Spo11-/- oocytes mount a meiotic silencing 
response involving a subset of asynapsed chromosomes (Carofiglio et al., 
2013; Daniel et al., 2011; Shin et al., 2010). It is therefore conceivable that 
silencing of critical genes in Spo11-/- oocytes could contribute to oocyte 
losses.   
In support of a meiotic silencing mechanism of Spo11-/- oocyte 
losses, disrupting the essential silencing factor HORMAD1 rescues Spo11-/- 
oocyte losses (Daniel et al., 2011; Kogo et al., 2012b). Hormad1-/- Spo11-/- 
oocytes do not initiate meiotic silencing due to defects in ATR recruitment 
and H2AFX accumulation (Daniel et al., 2011; Kogo et al., 2012a; Kogo et al., 
2012b; Wojtasz et al., 2012). While these studies implicate meiotic silencing 
as the cause of Spo11-/- oocyte losses, it is also possible that HORMAD1 
facilitates Spo11-/- oocyte losses via an alternative pathway, such as an 
asynapsis checkpoint (Daniel et al., 2011; Kogo et al., 2012b).  
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In summary, more research is needed to understand the role of 
meiotic silencing as a potential surveillance mechanism against asynapsis in 
mice.  Furthermore, it is still unclear which of the meiotic surveillance 
mechanisms contribute to germ cell losses in mice with chromosome 
abnormalities, such as XO mice. Determining the relative contributions of 
each putative mechanism of meiotic surveillance – the DNA damage 
checkpoint, asynapsis checkpoint, and meiotic silencing – to oocyte losses 
represents an important challenge.   
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Introduction Figure 9: Meiotic silencing model of germ cell loss in 
mice. 
Under the meiotic silencing model of germ cell loss, asynapsed 
chromosomes at pachynema trigger a the accumulation of meiotic silencing 
factors that causes the inactivation of critical genes, such as those required 
for meiosis and oogenesis. Starving germ cells of essential gene products is 
expected to lead to germ cell death. This mechanism has been proposed to 
explain oocyte losses in mice with chromosome abnormalities, i.e. XO female 
mice (Burgoyne et al., 2009).   
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1.6 Aims of thesis 
The principal goals of this thesis are: (1) to identify and characterize 
the meiotic surveillance mechanisms that mediate oocyte losses in female 
mice with chromosome abnormalities; (2) to characterize the meiotic 
silencing response in oocytes; and (3) to study the molecular factors 
involved in meiotic silencing pathway. 
 
Specifically, I will address the following aims: 
 
1. Determine the developmental timing of oocyte losses in mice with 
chromosome abnormalities.  
2. Examine the contribution of the following models of meiotic 
surveillance on oocyte loss in mice with chromosome 
abnormalities: 
a. DNA damage checkpoint  
b. Asynapsis checkpoint 
c. Meiotic silencing  
3. Characterize the meiotic silencing response in oocytes at the single 
gene level. 
4. Characterize the role of BRCA1 and HORMAD2 in meiotic silencing. 
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2 Materials and Methods 
2.1. Mice  
Unless otherwise noted, all mice were generated on a randomly bred 
MF1 Swiss albino background at NIMR according to UK Home Office 
Regulations. Wildtype XX mice used in this thesis were either of MF1 or 
C57BL/6 origin, as indicated in the particular experiment. A variety of 
mouse models were used in this study, and the origin of each are described 
below. 
To generate embryos at specific gestational ages, female mice were 
set up in matings and checked each morning for vaginal plugs. The day that 
a vaginal plug was identified was considered 0.5 days post coitum (dpc). 
Embryos were sacrificed at 17.5, 18.5, 19.5 and 20.5 dpc using UK Home 
Office Schedule I methods. Ovaries were dissected from embryos, flash 
frozen in liquid nitrogen, and stored at -80°C until later use.  
2.1.1 XO mice 
XO mice containing a single maternal X chromosome were produced 
by mating XX females with fertile XYO males. XYO males carry an X 
chromosome fused to a Y chromosome at a shared pseudoautosomal (PAR) 
region (Eicher et al., 1991). Because the XY chromosome segregates as one 
unit, XYO males produce XY and O gametes (see Punnett square, below). XO 
females (red) are generated when an O-bearing sperm from XYO studs 
fertilizes an X-bearing egg.  
 
 XYO 
 XY O 
XX 
X XXY XO 
X XXY XO 
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2.1.2 In(X)1H mice 
Heterozygous female carriers of the In(X)1H inversion were 
generated by crossing wildtype XX females with In(X)1H/Y males (see 
Punnett square, below) (Evans and Phillips, 1975; Tease and Fisher, 1986). 
The In(X)1H/Y male was originally derived from a mouse colony that had 
received radiation treatment (Evans and Phillips, 1975). This inversion 
encompasses 85% of the X chromosome, which disrupts meiotic pairing in a 
subset of In(1)1H oocytes (Koehler et al., 2004; Tease and Fisher, 1986). 
 
 In(X)Y 
 In(X) Y 
XX 
X In(X)X XY 
X In(X)X XY 
 
2.1.3 T(16;17)43H mice 
T(16;17)43H (referred to as T43H mice) females were a  gift from Jiří 
Forejt (Institute of Molecular Genetics of the ASCR, Czech Republic). These 
mice were generated on the C57BL/10ScSnPh (B10) background, as 
previously described (Forejt et al., 1980; Homolka et al., 2007; Searle, 1978).  
T43H/+ male heterozygote carriers are sterile and cannot be used for 
colony maintenance (Searle, 1978).  By contrast, T43H/T43H male 
homozygotes are fertile and are breed to wildtype XX females to generate 
T43H/+ female heterzygotes (See Punnet square, below) (Forejt et al., 
1980). T43H/T43H homozygous males were generated by crossing T43H/+ 
heterozygous females, which are fertile, to males homozygous for a 
Robertsonian translocation, Rb(16.17)7Brn, as previously described (Forejt 
et al., 1980; Searle, 1978). 
 
 
 
XY T43H/T43H 
 X T43H Y T43H 
XX +/+ 
X + XX T43/+ XY T43/+ 
X + XX T43/+ XY T43/+ 
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2.1.4 Tc1 mice 
Tc1 mice (i.e. hemizygous carriers of human chromosome 21) were 
produced by crossing Tc1 hemizygous males (h21/+) to XX wildtype 
females (+/+) (see Punnett square, below). The Tc1 transchromosomic 
mouse (Tc(Hsa21)1TybEmcf), a gift from Victor Tybulewicz, was originally 
developed as a model of Down syndrome and carries a single and near 
complete copy of human chromosome 21 (O'Doherty et al., 2005). Due to the 
irradiation used to generate this mouse model, the h21 chromosome is 
genetically shuffled and contains 25 structural rearrangements, six 
duplications and one deletion (Gribble et al., 2013). Since the accessory 
chromosome freely segregates as a distinct unit, Tc1 males generate both 
h21-bearing sperm and sperm carrying the wildtype (+) complement of 
chromosome. 
 
 h21/+ 
 h21 + 
+/+ 
+ h21/+ +/+ 
+ h21/+ +/+ 
 
2.1.5 XYd1 mice 
XYd1 mice contain Y chromosome with a deletion that prevents the 
expression of the sex-determining gene Sry in developing gonads. This 
causes XYd1 mice to develop as females (Capel et al., 1993; Mahadevaiah et 
al., 1998). The XYd1 female was originally produced by crossing XX females 
with XSxra/Y males, which contain a duplicated copy of the Y short arm (Yp) 
transposed on the X chromosome (XSxra) (Capel et al., 1993).  
Asymmetric meiotic recombination between the duplicated regions 
of the XSxra and Y chromosomes generates several variants of the X and Y 
chromosomes, including the Yd1 chromosome (Capel et al., 1993). The Yd1 
chromosome is missing several copies of Sx1 band C repeat on the Yp region 
of the chromosome, and this leads to Sry silencing by long range position 
effects (Capel et al., 1993). XYd1 females were maintained by mating them 
 85 
with normal XY males. XYd1 females were also used to generate XXYd1 
females (see Punnett square, next section). 
2.1.6 XXYd1 mice 
XXYd1 females were produced by mating a wild type XY stud to a sex-
reversed XYd1 female. The X and Y chromosomes rarely pair in oocytes 
(Mahadevaiah et al., 1993), and as a result the X and Yd1 chromosomes 
segregate randomly at metaphase I of meiosis. Because of X-Yd1 
nondisjunction, XYd1 females produce four types of gametes: X, Yd1, XYd1 and 
O (see Punnett square, below). Therefore, the XY x XYd1 mating generates 
eight different genotypes, and XXYd1 females (red) are produced when an X-
bearing sperm fertilizes an XYd1-bearing egg.   
 
 XY 
 X Y 
XYd1 
X XX XY 
Yd1 XYd1 Yd1Y 
XYd1 XXYd1 XYd1Y 
O XO YO 
 
2.1.7 H2afx-/- and XO H2afx-/- mice 
H2afx-/- mice were a gift from Andre Nussensweig (National 
Institutes of Health, USA), and contain a null mutation due to a neomycin 
resistance cassette inserted within the 5’ end of the single exon of the H2afx 
locus (Celeste et al., 2002; Petersen et al., 2001). H2afx-/- mice were used to 
generate XO H2afx-/- females (see below), H2afx-/- Spo11-/- females 
(Section 2.1.9), and H2afx-/- Dmc1-/- females (Section 2.1.10). 
XO H2afx-/- mice were produced in three generations of matings. In 
the first step, XO H2afx+/- females were produced.  This was achieved by 
crossing fertile XYO males with XX H2afx+/- females (see Punnett square, 
step 1). 
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Step 1:  XYO H2afx+/+ 
 XY H2afx+ O H2afx+ 
XX 
H2afx+/- 
X H2afx+ 
XXY 
H2afx+/+ 
XO 
H2afx+/+ 
X H2afx- 
XXY 
H2afx+/- 
XO 
H2afx+/- 
 
In the second step, the fertile XO H2afx+/- females were then used 
generate XYO H2afx+/- male mice. This was achieved by crossing XO 
H2afx+/- females with XYO fertile males (see Punnett square, step 2). 
 
Step 2:  XYO H2afx+/+ 
 XY H2afx+ O H2afx+ 
XO H2afx+/- 
X H2afx+ 
XXY 
H2afx+/+ 
XO 
H2afx+/+ 
O H2afx- 
XYO 
H2afx+/- 
OO 
H2afx+/- 
 
Finally, fertile XYO H2afx+/- males were crossed with XX H2afx+/- 
females to generate XO H2afx-/- females (see Punnett square, step 3). 
 
Step 3: XYO H2afx+/- 
 XY 
H2afx+ 
XY 
H2afx- 
O H2afx+ O H2afx- 
XX 
H2afx+/- 
X 
H2afx+ 
XXY 
H2afx+/+ 
XXY 
H2afx+/- 
XO 
H2afx+/+ 
XO 
H2afx+/- 
X 
H2afx- 
XXY 
H2afx+/- 
XXY 
H2afx-/- 
XO 
H2afx+/- 
XO 
H2afx-/- 
 
2.1.8 Spo11-/- and XO Spo11+/-  
Spo11-/- mice were a gift from Scott Keeney (Memorial Sloane-
Kettering Cancer Center, USA). The Spo11 knockout allele contains a 
neomycin resistance cassette that replaces exons 4 through 6, including the 
putative catalytic tyrosine encoded in exon 5, as previously described 
(Baudat et al., 2000). Spo11-/- mice were used for two separate purposes, to 
generate XO Spo11+/- females (see below) and H2afx-/- Spo11-/- females 
(Section 2.1.9). 
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XO Spo11+/- females were generated on a mixed C57BL/6 and MF1 
background by mating fertile XYO males (MF1) to XX Spo11+/- females 
(C57BL/6) (see Punnett square, below).  
 
 XYO 
 XY Spo11+ O Spo11+ 
XX 
Spo11+/- 
X 
Spo11+ 
XXY 
Spo11+/+ 
XO 
Spo11+/+ 
X 
Spo11- 
XXY 
Spo11+/- 
XO 
Spo11+/- 
 
2.1.9 H2afx-/- Spo11-/- mice 
H2afx-/- Spo11-/- females were generated in two generations of 
matings on a mixed C57BL/6 and MF1 background. In the first step, 
H2afx+/- Spo11+/- mice were generated by crossing Spo11+/- males and 
H2afx+/- females (see Punnett square, step 1). 
 
Step 1:  H2afx+/+ Spo11+/- 
 H2afx+ Spo11+ H2afx+ Spo11- 
H2afx+/- 
Spo11+/+ 
H2afx+ 
Spo11+ 
H2afx+/+ 
Spo11+/+ 
H2afx+/+ 
Spo11+/- 
H2afx- 
Spo11+ 
H2afx+/- 
Spo11+/+ 
H2afx+/- 
Spo11+/- 
 
Next, H2afx-/- Spo11-/- females were produced by crossing the 
double heterozygotes (see Punnett square, step 2). 
Step 2: H2afx+/- Spo11+/- 
 
H2afx+ 
Spo11+ 
H2afx+ 
Spo11- 
H2afx- 
Spo11+ 
H2afx- 
Spo11- 
H2afx+/- 
Spo11+/- 
H2afx+ 
Spo11+ 
H2afx+/+ 
Spo11+/+ 
H2afx+/+ 
Spo11+/- 
H2afx+/- 
Spo11+/
+ 
H2afx+/- 
Spo11+/- 
H2afx+ 
Spo11- 
H2afx+/+ 
Spo11+/- 
H2afx+/+ 
Spo11-/- 
H2afx+/- 
Spo11+/- 
H2afx+/- 
Spo11-/- 
H2afx- 
Spo11+ 
H2afx+/- 
Spo11+/+ 
H2afx+/- 
Spo11+/- 
H2afx-/- 
Spo11+/
+ 
H2afx-/- 
Spo11+/- 
H2afx- 
Spo11- 
H2afx+/- 
Spo11+/- 
H2afx+/- 
Spo11-/- 
H2afx-/- 
Spo11+/- 
H2afx-/- 
Spo11-/- 
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2.1.10 Dmc1-/- and H2afx-/- Dmc1-/- mice 
Dmc1-/- mice were a gift from Attila Tóth (Technische Universität 
Dresden, Germany) and were maintained on a mixed genetic background. 
Dmc1-/- mice contain a deletion in the region encoding the conserved DNA 
binding domain necessary for its RecA-like enzymatic activity (Pittman et 
al., 1998).  
Dmc1-/- mice were used to generate H2afx-/- Dmc1-/- females in two 
steps. The first step produced H2afx+/- Dmc1+/- double heterozygotes (see 
Punnett square, step 1). 
 
Step 1:  H2afx+/+ Dmc1+/- 
 H2afx+ Dmc1+ H2afx+ Dmc1- 
H2afx+/- 
Dmc1+/+ 
H2afx+ 
Dmc1+ 
H2afx+/+ 
Dmc1+/+ 
H2afx+/+ 
Dmc1+/- 
H2afx- 
Dmc1+ 
H2afx+/- 
Dmc1+/+ 
H2afx+/- 
Dmc1+/- 
 
In the second step, the double heterozygotes were crossed (see Punnett 
square, step 2) 
 
 
Step 2: H2afx+/- Dmc1+/- 
 H2afx+ 
Dmc1+ 
H2afx+ 
Dmc1- 
H2afx- 
Dmc1+ 
H2afx- 
Dmc1- 
H2afx+/- 
Dmc1+/- 
H2afx+ 
Dmc1+ 
H2afx+/+ 
Dmc1+/+ 
H2afx+/+ 
Dmc1+/- 
H2afx+/- 
Dmc1+/+ 
H2afx+/- 
Dmc1+/- 
H2afx+ 
Dmc1- 
H2afx+/+ 
Dmc1+/- 
H2afx+/+ 
Dmc1-/- 
H2afx+/- 
Dmc1+/- 
H2afx+/- 
Dmc1-/- 
H2afx- 
Dmc1+ 
H2afx+/- 
Dmc1+/+ 
H2afx+/- 
Dmc1+/- 
H2afx-/- 
Dmc1+/+ 
H2afx-/- 
Dmc1+/- 
H2afx- 
Dmc1- 
H2afx+/- 
Dmc1+/- 
H2afx+/- 
Dmc1-/- 
H2afx-/- 
Dmc1+/- 
H2afx-/- 
Dmc1-/- 
 
  
 89 
2.1.11 Hormad2-/- mice 
Hormad2-/- mice were a gift from Attila Tóth (Technische Universität 
Dresden, Germany), and were maintained on a mixed background. 
Hormad2-/- mice have a deletion of exon 4 (Wojtasz et al., 2012).  Hormad2-
/- mice were generated by crossing heterozygotes (see Punnett square, 
below). 
 
 Hormad2+/- 
 Hormad2+ Hormad2- 
Hormad2+/- 
Hormad2+ Hormad2+/+ Hormad2+/- 
Hormad2- Hormad2+/- Hormad2-/- 
 
2.1.12 Brca1-/- 53bp1-/- mice 
Deletion of Brca1 causes embryonic lethality at 5.5-8.5 days post 
coitum (dpc) in mice (Ludwig et al., 1997). This embryonic lethality can be 
overcome with a homozygous null mutation in 53bp1 (Bunting et al., 2012). 
Brca1-/- 53bp1-/- mice were a gift from Andre Nussenzweig (National 
Institutes of Health, USA), and were maintained on a genetically mixed 
background. In these mice, the Brca1 locus is disrupted by replacement of 
exon 2 with a neomycin resistance cassette (Ludwig et al., 1997), and 53bp1 
locus is disrupted at a 3’ exon with a neomycin resistance cassette  (Ward et 
al., 2003). Brca1-/- 53bp1-/- males were generated as shown in the Punnett 
square below: 
 
 Brca1+/- 53bp1-/- 
 Brca1+ 53bp1- Brca1- 53bp1- 
Brca1+/- 
53bp1-/- 
Brca1+ 
53bp1- 
Brca1+/+ 
53bp1-/- 
Brca1+/- 
53bp1-/- 
Brca1- 
53bp1- 
Brca1+/- 
53bp1-/- 
Brca1-/- 
53bp1-/- 
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2.1.13 Brca1p53+/- 
Brca111/11 p53+/- mice were generated on a mixed genetic 
background of 129/FVB/Black Swiss as previously described (Xu et al., 
2001). In these Brca1 mutants, exon 11 of the Brca1 gene is deleted, 
resulting in a truncated Brca1 isoform (Xu et al., 1999). Simultaneous 
heterozygous mutation of p53 overcomes the embryonic lethality of 
Brca111/11 mice (Xu et al., 2001). Brca111/11 p53+/- mice were 
generated as shown below: 
 
Step 1: Brca1+/+ p53+/- 
 Brca1+ p53+ Brca1+ p53- 
Brca111/- 
p53+/+ 
Brca111 
p53+ 
Brca111/+ 
p53+/+ 
Brca111/+ 
p53+/- 
Brca1 
p53+ 
Brca1+/+ 
p53+/+ 
Brca1+/+ 
p53+/- 
 
Step 2 
Step 2: 
Brca111/ p53+/- 
 Brca111 
p53+ 
Brca111 
p53- 
Brca1+ 
p53+ 
Brca1+ 
p53- 
Brca111/+ 
p53+/- 
Brca111 
p53+ 
Brca111/
11 p53+/+ 
Brca111/
11 p53+/- 
Brca111
/ p53+/+ 
Brca111
/ p53+/- 
Brca111 
p53- 
Brca111/
11 p53+/- 
Brca111/
11 p53-/- 
Brca111
/ p53+/- 
Brca111
/ p53-/- 
Brca1+ 
p53+ 
Brca111/ 
p53+/+ 
Brca111/
 p53+/- 
Brca1 
p53+/+ 
Brca1 
p53+/- 
Brca1+ 
p53- 
Brca111/ 
p53+/- 
Brca111/
 p53-/- 
Brca1 
p53+/- 
Brca1 
p53-/- 
 
2.2 Genotyping 
Mice were genotyped using DNA extracted from tail tips. Tail tips 
were digested in 200 µl GNTK buffer (50mM KCl, 1.5mM MgCl2, 10mM Tris-
HCl pH 8.5, 0.45% NP-40 (Fluka), 0.45% TWEEN-20 (Sigma)) and 1 µl 
Proteinase K (20 mg ml-1) (Roche) overnight at 55°C in a water bath. The 
next day, reactions were incubated in a heat block at 95°C for 15 min and 
then centrifuged at maximum speed for 5 min.  
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Each genotyping PCR reaction had the following contents: Koops 
Buffer (250mM Tris pH 9, 75mM ammonium sulphate, 35mM MgCl2, 0.85 
mg ml-1 bovine serum albumin (BSA) (Sigma) and 0.25% NP-40), 250 ng µl-1 
primers, 1x cresol red, 1.44 mM dNTPs (Invitrogen), Thermoprime Plus 
DNA Polymerase (ThermoFischer), and 1 µl of DNA. Genotyping PCR 
primers and cycling conditions are listed below (Table 4).  
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Table 4: Genotyping primers and PCR conditions.  
 
 
 
 
  
Mouse Primers 5’ --> 3’ Ref. PCR conditions 
H2afx ko HX5 CTCTTCTACCTCGTACACCATGTCCG 
RW CTCGGCGCGGGCCCCC 
KXR GTCACGTCCTGCACGACGCGAGC 
(Celeste et 
al., 2002) 
1x:   94°C, 3 min 
35x: 96°C, 10 sec 
         65°C, 30 sec 
         72°C, 30 sec 
1x:   72°C, 10 min  
Spo11 ko 
 
PRSF4 CTGAGCCCAGAAAGCGAAGGA 
SP16R ATGTTAGTCGGCACAGCAGTAG 
(Baudat et 
al., 2000) 
1x:   94°C, 5 min 
35x: 94°C, 30 sec 
         58°C, 30 sec 
         72°C, 45 sec 
1x:   72°C, 10 min 
Tc1 Neo1 ATTGAACAAGATGGATTGCAC 
Neo2 TTCGTCCAGATCATCCTGATCGAC 
(Marahrens 
et al., 1997) 
1x:   94°C, 3 min 
35x: 96°C, 10 sec 
         60°C, 30 sec 
         72°C, 30 sec 
1x:    72°C, 5 min 
Yd1 chrom. 
[Ymt2b] 
YMTfp1 CTGGAGCTCTACAGTGATGA 
YMTrc2 CAGTTACCAATCAACACATCAC 
 
(Bishop and 
Hatat, 1987) 
1x:   94°C, 5 min 
35x: 96°C, 10 sec 
         60°C, 30 sec 
         72°C, 30 sec 
1x:    72°C, 5 min 
XY chrom. 
[Sts] 
STS F GCTCGCTGACATCATCCTC 
STS R CACCGATGCCCAGGTCGTC 
(Salido et al., 
1996) 
1x:   94°C, 3 min 
35x: 96°C, 10 sec 
         58°C, 30 sec 
         72°C, 30 sec 
1x:   72°C, 10 min 
Hormad2 ko 
 
H2lox3 CACTTTAGCCCATATGAACAGCC 
H2lox5 AATACTTTATTAGCCCTCTTTCC 
H2FRT GTCTACAGAGTGAGTTTAAAATGC 
 
(Wojtasz et 
al., 2012) 
Performed by 
Attila Toth’s lab  
Brca1 ko 
[Brca1-/-] 
WT F GGACGGCAGATAAATCCATTTCTTCC 
WT R GTACAAAGCCAGTGTGGGTTACATG 
KO F GGAATGTTTCCACCCAATGTCGAGC  
KO R CATCAGAGCCGATTGTCTGTTG 
(Ludwig et 
al., 1997) 
1x:   94°C, 1 min 
35x: 94°C, 60 sec 
         60°C, 2 min 
         72°C, 1 min 
1x:   72°C, 10 min 
53BP1 ko  
10694 GAA CTT GGC TCA CAC CCA TT 
oIMR5316 CTA AAG CGC ATG CTC CAG AC 
(Ward et al., 
2003) 
1x:   94°C, 3 min 
35x: 94°C, 30 sec 
         62°C, 30 sec 
         72°C, 30 sec 
1x:   72°C, 2 min 
Brca111/11  
 
(Xu et al., 
2001) 
1x:   95°C, 60 sec 
30x: 95°C, 30 sec 
         60°C, 60 sec 
         68°C, 1 min 
1x:   68°C, 5 min 
p53 F TTTACGGAGCCCTGGCGCTCGATGT 
R ATGACTGCCATGGAGGAGTCACAGTC 
(Donehower 
et al., 1992) 
1x:   95°C, 60 sec 
30x: 95°C, 30 sec 
         60°C, 60 sec 
         68°C, 1 min 
1x:   68°C, 5 min 
Dmc1 ko/wt 
[Dmc1-/-] 
oIMR5332 GCCAGAGGCCACTTGTGTAG 
oIMR9132 CCGGCCAGATTACATTTCTT 
oIMR9133 AAAGGGACTGCTGAGGCATA 
(Pittman et 
al., 1998) 
1x:   94°C, 3 min 
25x: 94°C, 20 sec 
         54°C, 30 sec 
         72°C, 20 sec 
1x:   72°C, 7 min 
In(X)1H 
[In(X)1H] 
DXMit16f CTG CAA TGC CTG CTG TTT TA 
DXMit16r CCG GAG TAC AAA GGG AGT CA 
(Evans and 
Phillips, 
1975) 
1x:   94°C, 3 min 
35x: 96°C, 10 sec 
         58°C, 30 sec 
         72°C, 30 sec 
1x:    72°C, 5 min 
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To genotype for XXYd1 females (Section 2.1.6), female offspring were 
first genotyped for Ymt2b to check for the presence of a Y chromosome (see 
below diagram). Female offspring with a Y chromosome (Ymt2b+) were 
either XYd1 or XXYd1 females. To distinguish between these karyotypes, an 
assay was performed to check for the presence of an inactive X 
chromosome, marked by H3K27me3 antibody staining. An X chromosome is 
inactivated in XXYd1 female somatic tissue but not in XYd1 female somatic 
tissue. 
 
 
 
For the H3K27me3 detection assay, livers were removed from mice 
and were macerated using scalpels in RPMI (+L-glutamatine) (Invitrogen). 
Six drops of this cell suspension were dropped onto Superfrost Plus slides 
(ThermoScientific). Cells were simultaneously permeablized and fixed in six 
drops of a solution of 2% formaldehyde (TAAB), 0.02% sodium dodecyl 
sulphate (SDS) (Bio-Rad), and 0.05% Triton X-100 (Sigma) in distilled 
water, for 30 min in a humid chamber at room temperature. Slides were 
then washed in distilled water six times and allowed to air dry completely. 
Slides were blocked in PBT (0.15% bovine serum albumin, 0.10% TWEEN-
20 in phosphate buffer saline (PBS)) for 60 min at room temperature. Next, 
50 µl of rabbit polyclonal anti-H3K27me3 antibody (Millipore, ABE44) was 
applied at a concentration 1:100 in PBT, and slides were incubated in a 
Female offspring from XY x XYd1 cross:
XYd1, XXYd1, XX, XO
Ymt2b positive:
XYd1
XXYd1
H3K27me3 
positive
XXYd1
H3K27me3 
negative
XYd1
Ymt2b negative:
XX
XO
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humid chamber overnight at 37°C. The next morning, slides were washed 
three times in PBS for 5 min, 50 µl of secondary antibody (AlexaFluor 594, 
Invitrogen) was applied at a concentration of 1:500 in PBS and slides were 
incubated in a humid chamber for one hour at 37°C. Finally, slides were 
washed three times in PBS and then mounted in Vectashield with DAPI 
(Vector).   
2.3 Chromosome spreads and immunofluorescence 
Chromosome spreads were preformed using a protocol adapted from 
Barlow and colleagues (Barlow et al., 1997). Briefly, -80°C frozen ovaries 
were transferred into two drops of chilled RPMI medium (plus L-glutamine) 
on pre-boiled Superfrost glass slides (ThermoScientific). Ovaries were then 
macerated using 25G needles (BD), and cells were mechanically dispersed. 
The cells were permeablized for 10 min in two drops of 0.05% Triton X-100 
(Sigma) in distilled water, dropped from approximately 10 cm above the 
slide. Next, the cells were fixed for 60 min in six drops of 2% formaldehyde, 
0.02% SDS in PBS. The slides were rinsed in distilled water, allowed to air 
dry, and then were blocked in PBT (0.15% BSA, 0.10% TWEEN-20 in PBS) 
for 60 min.  
Next, primary antibodies (Table 5) were applied at a concentration 
of 1:100 in PBT and slides were incubated in a humid chamber overnight at 
37°C. The next morning, slides were washed three times in PBS, 50 µl of 
secondary antibodies (AlexaFluor 488, 594 and 647, Invitrogen) were 
applied at a concentration of 1:500 in PBS, and slides were incubated in a 
humid chamber for one hour at 37°C. Finally, slides were washed three 
times in PBS and then mounted in Vectashield with DAPI. 
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Table 5: Antibodies used for immunofluorescence experiments 
Antibody Type Source 
anti-SCYP3 Rb polyclonal Abcam, ab-15092 
anti-SYCP3 M polyclonal Santa Cruz, sc-74569 
anti-HORMAD1 Gp polyclonal Gift, Attila Tóth 
anti-HORMAD2 Gp polyclonal Gift, Attila Tóth 
anti-HORMAD2 Rb polyclonal Gift, Attila Tóth 
anti-H2AFX M monoclonal Upstate, 16-193 
anti-DMC1 G polyclonal Santa Cruz (C-20), sc 8973 
anti-RPA Rb polyclonal Abcam, ab-2175 
anti-RAD51 
(#1) 
Rb polyclonal Santa Cruz (H92), sc 8349 
anti-RAD51 
(#2) 
Rb polyclonal Calbiochem, PC130 
anti-BRCA1 Rb polyclonal Gift, Chu-Xia Deng 
anti-ATR G polyclonal SantaCruz, sc-1887 
 
2.4 Chromosome painting 
Chromosome painting was carried out using Cy3 STARFISH paints 
(Cambio) for mouse chromosome X or human chromosome 21 
(pseudocolored in images). Slides were washed once for 5 min in PBS and 
then once for 5 min in 2x saline sodium citrate (SSC). Slides were pre-
warmed for 6 min at 80°C in 2x SSC and then denatured for 5 min at 80°C in 
2x SSC and 70% formamide. Slides were quenched in ice cold 70% ethanol 
for 3 min, dehydrated in a series of ethanol dilutions (70%, 85%, 90%, 95%, 
100%) at room temperature and then allowed to air dry. Chromosome paint 
reactions, consisting of 3 µl concentrated paint and 12 µl hybridization 
buffer (Cambio), were denatured at 80°C for 10 min, allowed to cool to 37°C 
and then applied to slides. Coverslips were sealed to slides with Tip-Top 
Resin (Rema) and slides were incubated overnight in a covered tray in a 
37°C water bath. The next day, slides were washed four times for 3 min in 
2x SSC at 45°C, four times for 3 min in 0.1x SSC at 60°C and then once for 3 
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min in 4x SSC and 0.1% TWEEN-20 at 37°C, before mounting in Vectashield 
with DAPI.   
2.5 RNA fluorescent in-situ hybridization (RNA FISH) and 
immunofluorescence 
Frozen ovaries (-80°C) were transferred to two drops of RPMI 
medium (plus L-glutamine) on boiled Superfrost glass slides. Ovaries were 
macerated using needles, and cells were mechanically dispersed. The cells 
were then permeablized for 10 min in excess cold CSK buffer (100 mM NaCl, 
300 mM sucrose, 3 mM MgCl2, 10 mM PIPES, 0.5% Triton X-100, 1 mM EGTA 
and 2 mM vanadyl ribonucleoside (NEB), pH 6.8), and then fixed for 10 min 
in excess ice cold 4% paraformaldehyde (FischerScientific), pH 7-7.4. Slides 
were then washed in PBS, dehydrated in a series of ethanol dilutions (2 x 
70%, 80%, 95%, 100%) and air dried.   
RNA FISH digoxigenin-labelled probes were prepared from 1 µg of 
BAC DNA (from CHORI: Scml2, RP24-204O18; Zfx, RP24-204018, USP25, 
RP11-296D11; NRIP1, RP11-22D1; from ABgene: TPTE, CTD-2260D15; Utx, 
gift from Mike Mitchell, University Marseilles) using the Biotin Nick 
Translation Kit (Roche), according to manufacturer’s instructions. For each 
probe, 100 ng digoxigenin-labelled BAC was prepared in 15 µl formamide 
(Sigma), with 3 µg mouse (for XO) or human (for Tc1) Cot1 DNA 
(Invitrogen) and 10 µg sheared salmon sperm DNA (Ambion). Probes were 
denatured for 10 min at 80°C and then combined with 15 µl pre-warmed 
(37°C) of 2x hybridization buffer (2x SSC, 10% dextran sulphate (Sigma), 1 
mg ml-1 BSA and 2 mM vanadyl ribonucleoside) and incubated for 30 min at 
37°C. Finally, 30 µl pre-hybridized probes were applied to slides and 
incubated in a humid chamber overnight at 37°C.  
The next day, slides were washed at 42°C, three times in 2x SSC and 
50% formamide, and three times in 2x SSC, for 5 min per wash. Slides were 
then transferred to 4x SSC and 0.1% TWEEN-20, and then blocked (4x SSC, 4 
mg ml-1 bovine serum albumin and 0.1% TWEEN-20) for 30 min in a humid 
chamber at 37°C. Probes were detected using 30 µl of 1:10 anti-digoxigenin 
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fluorescein, diluted in detection buffer (4x SSC, 1mg ml-1 bovine serum 
albumin and 0.1% TWEEN-20) for 60 min in a humid chamber at 37°C.  
Slides were washed three times for 2 min in 4x SSC and 0.1% 
TWEEN-20. For subsequent immunofluorescence, 50 µl of primary antibody 
against γH2AFX (Upstate, 16-193), diluted 1:100 in 4x SSC and 0.1% 
TWEEN-20, was added to slides and incubated for 30 min in a humid 
chamber at room temperature. Slides were washed for 2 min in 4x SSC and 
0.1% TWEEN-20. Next, 50 µl of secondary antibody (AlexaFluor 594 
conjugated), diluted 1:100 in 4x SSC and 0.1% TWEEN-20, was added to 
slides and incubated for 30 min in a humid chamber at room temperature. 
Finally, slides were washed for 2 min in 4x SSC and 0.1% TWEEN-20 and 
mounted in Vectashield with DAPI. 
2.6 Ovarian sectioning and oocyte counting 
Ovaries were harvested from females at 20.5 days post-coitum (dpc), 
fixed in 4% paraformaldehyde overnight at 4°C and then transferred to 70% 
ethanol. Fixed ovaries were dehydrated by three successive 5min 
incubations with 95% ethanol, 100% ethanol, 100% xylene and were then 
embedded in paraffin wax. Ovaries were serially sectioned at 5-7 μm 
thickness. Sections were dewaxed using histoclear (2 x 5 min) and 1:1 
histoclear:ethanol (1 x 5 min), and then rehydrated using the following 
ethanol series: 100% ethanol (2 x 5 min), 95% ethanol (1 x 5 min), 80% (1 x 
5 min), 70% (1 x 5 min), 50% (1 x 3 min) and PBS (1 x 5 min). Sections were 
stained with DAPI and oocytes were identified based upon their distinct size 
and nuclear cytology, as described previously (Burgoyne and Baker, 1985). 
To quantify the relative number of oocytes in each ovary, I summed the 
oocyte counts from every tenth section, as described previously (Daniel et 
al., 2011). 
 
2.7 Imaging 
Imaging was performed using an Olympus IX70 inverted microscope 
with a 100-W mercury arc lamp. For chromosome spread and RNA FISH 
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imaging, an Olympus UPlanApo 100x/1.35 NA oil immersion objective was 
used. For ovary section imaging, an Olympus UPlanApo 20x/0.75 NA 
objective was used. A Deltavision RT computer-assisted Photometrics 
CoolsnapHQ CCD camera with an ICX285 Progressive scan CCD image 
sensor was utilized for image capture. 16-bit (1024x1024 pixels) raw 
images of each channel were captured and later processed using Fiji 
software. Quantitation of Cot1 and H2AFX intensities was performed as 
previously described (Mahadevaiah et al., 2008).  
For chromosome spreads, the cells were first categorized into 
meiotic stages based upon SYCP3 and HORMAD1 staining, as described in 
Figure 1 and Results Section 3.1. The cells were then assessed for γH2AFX 
domains or HORMAD2 staining and representative images were captured. 
For RNA FISH preparations, cells were first categorized based upon the 
presence or absence of a γH2AFX domain. Next, the FISH signals were 
examined and representative images were captured. The number of cells 
counted for each experiment is indicated in figure legends.   
2.8 Statistics 
Statistical calculations were performed using GraphPad Prism 6.0. 
For comparison of two means, unpaired t tests were performed. For 
multiple comparisons (more than two means), ANOVAs followed by the 
Tukey or Sidak multiple comparison were used, minimizing Type 1 error 
(i.e. detecting a difference when one is not present). P values are reported in 
graphs and/or figure legends. Error bars in graphs represent the standard 
error of the mean (s.e.m). 
 
2.9 Chromatin immunoprecipitation and sequencing (ChIP-seq) 
Chromatin immunoprecipitation (ChIP) was performed as described 
previously (Smagulova et al., 2011). Testes were surgically extracted from 
mice, and the tunicae albuginea was mechanically removed and discarded. 
The testis material was then fixed for 10 min in 10ml 1% fresh 
paraformaldehyde. After quenching the fixative with glycine for 10min, 
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tissue was homogenised on ice using a dounce homogenizer. The 
homogenized tissue was then filtered through 40 μm cell strainer, and 
washed in the following buffers: (1) PBS (twice); (2) 0.25% Triton X-100, 
10mM EDTA, 0.5mM EGTA, 10mM Tris pH 8; and (3) 0.2M NaCl, 1mM EDTA, 
0.5mM EGTA, 10mM Tris pH 8. Prior to each wash, cells were pelleted by 
centrifugation at 900g for 5min at 4°C. After the final wash, cells were 
pelleted and resuspended in 1.5 ml of lysis buffer (1% SDS, 10mM EDTA, 
50mM TrisCl pH8, 1X complete protein inhibitor cocktail (Roche)).  
The resulting chromatin was then sheared to ~1000 bp by sonication 
for 15min at 4°C using 15-sec on/45-sec off pulses. The sheared chromatin 
was then dialyzed against ChIP buffer (0.01% SDS, 1.1% Triton X-100, 
1.2mM EDTA, 16.7mM TrisHCl, 167mM NaCl) in a Slide-A-Lyser Dialysis 
Cassettes, 10K MWCO (ThermoScientific) for 4-5hrs at 4°C with constant 
rotation.  
Prior to addition of antibodies, samples were pre-cleared using 150 
μg of magnetic Protein G beads (Sigma) for 1 hr at 4°C, rotating constantly. 
Beads were pelleted, and the pre-cleared chromatin was removed. 50 μl of 
the pre-cleared sample was set aside for input controls (i.e. no antibody). 
The remainder of the sample was incubated with primary antibody 
overnight (12-16 hrs) at 4°C, rotating constantly (see below table for 
antibodies). 
 
Table 6: Antibodies used for ChIP-seq.  
Antibody Details Source 
anti-DMC1 Santa Cruz (C-20, sc 9873) (Smagulova et al., 2011) 
anti-BRCA1 Rb polyclonal Gift, Satoshi Namekawa 
anti-BRCA1 M monoclonal  Gift, Andre Nussenzweig 
  
The following day, the sample was incubated with 150 μg of magnetic 
Protein G beads for 2 hr at 4°C to pull down antibody-bound chromatin. The 
beads were pelleted and washed in the following buffers: (1) low salt 
immune complex wash buffer (0.1% SDS, 1% Triton X-100, 2mM EDTA, 
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20mM TrisHCl, 150mM NaCl); (2) high salt immune complex wash buffer 
(0.1% SDS, 1% Triton X-100, 2mM EDTA, 20mM TrisCl pH 8, 500mM NaCl); 
(3) LiCl immune complex wash buffer (0.25M LiCl, 1% Igepal, 1mM EDTA, 
10mM TrisCl, pH8, 1% Deoxycholic acid); (4) TE buffer (10mM Tris-HCl, 
1mM EDTA pH 8.0) (twice).  
Next, the protein/DNA complexes were eluted from magnetic beads 
using 100 μl of 1% SDS, 0.1M NaHCO3 pH 9 at 65°C for 30 min. Protein/DNA 
crosslinking was reversed in 12 ul of 5M NaCl at 65°C overnight. The sample 
was then deproteinized by addition of 6 μl of 0.5M EDTA, 12 μl 1M Tris-HCl 
pH 6.5, and 5 μl of Proteinase K (20 mg/ml), and incubating for 2 hr at 45°C. 
Finally, DNA was purified with a MiniElute Reaction Clean up kit (QIAGEN) 
and eluted in 12 ul of elution buffer. 
Standard sequencing library construction was done using New 
England Biolab reagents according to protocol provided by Illumina, as 
described previously (Khil et al., 2012). Sequencing libraries were prepared 
as follows: (1) End repair step: mix 10 μl DNA, 30 μl ddH2O, 5 μl 10X T4 
Buffer, 2 μl dNTPs, 1 μl T4 DNA pol, 1 μl Klenow (1:5 dilution), and 1 μl T4 
PNK, incubated for 30 min at 20°C, and then purified DNA using Qiagen 
MiniElute PCR purification kit, eluting in 10 μl; (2) A addition step: 10 μl 
DNA, 24 μl ddH2O, 5 μl Klenow Buffer, 10 μl 1mM dATP, 1 μl Klenow (exo-), 
and incubated for 30 min at 37°C, and then purified DNA, eluting in 10 μl; 
(3) Kinetic enrichment step (if necessary): incubated sample at 95°C for 3 
min, then cool to room temperature; (4) Adaptor ligation step: 10 μl DNA, 3 
μl ddH2O, 15 μl Ligation Buffer, 1 μl Adaptor mix (1:20 dilution of conc.), 1 
μl DNA Ligase, and incubated for 30 min at 20°C, purified, eluted in 10 μl; (5) 
PCR amplification step: 10 μl DNA, 26 μl H2O, 10 μl 5x Phusion B buffer, 1.5 
μl dNTPs, 1 μl Adaptor primer 1, 1 μl Adaptor primer 2, 0.5 μl Phusion Taq 
pol, and performed PCR under following conditions: (1) 30 sec @ 98°C; (2) 
18 cycles of 30 sec @ 98°C, 30 sec @ 65°C, 30 sec @ 72°C; and (3) 5 min @ 
72°C. The PCR product was purified using Qiaquick PCR Purification kit. 
Libraries were sequenced on an Illumina HiSeq 2000 platform at the NIDDK 
Genomics Core Facility (NIH, Bethesda, MD). 
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2.10 ChIP-seq data analysis 
Raw ChIP-seq data were processed and analyzed by computational 
biologist Dr. Kevin Brick (NIH, Dr. Camerini-Otero laboratory). Briefly, 
sequence fragments were aligned to the mm9 mouse reference genome 
using the Illumina GAII analysis pipeline. Quality filtered reads that mapped 
uniquely to the genome were utilized for downstream analyses. DMC1 and 
BRCA1 peaks were identified by comparing the sequence tag coverage for 
each ChIP sample with that of the tag-count matched control/input sample 
using MACS.  
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3 Results: Characterization of oocyte losses in 
chromosomally abnormal mice 
Mice with chromosome abnormalities, such as chromosome 
aneuploidies and translocations, have asynapsed chromosomes during 
meiosis and experience germ cell loss and a shortened reproductive lifespan 
or infertility (Burgoyne, 1979; Burgoyne and Baker, 1984; Forejt, 1976; 
Homolka et al., 2007). However, many fundamental questions remain about 
the mechanisms of germ cell loss in chromosomally abnormal mice.  
The first objective of this chapter is to define the developmental 
timing of oocyte arrest in female mice with either asynapsed sex 
chromosomes or autosomes, using several different chromosome variant 
mouse models. Previous work on XO females revealed that the proportion of 
oocytes with an asynapsed X chromosome decrease in proportion during 
progression through prophase I (Burgoyne and Baker, 1985), although the 
precise meiotic sub-stage of during which these losses remains unclear. 
Elucidating the kinetics of oocyte loss in different chromosome variant 
mouse models, including XO females, is vital for understanding the timing of 
meiotic surveillance in females.  
The next objective of this chapter is to examine the role for persistent 
unrepaired DNA DSBs in the elimination of chromosomally abnormal 
oocytes. Mice with persistent unrepaired DNA DSBs (i.e. Dmc1-/-) have 
severe oocyte losses during meiotic prophase I (Pittman et al., 1998; 
Yoshida et al., 1998). These oocyte losses can be partially relieved by 
preventing DNA DSB formation, indicating that persistent unrepaired DNA 
DSBs is the proximal trigger of oocyte losses (Di Giacomo et al., 2005; 
Reinholdt and Schimenti, 2005). To address the role of persistent DNA 
damage in oocyte losses in chromosome variant mice I studied markers of 
unrepaired DNA DSBs, including RAD51, DMC1, and RPA.  This study will 
shed light on whether DNA DSBs contribute to oocyte losses in the context 
of chromosome abnormalities. 
In the final section of this chapter, I examine the role of asynapsis per 
se in oocyte loss by determining the impact of accessory chromosomes on 
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oocyte survival. If asynapsis per se is the proximal trigger of oocyte losses, 
then any asynapsed chromosome, including asynapsed accessory 
chromosomes will trigger oocyte arrest. By contrast, if asynapsis alone is not 
sufficient to cause arrest, but rather depends on gene content or some other 
factor, then asynapsed accessory chromosomes should not elicit oocyte 
losses. In summary, determining the impact of persistent unrepaired DNA 
DSBs and accessory chromosomes will advance our understanding of the 
meiotic surveillance mechanisms that operate in oocytes.  
3.1 Timing of oocyte losses in mice with chromosome 
abnormalities 
3.1.1 Classification of oocytes into meiotic prophase I sub-stages 
Chromosome abnormalities lead to asynapsis at pachynema 
(Burgoyne et al., 2009). To address the impact of asynapsis on oocyte 
survival, oocytes must be monitored from pachynema to the end of 
prophase I. Prophase I of female meiosis occurs in a single semi-
synchronous wave between 13.5 and 20.5 dpc (Pepling and Spradling, 2001; 
Speed, 1986). Based on studies of wildtype mice, pachytene oocytes are 
abundant between the gestational ages of 16.5 and 18.5 dpc (Speed, 1982). 
By 18.5 dpc, a subset of oocytes have entered diplonema (Speed, 1982). 
Therefore, with the goal of studying oocytes from pachynema to diplonema, 
I focused my initial experiments on 18.5 dpc ovaries.  
To visualize oocytes, meiotic chromosome spreads were performed 
in combination with immunofluorescence (Peters et al., 1997). An antibody 
recognizing SYCP3, a component of the axial/lateral element of the SC (Yuan 
et al., 2000), was used to detect meiotic chromosome axes and identify 
pachytene oocytes. To aid with substaging diplotene oocytes, I combined 
anti-SYCP3 with an antibody recognizing HORMAD1, a protein that localizes 
exclusively to asynapsed chromosome axes (Fukuda et al., 2009; Wojtasz et 
al., 2009). Using this approach, I defined criteria for substaging oocytes into 
pachynema, early diplonema, and late diplonema.  
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At pachynema, SYCP3 clearly labels 20 synapsed chromosome pairs 
(Figure 1.1a). At this meiotic stage HORMAD1 staining is virtually 
undetectable (Figure 1.1a). At early diplonema, homologous chromosomes 
have begun to desynapse, which manifests as separation of the SYCP3-
labeled chromosome axes and accumulation of HORMAD1 (Figure 1.1b). 
Importantly, at this stage, there are still regions of synapsis. At late 
diplonema, by contrast, all chromosomes have completely desynapsed, 
shown by more extensive HORMAD1 staining (Figure 1.1c). For subsequent 
experiments, these criteria were used to substage oocytes.      
According to studies of female mice of CD1 and Swiss albino genetic 
backgrounds (Pepling and Spradling, 2001; Speed, 1986), mouse oocytes 
progress from pachynema and late diplonema between 17.5 to 19.5 dpc. 
Given that genetic background may impact meiotic processes (Koehler et al., 
2002), I first confirmed the developmental timing of meiotic prophase I in 
the NIMR MF1 wildtype mice, by analyzing surface spread oocytes double-
stained for SYP3 and HORMAD1.  
At 17.5 dpc, the vast majority (68%) of oocytes in the XX MF1 ovary 
were at pachynema (Figure 1.2), and the remaining oocytes had progressed 
to early diplonema (20%) and late diplonema (8%). At 18.5 dpc, still half of 
XX MF1 oocytes were at pachynema, but there was a higher representation 
of oocytes at early diplonema (33%) and late diplonema (13%) (Figure 
1.2). At 19.5 dpc, the majority of oocytes (49%) were at late diplonema, 
while a smaller percentage was found in early diplonema (12%) and 
pachynema (3%) (Figure 1.2). The remaining 36% of oocytes at 19.5 dpc 
had progressed to dicytate, where the HORMAD1/SYCP3-labeled 
chromosomes are extensively fragmented. In summary, consistent with 
other genetic backgrouds (Pepling and Spradling, 2001; Speed, 1986), 
wildtype MF1 oocytes progress from pachynema to late diplonema during 
the timeframe 17.5 to 19.5 dpc.  
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Figure 1.1. Oocyte sub-staging criteria.  
 (a) XX pachytene oocyte. At pachynema, SYCP3 labels 20 fully synapsed 
chromosome pairs. HORMAD1, if present at all, stains very weakly as foci. 
(b) XX early diplotene oocyte. At early diplonema, homologous 
chromosomes begin to desynapse, marked by HORMAD1 axial 
accumulation. At this stage, there are still stretches marked only by SYCP3 
(i.e. areas of synapsis). (c) XX late diplotene oocytes. At late diplonema, all 
chromosome pairs have desynapsed, as evident by near complete 
HORMAD1/SYCP3 co-localization. At this stage SYCP3 and HORMAD1 also 
begin to show signs of fragmentation. Scale bar represents 10μm. 
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Figure 1.2. Oocyte sub-stages at different gestational ages.  
The mean percentage (± s.e.m.) of XX oocytes at pachynema, early 
diplonema and late diplonema at 17.5 dpc, 18.5 dpc and 19.5 dpc. During 
this period of gestation, oocytes progress in a semi-synchronous wave 
between pachynema and late diplonema. n is the total number of oocytes 
counted in three non-littermate ovaries. 
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3.1.2 H2AFX marks the asynapsed X chromosome in XO oocytes 
XO females have a shortened reproductive lifespan due to late 
prophase I oocyte losses (Burgoyne and Baker, 1985). The kinetics and 
trigger of these prophase I oocyte losses remains unclear, but it has been 
proposed to be linked to the asynapsed X chromosome (Speed, 1986). 
Therefore, I sought to determine whether XO oocytes with an asynapsed X 
chromosome are eliminated, and if so, during what stages of meiotic 
prophase I.  
To address these questions, it is first imperative to be able to identify 
the asynapsed chromosome in surface spread XO oocytes. Although 
HORMAD1, which was used for staging oocytes (see Figure 1.1), is also 
enriched on the asynapsed X chromosome at pachynema (Figure 1.3a), it 
was also present on desynapsed axes in diplotene oocytes (Figure 1.3c-f, 
insets). Therefore, HORMAD1 is not useful for distinguishing the asynapsed 
X chromosome from desynapsed chromosomes at diplonema.  
Studies of spermatocytes have shown that the silencing factor and 
DDR epigenetic mark γH2AFX accumulates within the chromatin of 
asynapsed chromosomes between pachynema and diplonema 
(Mahadevaiah et al., 2001). Notably, γH2AFX also marks the asynapsed X 
chromosome in XO oocytes from pachynema and diplonema (Figure 1.3). 
Therefore, for subsequent surface spread experiments, I combined my 
substaging antibodies, anti-SYCP3 and anti-HORMAD1, with an antibody 
against γH2AFX, to allow for both substaging and identification of asynapsis.  
I utilized this triple immunostaining approach to analyze the 
behavior of the single X chromosome in 18.5 dpc XO oocytes. At pachynema, 
I observed two populations of XO oocytes. The first population of XO 
pachytene oocytes had a γH2AFX domain that marked the asynapsed X 
chromosome (Figure 1.3a, arrow). In these oocytes, the X chromosome was 
marked with the asynapsis marker HORMAD1 (Figure 1.3a, inset), further 
proof that these oocytes contained an asynapsed X chromosome.  
By contrast, the second population of pachytene XO oocytes did not 
have any markers of asynapsis, i.e. both γH2AFX and HORMAD1 staining 
was absent (Figure 1.3b), as reported previously (Turner et al., 2005). In 
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this population, the X chromosome had engaged in non-homologous self-
synapsis (Figure 1.3b, arrow), forming a small “hairpin” chromosome, as 
observed in previous electron microscopy studies (Speed, 1986). I 
confirmed that the self-synapsed chromosome was the X chromosome using 
X-specific chromosome paint (Figure 1.3b, inset). 
Similar populations of XO oocytes were observed at early diplonema 
and late diplonema: a H2AFX-positive population and a H2AFX-negative 
population. After late diplonema (i.e. dictyate), γH2AFX was no longer 
visible in XO oocytes, suggesting that this chromatin mark is removed at the 
end of prophase I, as observed with spermatocytes (Mahadevaiah et al., 
2001). In summary, γH2AFX can be used as a marker of the asynapsed X 
chromosome in XO oocytes between pachynema and late diplonema.  
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Figure 1.3. XO oocytes with an asynapsed X chromosome.  
Surface spread XO oocytes labeled with SYCP3 (green), which marks 
chromosome cores, H2AFX (red), which marks chromatin associated with 
the asynapsed X chromosome, and HORMAD1 (magenta, insets), which 
marks asynapsed cores. (a) Pachytene XO oocyte with H2AFX domain 
(asynapsed X chromosome) (arrow). (b) Pachytene XO oocyte with self-
synapsed X chromosome (H2AFX-negative). X chromosome painting shown 
in inset (magenta). (c) Early diplotene XO oocyte with a H2AFX domain 
(arrow). Both the asynapsed X chromosome and desynapsed axes are 
labeled with HORMAD1 (inset). (d) Early diplotene XO oocyte, H2AFX-
negative. (e) Late diplotene XO oocyte (extensive HORMAD1 staining, inset) 
with H2AFX domain (arrow). (f) Late diplotene XO oocyte, H2AFX-
negative.  
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3.1.3 Elimination of XO oocytes with an asynapsed X chromosome 
Previous studies have shown that compared to XX littermates, XO 
females lose 50% more oocytes during prophase I (Burgoyne and Baker, 
1985). Subsequent work revealed that the frequency of X chromosome self-
synapsis increases during prophase I progression (Speed, 1986). Taken 
together, this suggests that XO oocytes with an asynapsed X chromosome 
are lost during prophase I progression. To test this hypothesis and to 
pinpoint the timing of XO oocyte losses, I quantified the percentage of XO 
oocytes with an asynapsed X chromosome at pachynema, early diplonema, 
and late diplonema. If the asynapsed X chromosome is associated with XO 
oocyte losses, the percentage of XO oocytes with an asynapsed X 
chromosome should decrease by late diplonema.  
First, I confirmed that XO and XX females are developmentally 
matched. At 18.5 dpc, XO and XX ovaries contained similar proportions of 
oocytes at pachynema, early diplonema, and late diplonema (Figure 1.4a), 
indicating that XO oocyte development occurs with the expected kinetics. 
Next, I quantified the percentage of XO oocytes with an asynapsed X 
chromosome at 17.5, 18.5, and 19.5 dpc, corresponding to progression from 
pachynema to late diplonema (see Figure 1.2).  
At 17.5 dpc, 51% of XO oocytes had an asynapsed X chromosome, as 
determined by the presence of a γH2AFX domain (Figure 1.4b and Figure 
1.3a). The remaining γH2AFX-negative XO oocytes had a self-synapsed X 
chromosome (Figure 1.4b and Figure 1.3b). At 18.5 dpc, 43% of XO 
oocytes had a γH2AFX domain (Figure 1.4b). By contrast, at 19.5 dpc, 26% 
of XO oocytes had a γH2AFX domain (Tukey’s test, P=0.0002) (Figure 1.4b). 
This drop is consistent with the hypothesis that the asynapsed X 
chromosome triggers XO oocyte losses during late prophase I.  
To determine more precisely the stages during meiosis over which 
this drop occurs, I next analyzed XO oocytes specifically at pachynema, early 
diplonema, and late diplonema, by cytologically substaging oocytes within 
individual ovaries. These meiotic stages are well represented in ovaries 
from XO females at 18.5 dpc (Figure 1.4a). For this analysis, XO oocytes 
 111 
were first classified by meiotic substage based on SYCP3/HORMAD1 
immunostaining (Figure 1.1), and then I assessed for the presence of a 
γH2AFX domain (Figure 1.3).  
Within individual 18.5 dpc XO ovaries, 56% of pachytene oocytes had 
a γH2AFX domain at 18.5 dpc (Figure 1.4c), which is consistent with our 
earlier gestational age analysis. Notably, significantly fewer XO oocytes had 
a γH2AFX domain at early diplonema (39%; Tukey’s test, P=0.008), and at 
late diplonema, only 11% of XO oocytes had a γH2AFX domain (Tukey’s test, 
P<0.0001) (Figure 1.4c). This confirms that within individual XO ovaries, 
oocytes with an asynapsed X chromosome are depleted by late diplonema.  
Comparing the two methods of XO analyses, the percentage of XO 
oocytes with a H2AFX domain was slightly different depending on whether 
I studied oocytes based upon gestational age (Figure 1.4b) or meiotic sub-
stages (Figure 1.4c). This discrepancy is expected given that ovaries contain 
a mixed population of oocytes (Figure 1.4a). The less precipitous drop 
observed between 17.5 to 19.5 dpc (two-fold drop), compared to between 
pachynema and late diplonema (five-fold drop), can be explain by this 
oocyte heterogeneity.  
A drop in XO oocytes with an asynapsed X chromosome could reflect 
an increase in X chromosome self-synapsis. However, this would not explain 
the drop at late diplonema because desynapsis, not synapsis, occurs during 
this transition. This drop could also be due to dephosphorylation of γH2AFX. 
However, in spermatocytes H2AFX dephosphorylation occurs after late 
diplonema (Mahadevaiah et al., 2001). Therefore, this drop is more 
consistent with XO oocyte losses.  
Notably, the XO oocyte composition analysis (Figure 1.4a) did not 
reveal a significant drop in the proportion of late diplotene oocytes at 18.5 
dpc in XO versus XX females, as would be expected if significant XO oocyte 
losses occur. However, a significant drop may not be apparent due to the 
small percentage of oocytes present at late diplonema at 18.5 dpc. It may 
become more evident at an age where more oocytes are at late diplonema. 
Consistent with this, previous studies have revealed that XO oocytes losses 
are only evident starting at 19.5 dpc (Burgoyne and Baker, 1985). 
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Figure 1.4. Elimination of XO oocytes with an asynapsed X 
chromosome. 
(a) The mean percentage of XO oocytes and XX oocytes at pachynema, early 
diplonema, and late diplonema at 18.5 dpc. Three non-littermate ovaries 
were analyzed per age, and 100-200 oocytes were counted per ovary. (b) 
The mean percentage of XO oocytes with a H2AFX domain at 17.5, 18.5, and 
19.5 dpc. n is the number of ovaries analyzed, with 100-200 oocytes 
analyzed per ovary. (c) The mean percentage of XO oocytes with a H2AFX 
domain in 18.5 dpc ovaries, where oocytes were sub-staged into pachynema, 
early diplonema, and late diplonema. Three ovaries were analyzed, and n is 
the number of total oocytes analyzed. P values were generated from Tukey’s 
multiple comparison test, and significant P values (P<0.05) are shown in 
red.  
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3.1.4 Elimination of In(X)1H oocytes with asynapsed X chromosomes 
My previous analysis indicates that X chromosome asynapsis is 
associated with oocyte losses. To determine if this finding is specific to XO 
females, I then studied another mouse model with X chromosome asynapsis, 
the In(X)1H female. In(X)1H heterozygous females have two X 
chromosomes, but one X chromosome harbors a large inversion that 
disrupts X-X synapsis in a proportion of oocytes (Tease and Fisher, 1986). 
As with XO females, perinatal oocyte losses have been reported previously 
in In(X)1H females (Burgoyne and Baker, 1985; Tease and Fisher, 1986).  
Using the SYCP3/HORMAD1/H2AFX immunostaining, I identified 
two populations of pachytene In(X)1H oocytes: oocytes with a γH2AFX 
domain, indicative of X asyanpsis (Figure 1.5a), and oocytes with no 
H2AFX domain (Figure 1.5b). Within those H2AFX domain-negative 
oocytes, the In(X) and X chromosomes achieved complete synapsis, 
presumably through non-homologous pairing (Tease and Fisher, 1986). 
While at 17.5 dpc, 13% of In(X)1H oocytes had a γH2AFX domain, this 
percentage dropped nearly 2-fold by 19.5 dpc (8%) (Tukey’s test, P=0.009) 
(Figure 1.5c). Similarly, within substaged In(X)1H oocytes at 18.5 dpc, there 
was a 3.5-fold drop in the percentage of oocytes with a γH2AFX domain 
between pachynema (17%) and late diplotene (5%) (Tukey’s test, P=0.002) 
(Figure 1.5d). Therefore, In(X)1H oocytes with partial X chromosome 
asynapsis are lost by late diplonema, indicating that X chromosome 
asynapsis in general is associated with oocyte losses.  
It is possible that a subset of In(X)1H oocytes with a H2AFX domain 
which I classified as pachytene oocytes are actually late zygotene oocytes 
that are on their way to achieve full synapsis. Distinguishing these 
categories of cells more definitively requires use of other markers, such as 
DNA DSB repair protein makers, e.g. RPA. This DNA DSB marker is much 
more abundant on synapsed autosomes in zygotene nuclei compared to 
pachytene nuclei (Guioli et al., 2012).  
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Figure 1.5. Elimination of In(X)1H oocytes with asynapsis. 
(a) In(X)1H pachytene oocyte showing partial X chromosome asynapsis 
(arrow), marked by H2AFX (red) and HORMAD1 (magenta, inset). (b) 
In(X)1H pachytene oocyte with complete synapsis, and no H2AFX or 
HORMAD1 staining. (c) The mean percentage of In(X)1H oocytes with a 
H2AFX domain at 17.5, 18.5, and 19.5 dpc. n is the number of ovaries 
analyzed, with 100-200 oocytes analyzed per ovary. (d) The mean 
percentage of In(X)1H oocytes with a H2AFX domain in 18.5 dpc ovaries, 
where oocytes were sub-staged into pachynema, early diplonema, and late 
diplonema. Three ovaries were analyzed, and n equals the number of total 
oocytes analyzed. P values were generated from Tukey’s multiple 
comparison test, and significant P values (P<0.05) are shown in red. Scale 
bar = 10μm. 
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3.1.5 Elimination of T(16;17)43H oocytes with asynapsed autosomes 
To determine whether oocyte loss is specific to X chromosome 
asynapsis or can also occur in the presence of asynapsed autosomes, I then 
analysed oocytes carrying asynapsed autosomes. To address this, I studied 
T(16;17)43H (designated T43H) female mice, which have an autosomal 
translocation involving chromosomes 16 and 17 (Forejt et al., 1980). This 
translocation disrupts chromosomes 16 and 17 synapsis in a subset of T43H 
oocytes, and this is associated with γH2AFX chromatin enrichment and 
HORMAD1 axial staining (Figure 1.6a), as reported recently (Bhattacharyya 
et al., 2013). However, in a subset of T43H oocytes the translocation product 
achieves a fully synapsed quadrivalent configuration via non-homologous 
synapsis. The structure of this quadrivalent configuration has been 
previously reported (Homolka et al., 2007). These oocytes are negative for 
the asynapsis marker γH2AFX (Figure 1.6b, arrow).  
To evaluate the consequence of autosomal asynapsis in T43H 
oocytes, I quantified the percentage of T34H oocytes with asynapsis 
between 17.5 and 19.5 dpc. At 17.5 dpc, 45% of T43H oocytes had a γH2AFX 
domain (Figure 1.6c), consistent with a recent study (Bhattacharyya et al., 
2013). At 19.5 dpc, there was a two-fold drop in oocytes with a γH2AFX 
domain (23%; Tukey’s test, P=0.0007) (Figure 1.6c), indicating that T43H 
oocytes with autosomal asynapsis are depleted by late diplonema.  
Similar results were obtained when I analyzed sub-staged oocytes at 
18.5 dpc. The percentage of T34H oocytes with asynapsis dropped nearly 
three-fold between pachynema (41%) and late diplonema (14%) (Tukey’s 
test, P=0.003) (Figure 1.6d). These results, in conjunction with the results 
from XO and In(X)1H females, indicate that oocytes with asynapsed 
chromosomes, whether it involves the X chromosome or autosomes, are 
eliminated by the end of prophase I.   
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Figure 1.6. Elimination of T(16;17)43H oocytes with asynapsed 
autosomes. 
(a) T43H pachytene oocyte with autosomal asynapsis (arrow), marked by 
H2AFX (red) and HORMAD1 (magenta, inset). (b) T43H pachytene oocyte 
with complete synapsis, involving a quadrivalent structure (arrow), 
showing no H2AFX or HORMAD1 staining. (c) The mean percentage of 
T43H oocytes with a H2AFX domain at 17.5, 18.5, and 19.5 dpc. n is the 
number of ovaries analyzed, with 100-200 oocytes analyzed per ovary. (d) 
The mean percentage of T43H oocytes with a H2AFX domain in 18.5 dpc 
ovaries, where oocytes were sub-staged into pachynema, early diplonema, 
and late diplonema. Three ovaries were analyzed, and n is the number of 
total oocytes analyzed. P values were generated from Tukey’s multiple 
comparison test, and significant P values (P<0.05) are shown in red. Scale 
bar = 10μm. 
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3.1.6 Elimination of XX oocytes with asynapsis 
Synaptic errors have previously been reported to occur in a small 
percentage of oocytes in wildtype XX females (Alton et al., 2008; 
Kouznetsova et al., 2009). I therefore tested whether asynapsis in normal XX 
females also lead to oocyte losses. Using SYCP3/HORMAD1/γH2AFX triple-
immunofluorescence on chromosome spreads, I examined the prevalence of 
asynapsed chromosomes in XX females. Consistent with these previous 
studies, I observed a small population of XX pachytene oocytes with γH2AFX 
domains (Figure 1.7a), indicative of synaptic errors. However, the majority 
of XX pachytene oocytes had no γH2AFX domains, showing complete 
synapsis (Figure 1.7b).  
I quantified the percentage of XX oocytes with a H2AFX domain as a 
function of meiotic prophase I progression. At 17.5 dpc, 10% of XX oocytes 
had a H2AFX domain (Figure 1.7c). Notably, only 4% of XX oocytes had a 
H2AFX domain at 19.5 dpc (Tukey’s test, P=0.02) (Figure 1.7c). More 
strikingly, analysis of sub-staged XX oocytes at 18.5 dpc revealed a 10-fold 
drop in the percentage of oocytes with a H2AFX domain between 
pachynema (10%) and late diplonema (1%) (Tukey’s test, P=0.03) (Figure 
1.7d).  
Therefore, XX oocytes with synaptic defects are also depleted by late 
diplonema. In summary, based upon my analyses of several chromosomally 
variant mouse models as well as normal females, I conclude that a meiotic 
surveillance mechanism operates to eliminate oocytes with asynapsis 
during diplonema (Figure 1.8). 
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Figure 1.7. Elimination of XX oocytes with asynapsis. 
(a) XX pachytene oocyte with asynapsis (arrow), marked by H2AFX (red) 
and HORMAD1 (magenta, inset). (b) XX pachytene oocyte with complete 
synapsis showing no H2AFX or HORMAD1 staining. (c) The mean 
percentage of XX oocytes with a H2AFX domain at 17.5, 18.5, and 19.5 dpc. 
n is the number of ovaries analyzed, with 100-200 oocytes analyzed per 
ovary. (d) The mean percentage of XX oocytes with a H2AFX domain from 
18.5 dpc ovaries, where oocytes were sub-staged into pachynema, early 
diplonema, and late diplonema. Three ovaries were analyzed, and n is the 
number of total oocytes analyzed. P values were generated from Tukey’s 
multiple comparison test, and significant P values (P<0.05) are shown in 
red. Scale bar = 10μm. 
  
 119 
 
Figure 1.8. Schematic depicting fate of prophase I oocytes with 
chromosome abnormalities.  
Left panel: pachytene oocyte with an asynapsed X chromosome or autosome 
labelled with the silencing factor H2AFX are subject to elimination during 
diplonema. Right panel: pachytene oocyte with homologous synapsis and 
non-homologous self-synapsis do not elicit H2AFX domain formation or 
oocyte elimination.  
  
 120 
3.2 The role of meiotic DNA DSBs in oocyte losses in 
chromosomally abnormal mice 
3.2.1 DNA DSB repair proteins do not persist on the asynapsed X 
chromosome in XO oocytes  
After determining that oocytes with asynapsis are eliminated during 
diplonema, I then sought to understand the mechanism by which this 
occurs. I first tested the DNA damage model of oocyte arrest in 
chromosomally abnormal females. To examine this model, I first looked for 
the presence of persistent unrepaired DNA DSBs, which is the presumed 
trigger of the DNA damage checkpoint (Di Giacomo et al., 2005), in XO mice.  
I studied the localization of three DNA repair proteins, namely 
RAD51, DMC1, and RPA, which are commonly used as proxy markers for 
DNA DSB repair in mammalian germ cells (Moens et al., 2002). First, I 
examined surface spread XO oocyte from 18.5 dpc ovaries and performed 
immunofluorescence for three proteins: SYCP3, to sub-stage oocytes; 
HORMAD2, to identify the asynapsed X chromosome, and RPA (Figure 2.1). 
HORMAD2 labels asynapsed chromosome axes, but not desynapsed axes, 
between pachynema and late diplonema (Wojtasz et al., 2009). HORMAD2 
was used instead of γH2AFX to identify the asynapsed X chromosome 
because it identifies specifically the asynapsed core with which RPA foci are 
located.  
Using this approach, I found that the asynapsed X chromosome in XO 
oocytes has variable numbers of RPA foci depending upon the substage of 
prophase I. At pachynema, there were on average 5 ±0.5 RPA foci on the 
asynapsed X chromosome, although the range (0-15 foci) was wide (Figure 
2.1). At early diplonema, there were significantly fewer RPA foci on the 
asynapsed X chromosome (1 ±0.5), with a narrower range (0 to 4) 
(P=0.0435). By late diplonema, most oocytes had no RPA foci on the 
asynapsed X chromosome (mean=0.5 ±0.3 foci, range=0 to 1). Therefore, the 
majority of XO oocytes do not have X chromosome-associated RPA foci after 
pachynema.  
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Next, I examined whether the drop in the number of RPA foci on the 
asynapsed X chromosome occurs specifically during pachynema. To test 
this, I compared the number of RPA foci on the asynapsed X chromosome in 
XO oocytes further substaged into early pachynema and late pachynema. 
With the help of Dr. Shantha Mahadevaiah, I categorized oocytes into 
pachytene sub-stages based on the number of RPA foci on the synapsed 
autosomes, as described previously (Guioli et al., 2012). Numerous foci of 
RPA are present on synapsed autosomes at early pachynema (Figure 2.1a) 
but disappear thereafter, with few left by late pachynema (Figure 2.1b) 
(Guioli et al., 2012). Therefore, I subdivided XO pachytene oocytes into those 
with >30 autosomal RPA foci (early pachynema) and those with ≤30 
autosomal RPA foci (late pachynema). Based on these sub-staging criteria, I 
observed abundant RPA foci on the asynapsed X chromosome in XO oocytes 
at early pachynema (Figure 2.1a,d), but significantly lower RPA counts at 
late pachynema (Figure 2.1b,d). 
To verify these results, I also assessed the behavior of recombinases 
RAD51 and DMC1 on the asynapsed X chromosome in XO oocytes. In 
accordance with my RPA analyses, both RAD51 and DMC1 were abundant 
on the asynapsed X chromosome during pachynema in a subset of oocytes 
(Figure 2.1e,g). However, in many pachytene oocytes there were few or no 
RAD51 and DMC1 foci on the asynapsed X chromosome (Figure 2.1f,h). 
This second population of oocytes represented later pachytene oocytes in 
which DNA DSB repair has completed on the asynapsed X chromosome. This 
suggests that most RAD51/DMC1 foci are lost by late pachynema. In 
accordance with this, RAD51 and DMC1 were not observed on the 
asynapsed X chromosome at early diplonema (data not shown).  
Together, these data reveal that DNA DSBs markers disappear by late 
pachynema. Therefore, the asynapsed X chromosome does not harbor 
persistent unrepaired DNA DSBs during the stage when XO oocyte losses are 
observed (i.e. diplonema). This suggests that persistent unrepaired DNA 
DSBs are not the proximal cause of oocyte losses in XO mice. 
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Figure 2.1 DNA DSB repair proteins do not persist on the 
asynapsed X chromosome in XO oocytes.  
(a) Early pachytene XO oocyte with numerous RPA foci (green) on 
asynapsed X chromosome (arrow, and inset). RPA foci are abundant on all 
synaptic axes at early pachytene, but rapidly decrease by late pachynema. 
(b) Late pachytene XO oocyte with no RPA foci on the asynapsed X 
chromosome (arrow and inset), and few autosomal foci. (c) Early diplotene 
XO oocytes with no RPA foci on asynapsed X chromosome. (d) Number of 
RPA foci on asynapsed X chromosome at pachynema, early diplonema, and 
late diplonema. P value determined by Tukey’s multiple comparison test. (e) 
Early pachytene XO oocyte with several RAD51 foci on asynapsed X (arrow). 
(f) Late pachytene XO oocyte with no RAD51 foci. (g) Early pachytene XO 
oocyte with numerous DMC1 foci on asynapsed X (arrow) and autosomes. 
(h) Late pachytene XO oocyte with no DMC1 foci. (i) Schematic showing RPA 
turnover from the asynapsed X chromosome by late pachynema. 
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3.2.2 DNA DSB repair proteins do not persist on multiple asynapsed 
chromosomes in PWDxB6 F1 oocytes  
The analysis of DNA repair in XO oocytes suggests that meiotic DNA 
DSBs are repaired even in the absence of a homolog. To better characterize 
this DNA repair response, I next examined whether more extensive 
asynapsis challenges this DNA DSB repair pathway. To address this, with 
help from Dr. Shantha Mahadevaiah, I examined RPA turnover in oocytes 
that contain multiple asynapsed chromosomes. For unknown reasons, 
progeny from PWD females and C57BL/6 males, which are highly 
genetically divergent, show extensive and variable levels of asynapsis in 
germ cells (Bhattacharyya et al., 2013; Mihola et al., 2009). Therefore, I 
assessed RPA turnover in PWDxB6 F1 oocytes.  
First, I estimated the number of asynapsed chromosomes present in 
PWDxB6 F1 oocytes by SYCP3/HORMAD2 immunostaining. At 18.5 dpc, 
77% of oocytes from F1 PWDxB6 females had HORMAD2-positive 
asynapsed chromosomes (Figure 2.2a-c, arrows). At pachynema, there 
were on average nine asynapsed chromosomes (Figure 2.2a). A similarly 
high level of asynapsis was observed at early diplonema (mean=9 
asynapsed chromosomes) (Figure 2.2a) and late diplonema (mean=8 
asynapsed chromosomes). In summary, PWDxB6 F1 females have extensive 
asynapsis between pachynema and late diplonema. It is possible that some 
oocytes that I classified as pachytene nuclei with asynapsis are actually 
zygotene nuclei. However, zygotene oocytes tend to have longer SC cores 
compared to pachytene oocytes (Wojtasz et al., 2009). Furthermore, the 
majority of oocytes at 18.5 dpc have progressed beyond zygonema (see 
Figure 1.2). Use of other markers more prevalent on zygotene nuclei, such as 
DNA DSB markers, could be used to confirm this substaging.  
Next, I quantified the number of RPA foci on asynapsed 
chromosomes in PWDxB6 F1 oocytes between pachynema and late 
diplonema. As with the XO RPA analysis, I subdivided PWDxB6 F1 pachytene 
oocytes into early pachynema (Figure 2.2b) and late pachynema (Figure 
2.2c) based on the decreasing number of RPA foci on synapsed 
chromosomes with pachytene progression. At early pachynema, there were 
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on average 7 RPA foci associated with all asynapsed chromosomes (Figure 
2.2b,d). Notably, at late pachynema there were significantly fewer RPA foci 
on asynapsed chromosomes (mean=1 RPA focus; Tukey’s test, P<0.0001) 
(Figure 2.2c-d). In fact, most oocytes had no RPA foci on asynapsed 
chromosomes at late pachynema. Very low RPA counts were also observed 
at early diplonema (mean=1 focus) and late diplonema (mean=0.5 foci) 
(Figure 2.2d).  
These data reveal that, like in XO oocytes, most RPA foci are resolved 
from multiple asynapsed chromosomes in F1 PWDxB6 oocytes by late 
pachynema (Figure 2.2e). Therefore, oocytes have the capacity to efficiently 
repair DNA DSBs when an extensive number of chromosomes are 
asynapsed. Importantly, these data support the theory that unrepaired DNA 
DSBs do not persist into diplonema in chromosomally abnormal mice, and 
therefore that DNA damage is unlikely to contribute to oocyte losses in mice 
with asynapsed chromosomes.   
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Figure 2.2. DNA DSB repair proteins do not persist on multiple 
asynapsed chromosomes in PWDxB6 F1 oocytes.  
(a) Characterization of PWDxB6 F1 oocytes with asynapsed chromosomes 
at pachynema, early diplonema, and late diplonema. (b) Early pachytene 
PWDxB6 F1 oocyte with numerous asynapsed chromosomes (approx. 8), 
marked by HORMAD2 and containing abundant RPA foci. (c) Late pachytene 
PWDxB6 F1 oocyte with numerous asynapsed chromosomes (approx. 9) 
containing much fewer RPA foci. Late pachytene stage is indicated by the 
dearth of RPA foci on synapsed bivalents. (d) Number of RPA foci on 
asynapsed axes in PWDxB6 F1 oocytes. (e) Schematic showing repair of 
DNA DSBs from numerous asynapsed axes. 
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3.2.3 Spo11 heterozygosity does not attenuate XO oocyte losses 
To further examine the role of DNA DSBs in oocyte loss in 
chromosomally abnormal mice, I assessed the effect of genetically reducing 
meiotic DNA DSBs on XO oocyte elimination. Studies of Spo11+/- mouse 
spermatocytes have shown that Spo11 heterozygosity reduces the number 
of RAD51 foci at leptonema by 18-30%, suggesting a reduction in DNA DSB 
formation (Bellani et al., 2010; Carofiglio et al., 2013). There is a similar 
reduction in RAD51 foci numbers at leptonema in oocytes heterozygous for 
Spo11 (Carofiglio et al., 2013).   
I studied XO Spo11+/- females to examine whether reducing meiotic 
DNA DSBs effects the elimination of XO oocyte with an asynapsed X 
chromosome. I quantified the percentage of XO Spo11+/- oocytes with an 
asynapsed X chromosome at pachynema, early diplonema, and late 
diplonema. As with my previous analyses, I studied 
SYCP3/HORMAD2/H2AFX triple-immunostained oocyte spreads from 18.5 
dpc XO Spo11+/- females. At pachynema, nearly half of XO Spo11+/- oocytes 
had a H2AFX domain, consistent with age-matched XO Spo11+/+ females 
(Figure 2.3). At early diplonema, only 20% of XO Spo11+/- oocytes had a 
H2AFX domain, indicating that significant oocyte losses occur from 
pachynema to early diplonema (Figure 2.3). Additional oocyte losses are 
observed by late diplonema (Figure 2.3).  
Therefore, Spo11 heterozygosity does not alleviate XO oocyte losses. 
It is possible, however, that Spo11 heterozygosity does not sufficiently 
reduce DNA DSBs to significantly alter the number of DNA DSBs on the 
asynapsed X chromosome. Addressing this requires quantitation of the 
number of RAD51 foci on the asynapsed X chromosome in XO Spo11+/- 
oocytes. Nevertheless, combined with my earlier analyses of 
RPA/RAD51/DMC1 turnover, these data suggest that persistent DNA 
damage on asynapsed chromosomes is unlikely to trigger oocyte loss in 
chromosomally abnormal mice.  
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Figure 2.3. Elimination of XO Spo11+/- oocytes. 
The mean percentage of XO Spo11+/- oocytes with a H2AFX domain in 18.5 
dpc ovaries. n is the number of oocytes analyzed at each stage from one 
ovary. 
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3.3 The role of an asynapsis checkpoint in oocyte losses in 
chromosomally abnormal mice 
Given that my above analyses suggested that DNA damage is unlikely 
to contribute to oocyte losses in chromosomally abnormal females, I then 
tested the role of an asynapsis checkpoint. Evidence for an asynapsis 
checkpoint comes from mice lacking DNA DSBs, i.e. Spo11-/- mice. 
Specifically, Spo11-/- oocytes have extensive asynapsis and suffer oocyte 
losses resulting in infertility (Di Giacomo et al., 2005). The molecular details 
of this DNA DSB-independent mechanism remain unclear.  
One putative pathway for DNA DSB-independent oocyte losses is an 
asynapsis checkpoint (Di Giacomo et al., 2005). Asynapsis checkpoints are 
triggered by some feature of asynapsed chromosomes, such as defective SC 
morphogenesis, and lead to meiotic prophase I arrest (MacQueen and 
Hochwagen, 2011). Although asynapsis checkpoints have been well 
characterized in C. elegans (Bhalla and Dernburg, 2005) and S. cerevesiae 
(Roeder and Bailis, 2000), it is unclear whether an analogous system 
operates in mammals. In the next section, I test whether an asynapsis 
checkpoint operates in mice with chromosome abnormalities.  
3.3.1 Predictions under asynapsis checkpoint model 
Ascertaining whether an asynapsis checkpoint operates in mammals 
is not trivial. Genes with putative asynapsis checkpoint functions, e.g. 
HORMAD1 and ATR, are also required for meiotic silencing (Daniel et al., 
2011; Royo et al., 2013). Meiotic silencing has been also proposed to cause 
germ cell arrest by inactivating essential genes on asynapsed chromosomes 
(Burgoyne et al., 2009) (see Chapter 4). Owing to the interdependence of 
proteins involved in the putative asynapsis checkpoint and meiotic silencing 
pathways, distinguishing between them as triggers of oocyte loss is 
challenging. 
Importantly, however, these two models predict different outcomes 
depending on whether the asynapsed chromosome contains essential genes. 
Under the asynapsis checkpoint model, any asynapsed chromosome will 
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lead to oocyte losses, irrespective of the genes that are associated with the 
asynapsed chromosome. By contrast, under the meiotic silencing model, 
oocyte arrest will only occur when asynapsed chromosomes contain 
essential genes. If asynapsed chromosomes contain non-essential genes, 
meiotic silencing would not have an effect on transcription that would be 
detrimental to developing oocytes.  
Therefore, it is possible to distinguish between these two models by 
examining the fate of oocytes containing asynapsed chromosomes that 
harbor no essential genes, i.e. accessory/supernumerary chromosomes. If 
the asynapsis checkpoint operates in oocytes, then such oocytes would be 
eliminated by diplonema (Figure 2.4). However, if meiotic silencing is the 
primary mechanism driving oocyte losses, then these oocytes would escape 
elimination and survive into diplonema (Figure 2.4). 
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Figure 2.4. Predictions for fate of oocytes with asynapsed 
chromosomes containing non-essential genes. 
Asynapsis checkpoint model: oocytes with asynapsed chromosomes are 
eliminated, irrespective if the chromosomes contain non-essential or 
essential genes. Meiotic silencing model: oocytes with asynapsed 
chromosomes containing non-essential genes are not eliminated, because 
this model predicts that silencing only causes loses when it silences 
essential genes. 
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3.3.2 RNA FISH analysis of transcription in XX oocytes 
As discussed above, distinguishing between the asynapsis checkpoint 
and the meiotic silencing models of oocyte loss requires analysis of 
chromosomes that do not express genes essential for oocyte survival. Such 
an analysis can be performed on XX wildtype oocytes provided that they 
harbor chromosomes, or chromosome regions, that are underrepresented in 
oocyte-expressed genes (i.e. non-essential genes).  
To assess for underexpressed chromosomes, I first examined the 
nuclear-wide transcriptional status of wildtype oocytes. In collaboration 
with Dr. Shantha Mahadevaiah (NIMR), Cot-1 RNA FISH was performed in 
18.5 dpc XX oocytes to estimate global transcription levels in prophase I 
sub-staged oocytes. Cot-1 DNA is enriched for repetitive sequence that can 
be used as a probe to detect repeat-rich regions of nascent RNA transcripts, 
such as intronic and 3’ untranslated regions (Turner et al., 2005). The 
intensity of nuclear Cot-1 RNA FISH immunofluorescence correlates with 
the level of nuclear transcription (Bellani et al., 2010). Therefore, I used Cot-
1 RNA FISH to assess whether oocytes have any chromosomes showing 
underexpression.  
Using HORMAD1 for substaging, I analyzed Cot-1 staining at 
pachynema, early diplonema, and late diplonema (Figure 2.5). As expected, 
Cot-1 staining was low at sites of DAPI-dense constitutive heterochromatin 
(i.e. centromeres, telomeres, etc.) (Figure 2.5c, asterisks). Outside of sites of 
constitutive heterochromatin, there was diffuse nuclear-wide Cot-1 staining 
(Figure 2.5a-c), indicative of global transcription. This staining pattern is in 
contrast to that observed in previous studies of XO oocytes, which have a 
Cot-1 negative “hole” corresponding to the inactive asynapsed X 
chromosomes (Turner et al., 2005). This indicates that all mouse 
chromosomes are transcriptionally active except at sites of constitutive 
heterochromatin. 
To determine if oocyte transcription levels change during meiotic 
prophase I progression, I then measured the intensity of Cot-1 signal, 
corrected for background, in XX oocytes at pachynema, early diplonema, and 
late diplonema. Cot-1 staining intensity increased significantly from 
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pachynema and late diplonema (Figure 2.5d) (Tukey’s test, P<0.0001), 
indicating a rise in nuclear-wide transcription during prophase I 
progression. 
These results suggest that the oocyte genome is highly 
transcriptionally active, especially at diplonema. Therefore, it would be 
challenging to identify a single endogenous chromosomes or chromosome 
region that would satisfy the criteria of having non-essential oocyte genes. 
To distinguish between the asynapsis checkpoint versus meiotic silencing 
models of meiotic surveillance, therefore, requires analysis of an exogenous, 
accessory chromosome, which by definition has no essential genes.  
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Figure 2.5. Cot-1 RNA FISH analysis of wildtype XX oocytes. 
(a) Representative pachytene XX oocyte subject to Cot-1 RNA FISH (green), 
substaged based on the absence of the asynapsis marker HORMAD1 (inset). 
(b) Representative early diplotene oocyte, sub-staged by intermediate levels 
of HORMAD1. (c) Representative late diplotene oocyte, substaged by 
extensive HORMAD1 staining. Note the higher levels of Cot-1 staining 
compared to pachytene and early diplotene oocytes. Asterisks represent 
sites of constitutive heterochromatin. (d) Quantitation of nuclear Cot-1 RNA 
FISH staining intensity. n is the number of oocytes analyzed. P values were 
generated from Tukey’s multiple comparison test, and significant P values 
(P<0.05) are shown in red. 
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3.3.3 Meiotic characterization of Tc1 mouse model of Down syndrome 
I studied two different accessory chromosome mouse models to help 
distinguish between the asynapsis checkpoint model and the meiotic 
silencing model of meiotic surveillance. The first accessory chromosome 
mouse model that I studied was the Tc1 mouse model of Down syndrome, 
which contains a hemizygous copy of the human chromosome 21 (h21) 
(O'Doherty et al., 2005). Given that the asynapsed h21 chromosome is 
accessory it by definition contains only non-essential genes. Therefore, the 
Tc1 mouse model satisfies the criteria for distinguishing between the two 
DNA DSB-independent models of meiotic surveillance.  
Before assessing the consequence of the accessory h21 on oocyte 
survival, I first verified that meiotic events occur normally in Tc1 oocytes. 
To assess whether the kinetics of meiotic progression are changed by the 
exogenous h21 chromosome, I substaged Tc1 oocytes at 18.5 dpc and 
compared the results to my previous analysis of XX oocytes. The percentage 
of pachytene, early diplotene, and late diplotene oocytes at 18.5 dpc was not 
significantly different between Tc1 and XX ovaries (Figure 2.6a), implying 
that meiotic progression occurs with normal kinetics in Tc1 ovaries. 
Second, I assessed whether the components involved in the asynapsis 
responses are unchanged in Tc1 oocytes. Using chromosome spreads and 
immunostaining, I analyzed the localization of BRCA1, ATR, HORMAD1, and 
H2AFX in Tc1 oocytes. Importantly, all of these proteins localized as 
expected to the asynapsed h21 chromosome in pachytene oocytes (Figure 
2.6b-e). This confirms that asynapsis signalling is proficient in Tc1 oocytes. 
Next, I examined the synaptic behavior of the accessory h21 
chromosome in Tc1 pachytene oocytes. Using SYCP3/HORMAD1/γH2AFX 
triple-immunostaining, I found that one population of Tc1 pachytene 
oocytes contained a γH2AFX chromatin domain, which marked the 
asynapsed h21 chromosome (Figure 2.6d, arrow), as verified by h21 
painting (not shown). A second population of Tc1 oocytes had a self-
synapsed and γH2AFX-negative h21 chromosome (Figure 2.6e, arrow). 
Therefore, the synaptic behavior of the h21 is similar to that observed for 
the X chromosome in XO oocytes.  
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To assure the comparability of the Tc1 model to the XO model, I also 
determined whether the level/intensity of γH2AFX signalling on the h21 
was comparable to that of the asynapsed X in XO oocytes. The h21 (42Mb) in 
Tc1 oocytes is significantly smaller than the mouse X chromosome (171Mb) 
in XO oocytes. To assess whether this size difference affects the 
level/intensity of γH2AFX chromatin signalling, Dr. Shantha Mahadevaiah 
and I quantified the background-normalized intensity of the γH2AFX domain 
associated with the asynapsed X chromosome and h21 chromosome, 
respectively. This analysis was performed specifically on diplotene oocytes, 
the stage when oocyte losses occur in our chromosomally abnormal mice 
(see Figure 1). Notably, despite the difference in size of each chromosome, 
the intensity of γH2AFX signalling was not significantly different between 
XO and Tc1 oocytes (T test, two-way, P=0.9489) (Figure 2.6f).  
Finally, I examined whether DNA DSB repair proteins persist on the 
asynapsed h21, or if they are resolved with normal kinetics. In XO oocytes, 
RPA on the asynapsed X chromosome were resolved in the majority of 
oocytes by late pachynema.  In Tc1 oocytes, the asynapsed h21 had on 
average 3 ±0.4 RPA foci (range=0-10 foci) at pachynema (Figure 2.5i). At 
early diplonema the majority of Tc1 oocytes did not have RPA foci on the 
asynapsed h21 (mean=0.3 ±0.1) (Tukey’s test, P=0.0002) (Figure 2.5i). This 
indicates that like in XO females the asynapsed h21 does not harbor 
persistent DNA DSBs beyond late pachynema.  
In summary, my analyses of meiotic kinetics, the asynapsis response, 
and DNA DSB repair did not reveal any differences between Tc1 and XO 
oocytes. Therefore, Tc1 oocytes are a suitable model with which to compare 
to XO oocytes.   
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Figure 2.6. Meiotic characterization of Tc1 oocytes with an 
asynapsed h21 chromosome. 
(a) Comparison of the mean percentage of oocytes at pachynema, early 
diplonema, and late diplonema between XX and Tc1 females at 18.5 dpc. (b) 
Pachytene Tc1 oocyte showing BRCA1 enrichment on the asynapsed h21 
chromosome (arrow). (c) Tc1 pachytene oocyte showing ATR enrichment 
on the asynapsed h21 chromosome (arrow). (d) Tc1 pachytene oocyte 
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showing H2AFX (arrow) and HORMAD1 (inset) enrichment on the 
asynapsed h21 chromosome. (e) Tc1 pachytene oocyte with a self-synapsed 
h21 chromosome, lacking H2AFX staining. Scale bar=10m. (f) Comparison 
of H2AFX domain integrated intensity in XO and Tc1 early diplotene 
oocytes at 19.5 dpc. n is the number of oocytes analyzed. P value determined 
from unpaired T test. (g) Number of RPA foci on asynapsed h21 
chromosome at pachynema, early diplonema, and late diplonema. Tukey’s 
multiple comparison test, P value significance shown in red. 
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3.3.4 Tc1 oocytes with an asynapsed h21 chromosomes persist into 
diplonema 
After verifying that meiotic events occur as expected in Tc1 oocytes, I 
then examined the fate of oocytes with an asynapsed h21. If asynapsis per se 
is sufficient to trigger oocyte losses, as expected by an asynapsis checkpoint, 
then Tc1 oocytes with an asynapsed h21 should be eliminated by late 
diplonema, as observed with XO, In(X)1H, T43H, and XX oocytes (Figure 
2.4, left panel). On the other hand, if meiotic silencing, rather than an 
asynapsis checkpoint, is the underlying cause of oocyte arrest, then oocytes 
with an asynapsed h21 chromosome should persist through diplonema, 
since the h21 chromosome contains only non-essential genes (Figure 2.4, 
right panel).  
To test these predictions, I quantified the percentage of Tc1 oocytes 
with an asynapsed, γH2AFX-positive h21 chromosome between pachynema 
and late diplonema. At 17.5 dpc, on average 36% of Tc1 oocytes had an 
asynapsed h21 chromosome (Figure 2.7a). Notably, at 18.5 and 19.5 dpc, 
the percentage of oocytes with an asynapsed h21 chromosome remained 
unchanged (34% and 35%, respectively) (Tukey’s test, P=0.9504 and 
P=0.9820, respectively) (Figure 2.5l).  
To confirm this result, I also analyzed substaged Tc1 oocytes from 
18.5 dpc ovaries. At pachynema, 40% of Tc1 oocytes had an asynapsed h21 
chromosome (Figure 2.7b). Notably, this was not significantly different 
from the percentage of oocytes with an asynapsed h21 chromosome at early 
diplonema (37%; Tukey’s test, P=0.9788) or late diplonema (31%, Tukey’s 
test, P=0.8026) (Figure 2.7b).  
In conclusion, Tc1 oocytes with an asynapsed h21 chromosome 
persist into late diplonema (Figure 2.7c). This result suggests that 
asynapsis per se is not sufficient to trigger significant oocyte losses, thus 
supporting the meiotic silencing model of meiotic surveillance. 
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Figure 2.7. Tc1 oocytes with an asynapsed h21 persist to late 
diplonema. 
(a) The mean percentage of Tc1 oocytes with aH2AFX domain, 
representing the asynapsed h21 chromosome, at 17.5, 18.5, and 19.5 dpc. n 
is the number of ovaries analyzed, with 100-200 oocytes analyzed per 
ovary. (b) The mean percentage of Tc1 oocytes with a H2AFX domain from 
18.5 dpc ovaries, where oocytes were substaged into pachynema, early 
diplonema, and late diplonema. Three ovaries were analyzed, and n is the 
total number of oocytes analyzed. P values were generated from Tukey’s 
multiple comparison test, and significant P values (P<0.05) are shown in 
red. (c) Schematic showing fate of Tc1 oocytes with either an asynapsed h21 
chromosome or self-synapsed h21 chromosome. In both cases, oocytes 
progress to late diplonema.  
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3.3.5 XXYd1 oocytes with an asynapsed accessory Y chromosome 
persist to late diplonema 
To verify the results of the Tc1 mouse model, I also analyzed another 
accessory chromosome mouse model in which the accessory chromosome 
was of mouse origin: the sex-reversed XXYd1 mouse. XXYd1 females harbor a 
single accessory copy of the mouse Y chromosome (denoted Yd1) containing 
a 3-4Mb repeat deletion that results in positional inactivation of the male-
determining factor Sry in the developing gonad, such that XXYd1 embryos 
develop as females (Capel et al., 1993; Mahadevaiah et al., 1998).  
 To study the synaptic status of the accessory Yd1 chromosome, I 
immmunostained surface spread XXYd1 oocytes with 
SYCP3/HORMAD1/H2AFX. In a subset of XXYd1 pachytene oocytes, the 
accessory Yd1 chromosome remained asynapsed, and was positive for both 
γH2AFX and HORMAD1 (Figure 2.8a, arrow, inset). In the remaining XXYd1 
oocytes, the single Yd1 chromosome was self-synapsed and γH2AFX- and 
HORMAD1-negative (Figure 2.8b, arrow).  
Next, I quantified the percentage of XXYd1 oocytes with a H2AFX 
domain (i.e. asynapsed Yd1 chromosome) in substaged oocytes from 18.5 
dpc ovaries. Notably, the percentage of XXYd1 oocytes with an asynapsed Yd1 
chromosome was unchanged between pachynema (38%), early diplonema 
(39%), and late diplonema (36%) (Figure 2.8c).  Therefore, the asynapsed 
Yd1 chromosome does not trigger oocyte losses during prophase I (Figure 
2.8d).  
Taking into account both accessory chromosome mouse models, 
these data strongly suggest that an asynapsis per se is not sufficient to 
trigger oocyte arrest,. Furthermore, these data support the meiotic silencing 
model, rather than the asynapsis checkpoint model of meiotic surveillance.  
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Figure 2.8. XXYd1 oocytes with an asynapsed Yd1 chromosome 
persist to late diplonema. 
(a) Pachytene XXY oocyte showing H2AFX (arrow) and HORMAD1 (inset) 
enrichment on the asynapsed Yd1 chromosome. (b) Pachytene XXY oocyte 
with a self-synapsed Yd1 chromosome (arrow), devoid of H2AFX. Scale 
bar=10m. (c) The percentage of XXY oocytes with a H2AFX domain at 
pachynema, early diplonema, and late diplonema in an 18.5 dpc ovary. (d) 
Schematic showing fate of XXY oocytes with either an asynapsed Yd1 
chromosome or self-synapsed Yd1 chromosome. In both cases, oocytes 
progress to late diplonema.  
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3.4 Discussion  
A primary goal of this thesis was to determine the molecular basis of 
prophase I surveillance in mice with chromosome abnormalities. In this 
section, I studied several mouse models of common human conditions, 
including a model of Turner syndrome (X chromosome monosomy) and 
Down syndrome (accessory human chromosome 21), and other structural 
and numerical chromosome abnormalities, including inversions, 
translocations and sex chromosome additions. Turner syndrome, in 
particular, is strikingly prevalent in humans, accounting for 1-2% of all 
clinically recognized pregnancies (Hall et al., 2006). It has been clear since 
as early as 1959 that Turner syndrome females experience gonadal 
dysgenesis and infertility (Ford et al., 1959). Nevertheless, the precise 
mechanism basis for infertility in these and other patients with chromosome 
abnormalities remains to be worked out. 
To date, our understanding of meiotic prophase I surveillance 
mechanisms operating in mammals has been informed predominantly from 
studies of targeted meiotic mutants. Studies of several meiotic mutants have 
shown that at least two surveillance mechanisms operate in mammalian 
oocytes. Analysis of mutants with defects in DNA repair, i.e. Dmc1-/-, Msh5-
/- and Atm-/- mice, has revealed the existence of a surveillance mechanism 
that responds to persistent unrepaired DNA DSBs (Di Giacomo et al., 2005; 
Reinholdt and Schimenti, 2005). There is also evidence for a DNA damage-
independent meiotic prophase I surveillance mechanism that is triggered by 
some feature of asynapsis (Di Giacomo et al., 2005). This DNA DSB-
independent pathway has been invoked to explain the severe oocyte loss in 
Spo11-/- and Mei1-/- DSB-deficient oocytes, which lack meiotic DNA DSBs 
but still experience oocyte losses and infertility (Di Giacomo et al., 2005; 
Reinholdt and Schimenti, 2005). It is unclear whether either of these 
pathways have a role in germ cell loss in mice with numerical or structural 
chromosome abnormalities.  
Studies of chromosomally variant mice are particularly valuable for 
understanding wildtype biology because these mouse models do not contain 
mutations in important genes. Most meiotic mutant mice may have defects 
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in critical meiotic processes, and these genetic changes may impact the 
behavior of surveillance mechanisms. Therefore, chromosomally variant 
mouse models are perhaps more applicable for understanding the 
mechanisms that operate in the context of normal mammalian biology. 
Using an extensive array of these mouse models, I first determined 
the timing of oocyte losses in a variety of mice with chromosome 
abnormalities. In XO, In(X)1H, T(16;17)43H, and normal XX females, I 
observed a significant drop in the percentage oocytes with an asynapsed 
chromosomes, marked by H2AFX, from pachynema to late diplonema. 
Importantly, this drop cannot reflect an increase in the frequency of self-
synapsis, because chromosomes desynapse during this period of meiosis. 
Furthermore, this drop is unlikely due to progressive dephosphorylation of 
H2AFX for several reasons: (1) H2AFX does not disappear until metaphase 
I in male germ cells (Mahadevaiah et al., 2001), and (2) oocytes with 
asynapsis that do not drop in frequency during meiotic prophase I (i.e. Tc1 
and XXY oocytes) retain H2AFX until late diplonema. Therefore, I conclude 
that the drop in the percentage of oocytes with asynapsed chromosomes 
reflects oocyte elimination.  
Taken together, these findings indicate that both an asynapsed X 
chromosome and asynapsed autosomes trigger oocyte losses during 
diplonema. This implies that a general mechanism operates in females with 
chromosome abnormalities and normal females to drive the elimination of 
oocytes with chromosome synaptic defects.  
Notably, oocyte arrest occurring during diplonema is inconsistent 
with the traditional pachytene checkpoint model of germ cell loss, which has 
been commonly invoked to explain germ cell arrest in male mice (Barchi et 
al., 2005). In spermatocytes, meiotic defects, including asynapsis, typically 
cause a strict arrest at mid-pachynema (Barchi et al., 2005; Burgoyne et al., 
2009). This indicates that there is a sexual dimorphism in the timing of 
arrest in mammals, with oocytes being eliminated later than spermatocytes.   
Furthermore, not all oocytes with asynapsis were eliminated by late 
diplonema, perhaps indicating that the prophase I surveillance mechanism 
in females is not 100% efficient. This has also been observed in several 
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meiotic mutants, such as Spo11-/- and Dmc1-/- females, which retain still 
50% of their oocytes at birth, corresponding to diplonema (Di Giacomo et 
al., 2005). My work confirms the sexual dimorphism in the timing of germ 
cell arrest between the sexes, and suggests that distinct mechanisms 
operate in spermatocytes and oocytes and/or that common ones operate 
with different stringencies.  
Persistent unrepaired meiotic DNA DSBs, as found in recombination 
mutants, e.g. Dmc1-/- females, are associated with severe germ cell loss and 
infertility (Pittman et al., 1998; Yoshida et al., 1998). I therefore considered 
the possibility that persistent unrepaired DNA DSBs occur on the asynapsed 
chromosomes in chromosomally variant mouse models. I addressed this 
possibility by studying the turnover of DNA repair proteins, i.e. RPA, RAD51, 
and DMC1, in XO mice. I found that the majority of X chromosome DNA 
DSBs, marked by RAD51/DMC1/RPA, are resolved by exit from pachynema. 
This drop in foci counts in XO oocytes cannot reflect elimination of XO 
oocytes with numerous foci because this RPA counts decreased before 
diplonema, the stage when oocyte losses were observed. Therefore, DNA 
DSBs do not persist on the asynapsed X chromosome in XO oocytes, and 
therefore are unlikely to contribute to oocyte arrest in XO females. I also 
found that DNA DSBs associated with greater than one asynapsed 
chromosome, as in PWD/Ph x C57Bl/6 F1 hybrid females, are resolved by 
late pachynema. This is in contrast to the situation in DNA DSB repair-
deficient mutant mice, like Dmc1-/- oocytes, where unrepaired breaks 
persist and cause oocyte arrest (Pittman et al., 1998; Yoshida et al., 1998). 
These pathways leading to oocyte arrest in chromosomally abnormal mice 
and those with persistent DNA damage are, therefore, mechanistically 
distinct.  
These results also suggest that a mechanism operates in oocytes to 
repair DNA DSBs in the absence of a homologous chromosome. This is 
consistent with previous immunocytological studies of the male germ line, 
which showed that DNA DSB markers disappear from the asynapsed X 
chromosome by mid-late pachynema (Mahadevaiah et al., 2008).  Additional 
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work will be required to identify the molecular nature of this mechanism of 
DNA DSB repair in oocytes. 
After discounting the DNA damage checkpoint as a likely mechanism 
for oocyte elimination in our chromosome variant mouse models, I then 
assessed the potential role of asynapsis per se in oocyte arrest. In mammals, 
asynapsis has been proposed to cause oocyte arrest through meiotic 
silencing or a checkpoint monitoring asynapsis, but distinguishing between 
these models has proved challenging because putative synapsis checkpoint 
proteins are necessary for silencing (Daniel et al., 2011; Kogo et al., 2012a; 
Shin et al., 2010; Wojtasz et al., 2012).  
The silencing model predicts that asynapsed chromosomes will 
trigger arrest only if they contain oogenesis-expressed genes, while the 
checkpoint model predicts that they will cause arrest irrespective of their 
gene content. My Cot1 RNA FISH analysis revealed high global gene 
expression levels in XX prophase I oocytes, especially during diplonema, 
indicating that all mouse chromosomes harbor oogenesis-expressed genes. 
To separate the effects of asynapsis and silencing, I therefore studied mice 
carrying additional, so-called “accessory” chromosomes, which harbor non-
essential genes. 
In Tc1 females, oocytes with a single accessory h21 chromosome 
were not eliminated during diplonema, despite the presence of BRCA1, 
HORMAD1, ATR, and H2AFX on the h21 chromosome. There was also no 
selection against XXYd1 oocytes with an asynapsed accessory Yd1 
chromosome (Figure 2.8). This demonstrates that presence of asynapsed 
chromosomes and asynapsis-associated factors, e.g. HORMAD1, HORMAD2, 
BRCA1, ATR and H2AFX, is insufficient to cause diplotene oocyte 
elimination.  
I consistently found that oocyte losses occurs only when asynapsed 
chromosomes carry oogenesis-expressed genes, as in XO, In(X)1H, T43H, 
and XX females. While it is conceivable that accessory chromosomes do not 
efficiently activate a putative synapsis checkpoint, it seems unlikely, since 
my experiments revealed no qualitative or quantitative differences in the 
asynapsis response between these models and those that exhibit diplotene 
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oocyte arrest. Thus, my data cannot be readily explained by either a DNA 
damage checkpoint or an asynapsis checkpoint, and instead suggest a role 
for meiotic silencing in oocyte loss in chromosomally abnormal mice. 
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4  Results: The role of H2AFX in oocyte losses in 
chromosomally abnormal mice  
As described in the previous chapter, oocyte arrest in chromosomally 
abnormal mice is unlikely to be triggered by persistent unrepaired DNA 
DSBs or an asynapsis checkpoint. In this chapter, therefore, I will examine 
the role of meiotic silencing in the elimination of oocytes with asynapsed 
chromosomes. First, I will test whether disrupting meiotic silencing 
prevents oocyte losses in chromosomally abnormal mice. To do this, I will 
examine the consequence of deleting H2afx, a histone variant essential for 
silencing (Fernandez-Capetillo et al., 2003), on XO oocyte survival.  
Following this, I will also test the role for H2AFX in the elimination of 
oocytes in targeted mutant mouse models, specifically Spo11-/- and Dmc1-/- 
females. Spo11-/- germ cells lack programmed DNA DSBs and have 
extensive asynapsis associated with H2AFX domain formation (Baudat et 
al., 2000; Carofiglio et al., 2013; Daniel et al., 2011; Romanienko and 
Camerini-Otero, 2000). Spo11-/- females experience prophase I oocyte 
losses, resulting in fewer oocytes compared to wildtype females at birth (Di 
Giacomo et al., 2005).  
Deletion of Hormad1 rescues oocyte losses in Spo11-/- female mice 
(Daniel et al., 2011; Kogo et al., 2012b). HORMAD1 has been proposed to 
mediate Spo11-/- oocyte losses by being in involved in an asynapsis 
checkpoint, or via its role in meiotic silencing (Daniel et al., 2011; Kogo et al., 
2012b). I test the role of the silencing model of Spo11-/- oocyte losses by 
H2afx-/- deletion experiments.  
Finally, I test the role for H2AFX in the elimination of Dmc1-/- 
oocytes. Dmc1-/- mice fail to repair meiotic DNA DSBs, and Dmc1-/- oocytes 
are eliminated by a DNA damage checkpoint. To examine whether H2AFX is 
involved in this DNA damage checkpoint, I test whether H2afx ablation 
rescues Dmc1-/- oocyte losses. 
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4.1 A role for H2AFX in XO oocyte losses 
4.1.1 Sub-staging XO H2afx-/- oocytes and identifying the asynapsed X 
chromosome 
To address the role for meiotic silencing in XO oocyte losses, I 
generated and studied XO females lacking the essential silencing factor 
H2afx. XO H2afx-/- females were first examined using a chromosome 
spreads combined with immunostaining. First, I quantified the percentage of 
XO H2afx-/- oocytes with an asynapsed X chromosome between pachynema 
and late diplonema, the timeframe when XO oocytes are eliminated (Figure 
1.4). As in my previous experiment, HORMAD1 immunostaining was used to 
sub-stage XO H2afx-/- oocytes into pachynema (Figure 3.1a), early 
diplonema (Figure 3.1b), and late diplonema (Figure 3.1c), based upon the 
extent of HORMAD1 staining.  
In my previous oocyte elimination analyses, I used γH2AFX as a 
marker of the asynapsed X chromosome (see Figure 1). Since H2AFX is 
abolished in XO H2afx-/- females, I used another marker of asynapsis, 
namely HORMAD2, to identify the asynapsed X chromosome. HORMAD2 
preferentially marks asynapsed chromosome axes, but unlike HORMAD1 
does not accumulate on desynapsed axes, between pachynema and late 
diplonema (Wojtasz et al., 2009).  
Using HORMAD1/HORMAD2 double-immunostaining, I was able to 
identify XO H2afx-/- oocytes with an asynapsed X chromosome at 
pachynema, early diplonema, and late diplonema. At pachynema, a subset of 
XO H2afx-/- oocytes contained a single asynapsed X chromosome, marked 
by HORMAD1/HORMAD2 (Figure 3.1a, arrow). In the remaining pachytene 
oocytes, the X chromosome achieved self-synapsis, and therefore the oocyte 
nucleus was negative for HORMAD1/HORMAD2 (not shown). During early 
and late diplonema, HORMAD1 accumulates on desynapsed chromosome 
axes (Figure 3.1b-c, arrowheads), and HORMAD2 preferentially mark the 
asynapsed X chromosome (Figure 3.1b-c, arrows).  
During the process of breeding XO H2afx-/- females, I noticed that XO 
H2afx-/- mice were significantly smaller than XO H2afx+/- and XO H2afx+/+ 
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littermates (Figure 3.1d, table). This was the case at all developmental ages 
analyzed, from 18.5 to 20.5 dpc (Figure 3.1d, table). This observation is 
consistent with previous work, which reported a growth delay in H2afx-/- 
mice (Celeste et al., 2002). 
Due to this growth defect, I next examined whether oocyte 
progression was disrupted or delayed in XO H2afx-/- females. To address 
whether oocytes reach the end of prophase I, I analyzed XO H2afx-/- oocytes 
at 19.5 dpc, when a significant number of oocytes have reached late 
diplonema in wildtype females (Figure 1.1). Indeed, a significant 
percentage of XO H2afx-/- oocytes were at late diplonema at 19.5 dpc, 
indicating that H2afx is not required for completion of meiotic prophase I 
(Figure 3.1e).  
Upon quantification of the percentage of 19.5 dpc oocytes at 
pachynema, early diplonema, and late diplonema, however, there was an 
apparent delay in oocyte progression, such that a substantial fraction of 
oocytes were at pachynema at 19.5 dpc (Figure 3.1e). Indeed, oocyte sub-
staging revealed that XO H2afx-/- oocyte composition at 19.5 dpc was not 
significantly different from XO oocyte composition at 18.5 dpc (Figure 
3.1e). This slight (~1 day) developmental delay in meiotic progression in XO 
H2afx-/- oocytes is likely linked to the overall growth delay in H2afx-/- mice 
(Celeste et al., 2002). I, therefore, focused the rest of my experiments on XO 
H2afx-/- ovaries from 19.5 dpc females.   
Notably, I did not observe any significant difference in the proportion 
of oocytes at late diplonema between XO 18.5 dpc and XO H2afx-/- 19.5 dpc 
ovaries (Figure 1.3e), as might be expected if H2afx deletion rescued XO 
oocyte losses. However, this analysis may not be sensitive enough to identify 
a difference in oocyte losses, given that only a fraction of oocytes are in late 
diplonema at these ages. Addressing this requires quantitative analysis of 
ovaries containing mostly late diplotene oocytes (addressed in Section 
4.1.3).  
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Figure 3.1. Characterization of XO H2afx+/- and XO H2afx-/- 
females. 
 (a) Pachytene XO H2afx-/- oocyte with an asynapsed X chromosome 
(arrow; marked by HORMAD1, green, and HORMAD2, red, and inset). (b) 
Early diplotene XO H2afx-/- oocyte, showing intermediate levels of 
desynapsis (HORMAD1, green) and an asynapsed X chromosome (arrow; 
marked with both HORMAD1 and HORMAD2, inset). (c) Late diplotene XO 
H2afx-/- oocyte, showing extensive desynapsis and an asynapsed X 
chromosome (arrow). Scale bar is 10μm. (d) Mass (g) of embryos of XO 
H2afx+/+, XO H2afx+/-, and XO H2afx-/- genotypes. Table shows P values 
from Tukey multiple comparison tests, with significance (P<0.05) shown in 
bold. (e) Mean percentage of oocytes at pachynema, early diplonema, and 
late diplonema. Table shows that XO H2afx+/+ at 18.5 dpc and XO H2afx-/- 
females at 19.5 dpc are not statistically significantly different in oocyte 
composition (grey shaded box). 
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4.1.2 Autosomal synapsis and DNA DSB repair in XO H2afx-/- oocytes 
H2afx-/- mice have male-specific infertility associated with failed 
silencing of the X and Y chromosomes (Celeste et al., 2002; Fernandez-
Capetillo et al., 2003). Besides the MSCI defect, H2afx deletion does not 
cause defects in autosomal synapsis or meiotic recombination in 
spermatocytes (Celeste et al., 2002). H2afx-/- females, on the other hand, are 
fertile, but produce a reduced litter size (Celeste et al., 2002). Whether H2afx 
deletion affects meiotic events, such as synapsis or recombination, in the 
female germ line is unclear. 
To determine the effect of H2afx deletion on female meiotic events, I 
studied autosomal synapsis in XO H2afx-/- pachytene oocytes. There are two 
“normal” synaptic configurations expected in XO H2afx-/- oocytes: those 
with an asynapsed X chromosome and those with a self-synapsed X 
chromosome (Figure 3.2a, arrow). I therefore defined XO H2afx-/- oocytes 
as having asynapsed autosomes if they contained more than one asynapsed 
chromosome (Figure 3.2b, arrows).  
Using HORMAD2 as a marker of asynapsis, I quantified the 
percentage of XO H2afx-/- oocytes with autosomal synaptic defects (i.e. >1 
asynapsed chromosome) at 19.5 dpc (Figure 3.2c). For a comparison, the 
same analysis was performed on age-matched XO H2afx+/- females (Figure 
3.2c). Notably, the percentage of pachytene oocytes with autosomal 
asynapsis was not significantly different between XO H2afx-/- and XO 
H2afx+/- females (T test, two-tailed, P=0.9813) (Figure 3.2c), indicating 
that autosomal synapsis is unaffected by H2afx deletion.  
Next, I studied meiotic DNA DSB repair protein turnover in XO H2afx-
/- oocytes. Because H2AFX has been proposed to create a chromatin 
microenvironment favorable for DNA DSB repair (Srivastava et al., 2009), 
H2AFX accumulation on the asynapsed X chromosome in XO oocytes may be 
important for the localization and/or retention of DNA DSB repair proteins. 
To address this possibility, I analyzed the number of RPA foci on the 
asynapsed X chromosome in XO H2afx-/- oocytes.  
To assess RPA turnover, I quantified the number of RPA foci on the 
asynapsed X chromosome in XO H2afx-/- oocytes at pachynema, early 
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diplonema, and late diplonema. At pachynema, there were on average 6 ±0.5 
RPA foci on the X chromosome in XO H2afx-/- oocytes (Figure 3.2d-f). This 
is not significantly different from the 5 ±0.5 RPA foci on the asynapsed X 
chromosome in XO H2afx+/+ oocytes (Tukey’s test, P=0.9559), as 
determined earlier (see Figure 2.1). Notably, there were also no significant 
differences in the number of RPA foci on the asynapsed X chromosome 
between XO H2afx-/- and control XO oocytes at early and late diplonema 
(Figure 3.2f) (Tukey’s test, P=0.9992 and P>0.9999, respectively).  
As in normal XO oocytes, there was also a significant drop in the 
number of RPA foci on the asynapsed X chromosome between pachynema 
and early diplonema (mean=1.9 ±0.5 foci) in XO H2afx-/- oocytes (Tukey’s 
test, P=0.0016) (Figure 3.2f). Thus, RPA foci do not persist on the 
asynapsed X chromosome beyond late pachynema in XO H2afx-/- oocytes. 
These data suggest that H2afx is not required for the resolution of DNA DSBs 
on the asynapsed X chromosome in XO oocytes, and that DSB repair is 
unaffected by H2afx deletion.  
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Figure 3.2. Autosomal synapsis and DNA DSB repair are 
unaffected in XO H2afx-/- oocytes.   
 (a) Pachytene XO H2afx-/- oocytes with normal synaptic configurations (≤1 
asynapsed chromosomes): (top left cell) single asynapsed X chromosome 
(arrow), and (bottom right cell) self-synapsed X chromosome. (b) Pachytene 
XO H2afx-/- oocyte with an autosomal synapsis defect (>1 asynapsed 
chromosome, arrows). (c) The mean percentage of XO H2afx+/- and XO 
H2afx-/- pachytene oocytes with autosomal synaptic defects. P value from 
unpaired t test. (d) Pachytene XO H2afx-/- oocyte with numerous RPA foci 
on the asynapsed X chromosome (arrow). (e) Pachytene XO H2afx-/- oocyte 
with no RPA foci on the asynapsed X chromosome. (f) Number of RPA foci 
on asynapsed X chromosome in 19.5 dpc XO H2afx-/- oocytes and 18.5 dpc 
XO H2afx+/+ oocytes at pachynema, early diplonema and late diplonema. n 
is the number of oocytes analyzed. Tukey’s multiple comparison test, P 
value significance (P<0.05) is shown in red. 
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4.1.3 XO H2afx-/- oocytes persist to late diplotene  
Next, I tested the meiotic silencing model of oocyte loss by studying 
the survival of XO H2afx-/- oocytes with an asynapsed X chromosome. To 
address this, I quantified the percentage of oocytes with an asynapsed X 
chromosome in XO H2afx+/- and XO H2afx-/- females at 19.5 dpc, using 
HORMAD1/HORMAD2 dual immunostaining.  
At pachynema, 52% of XO H2afx+/- oocytes had an asynapsed, 
HORMAD2-positive X chromosome (Figure 3.3a). This is similar to the 
percentage of XO H2afx+/+ oocytes with an asynapsed X chromosome at 
pachynema (56%), in which I used γH2AFX as a marker of the asynapsed X 
chromosome (Figure 1.4c). At early diplonema, 25% of XO H2afx+/- oocytes 
had an asynapsed X chromosome (Tukey’s test, P=0.0008), and by late 
diplonema only 11% of oocytes had one (Tukey’s test, P<0.0001) (Figure 
3.3a). This trend is reminiscent of the oocyte losses in XO wildtype females, 
indicating that H2afx heterozygosity does not improve the survival of XO 
oocytes with an asynapsed X chromosome during meiotic prophase I.  
Next, to evaluate the effect of H2afx nullizygosity on XO oocyte 
survival, I quantified the percentage of oocytes with an asynapsed X 
chromosome in XO H2afx-/- females at pachynema, early diplonema, and 
late diplonema at 19.5 dpc. At pachynema, 49% of XO H2afx-/- oocytes had 
an asynapsed X chromosome (Figure 3.3b). This is not significantly 
different from the percentage of XO H2afx+/- pachytene oocytes with an 
asynapsed X chromosome (Sidak’s test, P=0.9625). Notably, at early 
diplonema, there was no significant drop in the percentage of XO H2afx-/- 
oocytes with an asynapsed X chromosome (47%) (Tukey’s test, P=0.8885) 
(Figure 3.3b). At late diplonema, there was also no statistically significant 
drop in the percentage of XO H2afx-/- oocytes with an asynapsed X 
chromosome (39%) (Tukey’s test, P=0.1851) (Figure 3.3b).  
Therefore, XO H2afx-/- oocytes with an asynapsed X chromosome 
persist to the end of prophase I, such that at late diplonema there are 3.5 
times as many oocytes with an asynapsed X chromosome compared to XO 
H2afx+/- females (Sidak’s test, P=0.0004) (Figure 3.3c). By contrast, at 
pachynema, the percentage of oocytes with an asynapsed X chromosome 
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was not significantly different between XO H2afx-/- and XO H2afx+/- 
females (Sidak’s test, P=0.9625), indicating that H2afx deletion has no effect 
on the percentage of oocytes with an asynapsed X chromosome at 
pachynema (Figure 3.3c). Together, these data suggests that XO oocyte 
losses are dependent on H2afx and occur exclusively during diplonema.  
4.1.4 XO H2afx-/- oocytes with a non-phosphorylatable H2afx 
transgene persist to late diplonema  
Serine-139 phosphorylation of H2AFX is the critical epigenetic event 
in meiotic silencing (Ichijima et al., 2011). To confirm that the H2AFX-
dependent XO oocyte losses occur via S-139 phosphorylation, I examined 
oocyte survival in XO females carrying a non-phosphorylatable transgene of 
histone H2AFX (Celeste et al., 2003b). This H2afx transgene encodes a serine 
to alanine substation at position 139 (denoted H2afxS139A), which prevents 
H2AFX phosphorylation at that residue (Celeste et al., 2003b).  
For this analysis, I substaged oocytes into pachynema and diplonema 
using SYCP3 staining, and I identified the asynapsed X chromosome using 
BRCA1 staining, another marker of asynapsis (Kouznetsova et al., 2009; 
Turner et al., 2004). Pachytene oocytes have 20 SYCP3-positive 
chromosome pairs, while oocytes in diplonema show progressive 
desynapsis of SYCP3 cores (see Figure 1.1). BRCA1 is enriched on asynapsed 
chromosomes between pachynema and late diplonema in spermatocytes 
(Turner et al., 2004), and it has been used previously to identify the 
asynapsed X chromosomes in XO oocytes (Turner et al., 2005).  
Unexpectedly, using SYCP3-BRCA1 double-immunostaining, I found 
that BRCA1 also gradually accumulates on desynapsing chromosome axes in 
oocytes as diplonema progresses (data not shown). At late diplonema, 
therefore BRCA1 labels all chromosome axes, in a manner reminiscent of 
HORMAD1. However, at early diplonema the staining of BRCA1 on the 
asynapsed X chromosome is more intense that on desynapsed axes (data not 
shown). Due to this unexpected limitation in substaging, I focused my 
analysis only at pachynema and early diplonema, the time period when 
significant H2AFX-dependent XO oocyte losses occur (Figure 3.3c).  
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If H2AFX S-139 phosphorylation is a critical event for XO oocyte 
losses, then the percentage of XO H2afx-/- H2afxS139A oocytes with an 
asynapsed X chromosome should not change between pachynema and early 
diplonema. In the control XO H2afx+/- H2afxS139A females, there was a 
significant drop in the percentage of oocytes with an asynapsed X 
chromosome between pachynema and early diplonema (T test, P=0.0432) 
(Figure 3.3d). By contrast, in XO H2afx-/- H2afxS139A females, the 
percentage of oocytes with an asynapsed X chromosome did not change 
between pachynema and diplonema (T test, P=0.1495) (Figure 3.3d). While 
the percentage of oocytes at pachynema was not different between the 
genotypes (Sidak’s test, P=0.3835), there was a substantially higher 
percentage of diplotene oocytes in XO H2afx-/- H2afxS139A females (Sidak’s 
test, P=0.0063) (Figure 3.3d). This confirms that H2AFX phosphorylation at 
S-139 is a critical epigenetic event in the elimination of XO oocytes with 
asynapsis.   
4.1.5 XO H2afx-/- females have more oocytes than XO females 
perinatally 
Compared to XX females, XO females have approximately half the 
number of oocytes at birth (19.5-20.5 dpc) (Burgoyne and Baker, 1985). I 
therefore examined whether the oocyte rescue observed in XO H2afx-/- 
females by surface spread analysis results in an increased oocyte pool 
compared to XO females. To address this, I quantified the number of oocytes 
in XO and XO H2afx-/- ovaries at 20.5 dpc, when all oocytes have progressed 
to late diplonema (Burgoyne and Baker, 1985). I identified oocytes 
histologically in DAPI-stained ovarian sections based upon their unique 
nuclear morphology, as described previously (Burgoyne and Baker, 1985). 
The total oocyte numbers per ovary were estimated by summing oocyte 
counts from every 10th section in serial sectioned ovaries (Daniel et al., 
2011).  
Using this approach, I compared the number of oocytes in XX 
H2afx+/+, XO H2afx+/-, and XO H2afx-/- ovaries at 20.5 dpc. In XX H2afx+/+ 
females, there were on average 1223 ±89 oocytes. By comparison, in XO 
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H2afx+/- females, which experience oocyte losses similar to XO females (see 
Figure 3.3b), there were 40% fewer oocytes (759 ±72) at 20.5 dpc (Sidak’s 
test, P=0.0087) (Figure 3.3e), consistent with previous results on XO 
females (Burgoyne and Baker, 1985).  
Notably, XO H2afx-/- females had over 40% more oocytes compared 
to XO H2afx+/- females (Sidak’s test, P=0.0301) (Figure 3.3e). In fact, XO 
H2afx-/- females had oocyte numbers comparable to XX H2afx+/+ females 
(Sidak’s test, P=0.2447) (Figure 3.3e). In conclusion, abrogating meiotic 
silencing in XO oocytes by deleting H2afx rescues diplotene oocyte losses 
and increases the perinatal oocyte pool (Figure 3.3f). These genetic studies 
support that H2AFX-dependent meiotic silencing is the proximal trigger of 
oocyte loss in mice with chromosome abnormalities.  
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Figure 3.3. H2afx is required for the elimination of XO oocytes 
with an asynapsed X chromosome.  
 (a) Mean percentage of XO H2afx+/- oocytes with an asynapsed X 
chromosome (HORMAD1 and HORMAD2 double-positive) between 
pachynema and late diplonema at 19.5 dpc. Tukey multiple comparison test. 
(b) Mean percentage of XO H2afx-/- oocytes with an asynapsed X 
chromosome between pachynema and late diplonema at 19.5 dpc. Tukey 
test. (c) Enrichment of oocytes with an asynapsed X chromosome in XO 
H2afx-/- compared to XO H2afx+/-. Enrichment is the ratio of the mean 
percentage of oocytes with an asynapsed X at each stage in XO H2afx-/- 
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versus XO H2afx+/- control. (d) The mean percentage of oocytes with an 
asynapsed X chromosome at pachynema and diplonema (early) in XO H2afx-
/- H2afxS139A females and XO H2afx+/- H2afxS139A controls. The asynapsed X 
chromosome was identified by BRCA1 staining (not shown). (e) Mean 
number of oocytes in XX H2afx+/+, XO H2afx+/-, and XO H2afx-/- females at 
20.5 dpc. n is the number of non-littermate ovaries analyzed. Tukey tests. (f) 
Summary demonstrating the importance of H2AFX in XO oocyte elimination.    
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4.2 A role for H2AFX in Spo11-/- oocyte losses 
4.2.1 H2AFX domain frequency in Spo11-/- oocytes 
I then tested whether H2AFX is also important for the elimination of 
Spo11-/- oocytes, since meiotic silencing has been hypothesized to be a 
cause of oocyte losses in this mutant (Burgoyne et al., 2009; Daniel et al., 
2011). In my analysis of Spo11-/- oocytes, I first examined the frequency of 
H2AFX domains. Using SYCP3/HORMAD1/H2AFX triple-immunostaining 
on chromosome spreads, I found that 62% of Spo11-/- oocytes had a 
H2AFX domain at 18.5 dpc (Figure 3.4a,c). The remaining Spo11-/- 
oocytes did not have a H2AFX domain, despite having high levels of 
asynapsis (Figure 3.4b,c). These results are comparable with an 
independent analysis of Spo11-/- oocytes (Carofiglio et al., 2013). 
If meiotic silencing drives Spo11-/- oocyte losses, then the frequency 
of H2AFX domains in Spo11-/- oocytes should decrease during progression 
to late diplonema. Addressing this possibility in Spo11-/- females is 
challenging because high levels of asynapsis preclude accurate substaging of 
oocytes. To circumvent this limitation, I estimated pachynema to diplonema 
progression by analyzing ovaries from 18.5 and 20.5 dpc, the developmental 
period when oocytes progress from pachynema and late diplonema.  
Based on previous work, a 40% reduction in oocyte numbers in 
Spo11-/- females is observed at 19.5-20.5 dpc (Di Giacomo et al., 2005). 
Therefore, I expected to see a decrease in H2AFX domain frequency by 20.5 
dpc. Indeed, the percentage of Spo11-/- oocytes with a H2AFX domain 
dropped to 51% at 19.5 dpc (T test, P=0.0324)(Figure 3.4c). Furthermore, 
at 20.5 dpc, when nearly all oocytes have progressed to late diplonema, only 
35% of Spo11-/- oocytes had a H2AFX domain (Figure 3.4c). This nearly 
two-fold drop in the frequency of H2AFX domains from 18.5 to 20.5 dpc 
indicates that a significant proportion of Spo11-/- oocytes with a H2AFX 
domain are eliminated by late diplonema.  
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4.2.2 H2afx nullizygosity increases Spo11-/- oocyte numbers 
perinatally 
To genetically test a role for H2AFX in Spo11-/- oocyte arrest, I 
generated Spo11-/- H2afx-/- females and assessed oocyte survival. Since 
substaging Spo11-/- oocytes is challenging, I measured oocyte survival by 
quantifying the number of oocytes in sectioned ovaries. I counted oocyte 
numbers histologically using DAPI-stained ovarian sections, and compared 
the number of oocytes in Spo11-/- and H2afx-/- Spo11-/- females at 20.5 
dpc, when a 40% oocyte loss was previously reported in Spo11-/- females 
(Di Giacomo et al., 2005).  
At 20.5 dpc, Spo11-/- females had on average only 339 ±68 oocytes 
(Figure 3.4d), roughly 30% the number of oocytes found in XX H2afx+/+ 
ovaries (Figure 3.4d). This more severe reduction in Spo11-/- oocyte 
numbers compared to what was reported previously (Di Giacomo et al., 
2005) may reflect methodological counting differences or genetic strain 
variation. Notably, age-matched H2afx-/- Spo11-/- females had nearly twice 
the number of oocytes (mean=622 ±21) as Spo11-/- females (T test, 
P=0.0161) (Figure 3.4d). This indicates that H2afx deletion alleviates some 
Spo11-/- prenatal oocyte losses.  
However, despite the increased number of oocytes in H2afx-/- Spo11-
/- females compared to Spo11-/- females, this rescue is only partial. Indeed, 
H2afx-/- Spo11-/- females have only 50% the number of oocytes as XX 
H2afx+/+ control females (mean=1223 ±89) (Figure 3.4d). This lower 
oocyte number in H2afx-/- Spo11-/- may be due to an effect that H2afx-/- 
has on oocyte numbers, which would mask a full rescue. To address this, I 
compared the number of oocytes in H2afx-/- Spo11-/- female to age-
matched XX H2afx-/- females. While XX H2afx-/- females have on average 
more oocytes (mean=1027 ±203) compared to H2afx-/- Spo11-/- females 
(Figure 3.4d), the difference is not statistically significant (T test, 
P=0.1176). The mean number of oocytes is also not significantly different 
between XX H2afx-/- and XX H2afx+/+ females at 20.5 dpc (T test, 
P=0.4259).  
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In summary, the 2-fold increase in oocyte numbers in H2afx-/- 
Spo11-/- females compared to Spo11-/- females suggests that H2AFX has a 
role in the elimination of Spo11-/- oocytes perinatally.  
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Figure 3.4. H2afx nullizygosity increases Spo11-/- oocyte 
numbers perinatally. 
(a) Spo11-/- oocyte with severe asynapsis (HORMAD1-positive 
chromosomes) and a H2AFX domain. (b) Spo11-/- oocyte with severe 
asynapsis and no H2AFX domain. (c) The mean percentage of Spo11-/- 
oocytes with a H2AFX domain at 18.5, 19.5, and 20.5 dpc, corresponding to 
the transition from pachynema to late diplonema. (d) Mean number of 
oocytes in H2afx+/+, H2afx+/-, Spo11-/- H2afx+/-, and Spo11-/- H2afx-/- 
females at 20.5 dpc. n is the number of non-littermate ovaries analyzed. 
Tukey tests were used to calculate P values, significant P values shown in 
red. 
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4.2.3 SPO11-independent DNA DSBs in oocytes  
Based on other studies, the H2AFX domains in Spo11-/- 
spermatocytes rarely encompass the X and Y chromosomes, but rather 
occur on a random subset of asynapsed chromosomes (Bellani et al., 2005; 
Mahadevaiah et al., 2008). This finding raises the question of what feature of 
asynapsis targets H2AFX to a specific region of asynapsis.  
Previous work on irradiated mice carrying translocations has 
suggested that meiotic silencing may be triggered or enhanced by DNA DSBs 
(Inagaki et al., 2010; Schoenmakers et al., 2008). However, it is difficult to 
marry this hypothesis with the fact that Spo11-/- germ cells have a meiotic 
silencing response without programmed DNA DSBs. Therefore, I decided to 
re-examine DNA DSBs in Spo11-/- germ cells.  
To address this, I immunostained Spo11-/- oocytes for SYCP3 to label 
chromosome axes, H2AFX to identify regions of silencing, and one of three 
DSB repair proteins, RAD51, DMC1, and RPA, to identify an potential DNA 
DSBs. I focused my analysis on Spo11-/- oocytes from 18.5 dpc females. 
Strikingly, I observed a small number of RAD51, DMC1, and RPA foci in a 
subset of Spo11-/- oocytes (Figure 3.5a-c). Furthermore, 82% of Spo11-/- 
oocytes with a H2AFX domain contained at least one RPA focus (Figure 
3.5e). These DNA DSB repair foci were located on chromosome axes, and 
48% of the time they were found within the H2AFX domains (Figure 3.5e).  
To determine whether a correlation exists between DNA DSBs and 
meiotic silencing in Spo11-/- oocytes, I then assessed the degree of overlap 
between RPA foci and H2AFX domains. Of the cells containing RPA foci, 
59% (n=29/49) had at least one RPA foci co-localizing with a H2AFX 
domain. To determine if this frequency of RPA/H2AFX overlap was higher 
than expected by random chance, I compared the percentage area of the 
H2AFX domain to the oocyte nucleus to the percentage of RPA foci within 
H2AFX domains. Of those cells with at least RPA foci, the percentage of the 
nuclear RPA foci that co-localized with the H2AFX domains (21%) was 
nearly three times greater than the fraction of the nucleus that was covered 
by the H2AFX domain (8% of the total area). This suggests a higher 
 165 
frequency of DNA DSB repair proteins associated with H2AFX domain than 
expected due to chance. These findings have also been confirmed by an 
independent group (Carofiglio et al., 2013)(Carofiglio et al., 2013)(Carofiglio 
et al., 2013)(Carofiglio et al., 2013)(Carofiglio et al., 2013)(Carofiglio et al., 
2013)(Carofiglio et al., 2013)(Carofiglio et al., 2013)(Carofiglio et al., 
2013)(Carofiglio et al., 2013)(Carofiglio et al., 2013). 
In summary, DNA DSB repair foci occur in small numbers in Spo11-/- 
oocytes and they are frequently associated with H2AFX domains. The co-
localization of repair foci and H2AFX domains opens the possibility that 
meiotic silencing requires DNA DSBs. Furthermore, it is possible that a DNA 
damage may contribute to some Spo11-/- oocyte losses.  
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Figure 3.5. DNA DSB repair foci in Spo11-/- oocytes.  
(a) Spo11-/- oocyte with RAD51 foci on chromosome axes surrounded by a 
H2AFX domain (arrow, inset), and on chromosome axes outside of the 
domain (arrowhead). (b) Spo11-/- oocyte with DMC1 foci on chromosome 
axes surrounded by a H2AFX domain (arrow, inset), and on chromosome 
axes outside of the domain (arrowhead). (c) Spo11-/- oocyte with RPA foci 
on chromosome axes surrounded by a H2AFX domain (arrow, inset), and 
on chromosome axes outside of the domain (arrowhead). (d) Number of 
RPA foci within Spo11-/- nuclei. N=60 oocytes were analyzed. (e) 
Quantitative characterization of RPA foci in Spo11-/- oocytes.  
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4.3 H2AFX is not required for elimination of Dmc1-/- oocytes 
I next tested if H2AFX has a role in a meiotic DNA damage 
checkpoint, as has been described in somatic cells (Srivastava et al., 2009). 
Previous meiotic studies of the DNA damage checkpoint pathway have 
focused on Dmc1-/- female mice (Di Giacomo et al., 2005). Dmc1-/- mice fail 
to repair meiotic DNA DSBs, resulting in persistent unrepaired DNA DSBs, 
synaptic defects, and infertility in both sexes (Pittman et al., 1998; Yoshida 
et al., 1998). Dmc1-/- females have half the number of oocytes at birth, 
indicating a significant wave of oocyte loss occurring by the end of meiotic 
prophase I.  
Unlike in the case of the asynapsed X chromosome in XO oocytes, in 
which RPA foci are resolved by late pachynema, Dmc1-/- oocytes have 
persistent RPA foci into diplonema (Figure 3.6a). Dmc1-/- oocytes do not 
form a H2AFX domain (i.e. do not mount a meiotic silencing response), 
presumably because the upstream silencing factors BRCA1 and ATR are 
sequestered at unrepaired DSBs (Mahadevaiah et al., 2008).   
Previous work has shown that preventing DNA DSB formation in 
Dmc1-/- females, via Spo11 mutation, alleviates their oocyte losses, linking 
persistent unrepaired DSBs to oocyte arrest (Di Giacomo et al., 2005). If 
H2AFX is also involved in this DNA DSB-dependent mechanism of oocyte 
losses, H2afx deletion should also rescue Dmc1-/- oocyte losses.  
To test this possibility, I quantified oocyte counts on sectioned 
ovaries from Dmc1-/- females and H2afx-/- Dmc1-/- females at 20.5 dpc. At 
this age, Dmc1-/- females contained on average 246 ±52 oocytes (Figure 
3.6b). This is similar to the number of oocytes that I found in age-matched 
Spo11-/- females (T test, P=0.3396) (see Figure 3.4d), which have been 
reported to experience a similar degree of oocyte loss at birth (Di Giacomo 
et al., 2005).  
Notably, age-matched H2afx-/- Dmc1-/- females had a similar 
number of oocytes (268 ±109) as Dmc1-/- single mutants (Tukey’s test, 
P=0.9996) (Figure 3.6b). Therefore, H2afx nullizygosity does not alleviate 
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prenatal Dmc1-/- oocyte losses, indicating that H2afx does not function in a 
persistent DNA damage checkpoint in mammalian meiosis. 
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Figure 3.6. H2afx is not required for the elimination of Dmc1-/- 
oocytes.  
(a) Representative image of three Dmc1-/- oocytes from 19.5 dpc ovaries, 
when meiosis has reached diplonema. Each oocyte has widespread 
asynapsis, as shown by SYCP3 (blue) and HORMAD2 (red) co-localization, 
and persistent RPA foci (green) (n=50 oocytes). (b) Mean number of oocytes 
in H2afx+/+, H2afx-/-, Dmc1-/- H2afx+/-, and Dmc1-/- H2afx-/- females at 
20.5 dpc. n is the number of non-littermate ovaries analyzed. Tukey multiple 
comparison tests. Significant P values shown in red.  
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4.4 Discussion 
My results from the previous chapter indicate that neither persistent 
DNA DSBs nor asynapsis per se are likely contributors to oocyte arrest in 
chromosomally abnormal mice, and instead support a role for meiotic 
silencing. In this chapter, I directly examined the contribution of the meiotic 
silencing model of oocyte losses in mice with chromosome abnormalities. To 
formally address this model, I tested whether genetically ablating meiotic 
silencing via H2afx deletion would prevent diplotene oocyte elimination in 
the XO mouse model system.  
Notably, I found that H2afx relieves XO oocyte losses and restored 
oocyte numbers to wildtype levels at 20.5 dpc. Since H2afx deletion did not 
impacted the number of pachytene oocytes with an asynapsed X 
chromosome, I conclude that H2AFX-dependent oocyte losses occur at 
diplonema. I also showed XO diplotene oocyte rescue in females carrying a 
non-phosphorylatable form of histone H2AFX mutated at serine-139. Since 
serine-139 phosphorylation of H2AFX is the critical epigenetic event in 
silencing (Ichijima et al., 2011), this implicates meiotic silencing as the 
mechanism by which XO oocytes with asynapsis are eliminated. 
These findings are inconsistent with the hypothesis that silencing 
shields asynapsed chromosomes from triggering arrest (Checchi and 
Engebrecht, 2011). Under this scenario, oocytes with silenced, asynapsed 
chromosomes in XO, In(X)1H, T43H and XX females would be protected 
from elimation, and genetic ablation of silencing in XO females would 
trigger, rather than prevent oocyte loss. Based on my rescue data, I suspect 
that the prophase I meiotic surveillance functions of HORMAD1, HORMAD2, 
BRCA1, ATR, MDC1, and H2AFX are executed via meiotic silencing. This 
would account for the striking fact that all of these proteins have been 
shown to be essential components of the meiotic silencing pathway (Daniel 
et al., 2011; Fernandez-Capetillo et al., 2003; Ichijima et al., 2011; Shin et al., 
2010; Turner et al., 2004; Wojtasz et al., 2012). 
Importantly, H2afx nullizygosity did not influence HORMAD1 and 
HORMAD2 localization to the asynapsed X chromosome (Figure 3.1a-c) . 
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This indicates that the presence of HORMAD1/2 on asynapsed 
chromosomes is not sufficient to drive oocyte losses. Furthermore, during 
male meiosis, accumulation of HORMAD1, HORMAD2, BRCA1, ATR, MDC1, 
and H2AFX at asynapsed autosomes is associated with prophase I arrest, 
but localization of the same proteins to the asynapsed X and Y chromosomes 
is not.  
The meiotic silencing model readily explains this paradox. In contrast 
to the autosomes, the sex chromosomes are dramatically depleted in genes 
required for male meiosis (Khil et al., 2004; Wang, 2004). Furthermore, the 
silencing of X-linked housekeeping genes is compensated for by a unique 
system of autosomally-located, X-derived retrogenes. These are expressed 
in male but not in female germ cells and are essential for spermatogenesis 
(Bradley et al., 2004; McCarrey and Thomas, 1987; Wang, 2004).  
Therefore, in contrast to silencing of autosomes, silencing of sex 
chromosomes in the male would not trigger arrest. By extrapolation, I 
predict that asynapsed accessory chromosomes would also not cause 
prophase I elimination in the male. Indeed, studies of the Tc1 male mouse 
indicated that no prophase I losses occur in response to the asynapsed h21 
chromosome (Mahadevaiah et al., 2008). 
To validate that meiotic silencing is a mechanism by which oocytes 
with asynapsis are eliminated, I then tested the effect of deleting H2afx in 
Spo11-/- females. Indeed, deletion of H2afx resulted in a two-fold increase in 
oocyte numbers in Spo11-/- females at 20.5dpc. However, in contrast to the 
complete rescue of Spo11-/- oocyte losses by Hormad1 deletion, loss of 
H2afx only resulted in partial rescue, since H2afx-/- Spo11-/- had only half 
the wildtype numbers of oocytes at 20.5 dpc. This suggests that multiple 
mechanisms may be functioning to eliminate Spo11-/- oocytes.  
In agreement with a recent report (Carofiglio et al., 2013)(Carofiglio 
et al., 2013)(Carofiglio et al., 2013)(Carofiglio et al., 2013)(Carofiglio et al., 
2013)(Carofiglio et al., 2013)(Carofiglio et al., 2013)(Carofiglio et al., 
2013)(Carofiglio et al., 2013)(Carofiglio et al., 2013)(Carofiglio et al., 2013), 
I observed the presence of DNA repair foci indicative of DNA DSBs in Spo11-
/- oocytes (Figure 3.5). The origin of non-programmed DNA DSBs in Spo11-
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/- germ cells is unclear, but may involve several different mechanisms. First, 
DNA DSBs generated at stalled replication forks may be carried over from 
meiotic S phase (Inagaki et al., 2009). Second, DNA DSBs have been shown 
to occur at sites of active transcription (Aguilera, 2002). Third, there may be 
de-repression of transposable genetic elements, such as Line1 elements, 
which are capable of generating Spo11-independent DNA DSBs (Malki et al., 
2014; Soper et al., 2008). Other possibilities include exogenous DNA damage 
agents, include reactive oxygen species or dysregulation of topoisomerase 
activity (Carofiglio et al., 2013)(Carofiglio et al., 2013)(Carofiglio et al., 
2013)(Carofiglio et al., 2013)(Carofiglio et al., 2013)(Carofiglio et al., 
2013)(Carofiglio et al., 2013)(Carofiglio et al., 2013)(Carofiglio et al., 
2013)(Carofiglio et al., 2013)(Carofiglio et al., 2013). More work is required 
to further characterize the nature and origin of Spo11-independent DNA 
DSBs.  
Surprisingly, DNA repair foci were located within the H2AFX 
silencing domain more often than would be expected due to random chance, 
in agreement with a recent report (Carofiglio et al., 2013)(Carofiglio et al., 
2013)(Carofiglio et al., 2013)(Carofiglio et al., 2013)(Carofiglio et al., 
2013)(Carofiglio et al., 2013)(Carofiglio et al., 2013)(Carofiglio et al., 
2013)(Carofiglio et al., 2013)(Carofiglio et al., 2013)(Carofiglio et al., 2013). 
Historically, it was believed that the meiotic silencing occurs independent of 
DNA DSBs since a meiotic silencing response occurs in Spo11-/- oocytes 
(Mahadevaiah et al., 2001). However, these new observations that Spo11-/- 
oocytes have small numbers of DNA DSB repair foci opens up the possibility 
the meiotic silencing requires DNA DSBs.  
Interestingly, HORMAD1 regulates both meiotic silencing and DNA 
repair, and loss of Hormad1 can rescue both Spo11-/- and Dmc1-/- oocyte 
losses (Daniel et al., 2011; Kogo et al., 2012b; Shin et al., 2013).  It is 
possible, therefore, that Hormad1 deletion fully rescues Spo11-/- oocyte 
losses because HORMAD1 functions in two or more distinct meiotic 
surveillance mechanisms. By contrast, the partial rescue observed in H2afx-
/- Spo11-/- mutants suggests that H2AFX-dependent losses occur through 
disruption of a single pathway (i.e. meiotic silencing).    
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Additional proof that H2AFX-dependent oocyte losses occur through 
meiotic silencing and not a DNA damage checkpoint mechanism comes from 
my analysis of Dmc1-/- mutant females. In Dmc1-/- females, oocyte losses 
are triggered by persistent unrepaired DNA DSBs, and while γH2AFX is 
observed at these DNA DSBs, it does not spread to surrounding chromatin 
or induce meiotic silencing (Mahadevaiah et al., 2008). Notably, deletion of 
H2afx had no effect on oocyte numbers in Dmc1-/- females. This suggests 
that H2AFX acts at the level of asynapsed chromatin to exert its role in 
oocyte elimination, and that H2AFX plays an important role in the response 
to asynapsis but not in the response to persistent DNA damage. In summary, 
the data in this chapter strongly support a mechanism of prophase I 
surveillance of asynapsis that is mediated through an H2AFX-dependent 
meiotic silencing mechanism (Figure 3.7).  
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Figure 3.7. Meiotic silencing model of prophase I oocyte 
elimination. 
(a) Wildtype oocyte. Meiotic DNA DSBs are formed during early prophase I 
by SPO11 (lightening bolt). During pachynema, homologous chromosomes 
synapse and meiotic DNA DSB are repaired (DNA DSB repair proteins 
shown as a red star). At diplonema, homologs desynapse but remain 
connected at crossover sites (chiasma). Transcription of genes (green) 
increases between pachynema and diplonema (nascent transcripts=blue 
ribbon). (b) Events in oocytes containing a chromosome abnormality that 
disrupts meiotic synapsis. Meiotic DNA DSBs, formed in early prophase I, are 
repaired on both synapsed and asynapsed chromosomes during pachynema. 
At this point, the asynapsed chromosome, triggers meiotic silencing, marked 
by chromatin enrichment of H2AFX (red domain). The downstream 
consequence of this would be silencing of essential genes and oocyte 
elimination.  
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5 Results: Characterization of meiotic silencing in 
oocytes  
Chromosome abnormalities confer more severe germ cell loss in 
males than in females (Burgoyne et al., 2009; Hunt and Hassold, 2002). This 
is due in part to the reduced stringency of the metaphase I spindle 
checkpoint in females (LeMaire-Adkins et al., 1997; Nagaoka et al., 2011), 
but is also thought to reflect ill-defined sex differences in the efficacy of the 
prophase I response to asynapsis (Hunt and Hassold, 2002; Nagaoka et al., 
2012). Consistent with this, I noted that not all XO, In(X)1H, T43H, and XX 
oocytes with asynapsis were eliminated by late diplonema (see Figure 1). In 
this chapter, I attempt to identify a possible mechanistic basis for the sexual 
dimorphism in prophase I germ cell losses. 
In the previous chapter, I provided evidence that supports the 
meiotic silencing model of oocyte loss in mice with chromosome 
abnormalities. With the overall goal of understanding sex-specific 
differences in prophase I surveillance, I therefore set out to characterize the 
meiotic silencing response in mammalian germ cells at the transcriptional 
and epigenetic levels.  
In this chapter, I will study the efficiency of meiotic silencing in 
oocytes compared to spermatocytes using single and triple gene-specific 
RNA FISH in a variety of chromosomally variant mouse models. I will then 
evaluate for sex-specific differences in chromatin compaction and epigenetic 
marks associated with silencing. 
 
5.1 RNA FISH analysis of the X chromosome in germ cells 
5.1.1 Silencing of the X chromosome in XY spermatocytes 
Previous analyses of X gene transcription using several different 
approaches has revealed that in the spermatocytes meiotic silencing in the 
male germ line is robust and complete, i.e. no coding genes are transcribed 
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from the sex chromosomes at pachynema (Kierszenbaum and Tres, 1974; 
Mahadevaiah et al., 2009b; Margolin et al., 2014; Mueller et al., 2008).  
Initially, I sought to confirm the robustness of meiotic X chromosome 
silencing in spermatocytes using gene-specific RNA FISH for three X-linked 
genes: Scml2 (sex comb on midleg-like 2), Utx (ubiquitously transcribed 
tetratricopeptide repeat X), and Zfx (zinc finger protein, X-linked). Scml2, Utx, 
and Zfx are located in different regions of the mouse X chromosome, 
allowing for assessment of transcription across the length of the 
chromosome (Figure 4.1a). Utx encodes an H3K27-specific demethylase 
(Agger et al., 2007), Zfx encodes a putative transcription factor (Luoh et al., 
1997), and Scml2 encodes a polycomb repressor protein (Montini et al., 
1999).  
A previous RNA FISH analysis using a different subset of X-linked 
genes revealed no RNA FISH signals in pachytene spermatocytes 
(Mahadevaiah et al., 2008). To verify these results, I performed RNA FISH on 
XY wildtype spermatocytes. For these experiment, RNA FISH preparations 
were immunostained for HORMAD1 and H2AFX to unambiguously identify 
the axis and chromatin of the asynapsed X chromosome (Figure 4.1b-c). 
HORMAD1 staining also helped distinguish between spermatocytes at the 
pachytene stage from other prophase I stages – at pachynema, HORMAD1 
marks only the asynapsed X and Y chromosomes (Figure 4.1b-d, arrow). I 
focused my RNA FISH analysis specifically on spermatocytes at early 
pachytene, when silencing initiates. Compared to mid-late pachytene 
spermatocytes, in which the X and Y chromosomes are highly condensed, at 
early pachytene spermatocytes the X and Y chromosomes are more 
extended (Wojtasz et al., 2012), as shown by HORMAD1 staining (Figure 
4.1b). Furthermore, at early pachynema, late recombination foci associated 
with H2AFX staining are oftentimes visible, especially at higher exposure 
times (not shown). Together, these criteria were used to identify 
spermatocytes at early pachynema. 
I first assessed X-gene transcription in wildtype early pachytene 
spermatocytes. As expected, for all three X-linked genes, the vast majority of 
early pachytene XY spermatocytes did not contain an RNA FISH signal, 
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indicative of a silent X chromosome (Figure 4.1b,e-f). However, in a small 
subset (15%) of early pachytene spermatocytes Smcl2 was expressed 
(Figure 4.1c,e-f). For Utx and Zfx, a much smaller subset of spermatocytes 
(3% and 2%, respectively) showed expression (Figure 4.1e-f). I did not 
observe any RNA FISH signals in mid-late pachynema spermatocytes for any 
of the three genes, indicating that silencing is complete at mid-late 
pachynema (data not shown).   
I then compared this wildtype level of silencing to that of H2afx-/- 
mutants, which have defective MSCI (Fernandez-Capetillo et al., 2003). 
Silencing in H2afx-/- mice was also examined at early pachynema, which is 
before H2afx-/- cells arrest and undergo apoptosis (mid-pachytene) (Celeste 
et al., 2002). In comparison to XY wildtype spermatocytes, the majority of 
H2afx-/- early pachytene spermatocytes (74%) expressed Smcl2 (Figure 
4.1d-f, arrow). The X-linked genes Utx and Zfx were expressed in 27% and 
24% of early pachytene spermatocytes, respectively (Figure 4.1e-f). 
In conclusion, X-linked genes are robustly silenced in wildtype 
spermatocytes compared to H2afx-/- spermatocytes during early 
pachynema. These data highlight the efficiency of sex chromosome silencing 
in the male germ line, and confirm that H2AFX is a critical silencing factor 
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Figure 4.1. RNA FISH analysis of wildtype and H2afx-/- 
spermatocytes.  
(a) Schematic of mouse X chromosome showing the location of three genes, 
Utx, Zfx, and Scml2, which were used as RNA FISH probes to assess X 
chromosome transcription. PAR = pseudoautosomal region; cen. = 
centromere. (b) Early pachytene XY spermatocyte nucleus (DAPI, blue) 
subject to Scml2 RNA FISH, and HORMAD1 (green) and H2AFX 
immunostaining (red). This nucleus does not express Scml2. (c) Early 
pachytene XY spermatocyte showing Scml2 expression (white focus, arrow) 
near the asynapsed X chromosome (marked by HORMAD1/H2AFX) (d) 
Early pachytene XY H2afx-/- spermatocyte with an asynapsed X 
chromosome (marked by HORMAD1, green) showing expression of Smcl2 
(arrow). (e) Percentage of XY wildtype and XY H2afx-/- early pachytene 
spermatocytes expressing Utx, Zfx, and Scml2 in adult mice. (f) Raw data 
showing number of early pachytene spermatocytes expressing Utx, Zfx, and 
Scml2. Each row represents a different mouse.  
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5.1.2. Silencing of the X chromosome in XO oocytes 
After establishing the efficiency of meiotic silencing in the male germ 
line, I examined the level of silencing in XO oocytes. For comparison sake, X-
linked transcription was measured in XO oocytes using RNA FISH for Scml2, 
Utx, and Zfx genes. Taking advantage of the synchronous nature of oocyte 
development, I focused my initial analysis on 17.5 dpc ovaries, which are 
enriched in pachytene oocytes (see Figure 1.2).   
For analyses of XO oocytes, RNA FISH preparations were 
immunostained for H2AFX to identify XO oocytes with an asynapsed X 
chromosome, as done in previous experiments (see Figure 1.3). Using this 
approach, I classified XO oocytes into two populations: (1) XO oocytes with a 
H2AFX domain, indicative of an asynapsed X chromosome (Figure 4.2a-b); 
and (2) XO oocytes devoid of a H2AFX domain, reflecting a self-synapsed X 
chromosome (Figure 4.2c). For all RNA FISH analyses, I first categorized XO 
oocytes as H2AFX domain-positive or H2AFX domain-negative, and then 
examined for an RNA FISH signal.  
First, I assessed X-linked gene transcription in H2AFX domain-
negative XO oocytes (Figure 4.2c) to establish the level of X gene expression 
in the absence of silencing. Consistent with my previous Cot-1 RNA FISH 
analysis suggesting high transcription levels in oocytes (see Figure 2.5), I 
found that the self-synapsed X chromosome in XO oocytes was 
transcriptionally active. At 17.5 dpc, 100% of H2AFX domain-negative XO 
oocytes expressed Scml2 (Figure 4.2d-e). Similarly, 68% and 72% of 
H2AFX domain-negative XO oocytes expressed Utx and Zfx, respectively 
(Figure 4.2d-e).  
I predicted that the percentage of oocytes with an RNA FISH signal 
would be significantly lower in XO oocytes with a H2AFX domain due to 
meiotic silencing. Indeed, a smaller percentage of XO oocytes with a H2AFX 
domain had an RNA FISH signal (Figure 4.2d,e), indicating silencing. 
However, the level of silencing in XO oocytes with a H2AFX domain was not 
as robust as that observed in spermatocytes (see Figure 4.1 for comparison). 
Remarkably, 85% of H2AFX domain-positive XO oocytes at 17.5 dpc 
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expressed Scml2 (Figure 4.2c-e), compared to 15% of pachytene 
spermatocytes (Figure 4.1e-f). While a greater proportion of H2AFX 
domain-positive XO oocytes showed silencing of Utx and Zfx, still 30% and 
27% of oocytes showed expression, respectively (Figure 4.2d,e). These data 
suggest that silencing of the asynapsed X chromosome is less complete in 
females compared to males.  
I then examined whether the incompleteness of X chromosome 
silencing in oocytes is related to shortened length of prophase I in females 
compared to males. Pachynema of male meiosis lasts seven days (Bennett, 
1977), compared to the three day length of pachynema in females (Cohen et 
al., 2006). To address this, I examined whether the degree of meiotic 
silencing improves over time in female. I therefore assessed X gene silencing 
in XO oocytes at later time points, namely 18.5-20.5 dpc, when oocytes 
progress from pachynema to the end of prophase I.  
At 18.5, 19.5, and 20.5 dpc, the majority of XO oocytes (67-98%) with 
a self-synapsed X chromosome expressed the genes Scml2, Utx, and Zfx 
(Figure 4.2d,e), consistent with a transcriptional active X chromosome in 
the absence of silencing. In oocytes with a H2AFX domain, a smaller 
percentage (40-71%) expressed these three X-linked genes (Figure 4.2d,e). 
Nevertheless, a substantial percentage of H2AFX domain-positive XO 
oocytes at late prophase I, i.e. 19.5 and 20.5 dpc, expressed these genes 
(Figure 4.2d,e). This indicates that silencing of the X chromosome in XO 
oocytes does not improve substantially during prophase I progression.  
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Figure 4.2. Incomplete silencing of the X chromosome in XO 
oocytes.  
(a-c) Representative images of XO oocyte nuclei (DAPI, blue) subject to RNA 
FISH (green) and H2AFX immunostaining (red). (a) XO oocyte with an 
asynapsed X chromosome (H2AFX domain-positive) with no RNA FISH 
signal, demonstrating silencing of Scml2. (b) XO oocyte with an asynapsed X 
chromosome (H2AFX domain-positive) with an RNA FISH signal (arrow), 
demonstrating expression of Scml2 and incomplete X silencing. (c) Control 
XO oocyte with a self-synapsed X chromosome (H2AFX domain-negative) 
with an RNA FISH signal (arrow), indicating expression of the X-linked gene 
Scml2. Oocytes were distinguished from somatic cells based upon DAPI 
staining and nuclear morphology. Scale bar represents 5m. (d) The 
percentage of XO oocytes expressing Utx, Zfx, and Smcl2 at 17.5, 18.5, 19.5 
and 20.5 dpc. XO oocytes were subdivided into those with a H2AFX domain 
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(red bars) and those without a H2AFX domain (gray bars). (e) Raw data 
showing number of XO oocytes expressing Utx, Zfx, and Scml2 at 17.5, 18.5, 
19.5, and 20.5 dpc.  
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5.1.3 Mosaic gene inactivation of the X chromosome in XO oocytes 
Next, I examined whether silencing in XO oocytes is mosaic in 
individual cells. Mosaic silencing would manifest as inactivity of some X-
linked genes and expression of others within individual cells. By contrast, 
non-mosaic silencing would manifest as all X-linked genes being either 
active or inactive within individual cells.  
To distinguish between these possibilities, I performed simultaneous 
three-gene RNA FISH on 19.5 dpc XO oocytes for Scml1, Utx, and Zfx. Of the 
XO oocytes with self-synapsed X chromosomes (H2AFX domain-negative 
XO oocytes) (Figure 4.3a), 60% expressed all three X-linked genes 
simultaneously at 19.5 dpc (Figure 4.3c). By contrast, only 12% of XO 
oocytes with an asynapsed X chromosome (H2AFX domain-positive XO 
oocytes) expressed all three genes simultaneously (Figure 4.3c). Notably, 
only 29% of XO oocytes with a H2AFX domain had all three genes inactive 
(Figure 4.3c), indicating that multi-gene silencing occurs in only a subset of 
XO oocytes. Notably, the vast majority (88%) of XO oocytes with an 
asynapsed X chromosome had at least one of the three genes inactive 
(Figure 4.3c). Therefore, even when an XO oocyte with a H2AFX domain 
has one active X-linked gene, usually at least one other X-linked gene is 
inactive. This indicates that the silence response in oocytes leads to 
stochastic/mosaic X-linked gene silencing patterns (Figure 4.3d).  
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Figure 4.3. Mosaic silencing of the X chromosome in XO oocytes.  
(a,b) Representative images of 19.5 dpc XO oocyte nuclei (DAPI, blue) 
subject to three-gene RNA FISH for Utx (green), Zfx (red), and Scml2 (white), 
and H2AFX immunostaining (magenta) to identify the asynapsed X 
chromosome. (a) XO oocyte with a self-synapsed X chromosome (H2AFX-
negative) showing RNA FISH signals for all three genes, indicative of a 
transcriptionally active X chromosome. (b) XO oocyte with an asynapsed X 
chromosome (H2AFX-positive) showing an RNA FISH signal only for Scml2 
(white, arrow), indicating that two of three genes are silent. Scale bar = 5m.  
(c) Quantitation of three-gene RNA FISH. Pie chart: the percentage of XO 
oocytes with an asynapsed X chromosome (H2AFX-positive) that have at 
least one gene silenced (88%). Bar chart: breakdown of the percentage of 
oocytes with one, two, and three genes silenced. n is the number of oocytes 
analyzed. (d) Schematic showing differential gene expression between the 
H2AFX-negative self-synapsed X chromosome (highly transcriptionally 
active) and the H2AFX-positive asynapsed X chromosome (mosaically 
silenced X genes).  
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5.2 RNA FISH analysis of the h21 chromosome in Tc1 germ cells 
5.2.1 Silencing of the h21 chromosome in Tc1 spermatocytes 
I next tested the possibility that XO oocytes with complete X 
chromosome silencing were eliminated, thus overestimating the prevalence 
of escape from silencing in XO oocytes. Distinguishing between this artefact 
and a true mosaic silencing phenotype is possible using the Tc1 mouse 
model, because Tc1 oocytes with an asynapsed h21 are not eliminated 
during prophase I (see Figure 2.7). I therefore performed a similar RNA 
FISH study on Tc1 males and females.  
First, I established the degree of silencing in Tc1 males. Previously 
Cot-1 RNA FISH work showed that the asynapsed h21 chromosome in Tc1 
spermatocytes is Cot-1 negative, indicative of transcriptional silencing 
(Mahadevaiah et al., 2008). By contrast, when the h21 is self-synapsed, it is 
Cot-1 positive, and therefore transcriptionally active (Mahadevaiah et al., 
2008). I confirmed the silencing of the asynapsed h21 using gene-specific 
RNA FISH for three h21 genes: USP25 (ubiquitin specific peptidase 25), which 
encodes a protease; NRIP1 (nuclear receptor interacting protein 1), which 
encodes a transcriptional modulator of the estrogen receptor; and TPTE 
(transmembrane phosphatase with tensin homology), which encodes a 
tyrosine phosphatase (Figure 4.4a).  
I identified the asynapsed h21 in Tc1 oocytes using H2AFX; those 
with a self-synapsed h21 were devoid of H2AFX. I focused my analysis on 
Tc1 pachytene spermatocyte. In pachytene Tc1 spermatocytes with a self-
synapsed h21 chromosome (H2AFX domain-negative), USP25 and TPTE 
were expressed in 93% (n=27/29) and 100% (n=26/26) of spermatocytes, 
respectively (data not shown). No RNA FISH signals were observed for 
NRIP1, suggesting that it is not expressed in spermatocytes.  
By contrast, in pachytene Tc1 spermatocytes with an asynapsed h21 
chromosome (H2AFX domain-positive), only 7% of early pachytene 
spermatocytes with a H2AFX domain expressed Usp25 (n=1/14) and zero 
expressed TPTE (n=0/16) (data not shown). These data confirm that 
silencing of the asynapsed h21 chromosome in spermatocytes is robust.  
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5.2.2 Silencing of the h21 chromosome in Tc1 oocytes 
Next, I assessed transcription in Tc1 oocytes using RNA FISH and 
H2AFX immunostaining. I identified two populations of Tc1 oocytes: those 
with a H2AFX domain, indicative of an asynapsed h21 chromosome 
(Figure 4.4b,c); and those with no H2AFX domain, indicative of self-
synapsis (Figure 4.4d).   
At 17.5 dpc, nearly all Tc1 oocytes with a self-synapsed h21 
expressed USP25 (94%), NRIP1 (96%), and TPTE (93%) (Figure 4.4e,f), 
indicating that the self-synapsed h21 chromosome is highly 
transcriptionally active. By contrast, the percentage of Tc1 oocytes with a 
H2AFX domain and an RNA FISH signal for USP25, NRIP1, or TPTE was 
lower (Figure 4.4e,f), consistent with meiotic silencing. Nevertheless, in the 
majority of H2AFX domain-positive oocytes an RNA FISH signal was visible 
(75%, 81% and 65%, respectively) (Figure 4.4e,f).  
To address whether the degree of silencing in Tc1 oocytes is 
influenced by gestational age, I then performed h21 RNA FISH in oocytes 
from 18.5, 19.5, and 20.5 dpc Tc1 ovaries. At all of these time points, the 
majority of Tc1 oocytes with a self-synapsed h21 expressed USP25, NRIP1, 
and TPTE (Figure 4.4e,f). By contrast, the percentage of Tc1 oocytes with a 
H2AFX domain that express an h21 gene was between 30-76%, depending 
upon the gene and developmental age (Figure 4.4e-f). Therefore, at least 
30% of the oocytes showed an RNA FISH signal at all developmental ages. 
These data, combined with results from the XO oocyte analysis, suggest that 
meiotic silencing is less complete in the female germ line.  
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Figure 4.4. Incomplete silencing of the h21 chromosome in Tc1 
oocytes.  
(a) Schematic of the Tc1 human chromosome 21 (h21) showing the location 
of three genes, USP25, NRIP1, and TPTE, which were used as RNA FISH 
probes to assess h21 gene transcription. cen. = centromere. (b-d) 
Representative images of Tc1 oocytes (DAPI, blue) subject to RNA FISH 
(green) and H2AFX immunostaining (red). (b) Tc1 oocyte with an 
asynapsed h21 chromosome (H2AFX domain-positive) and no RNA FISH 
signal, demonstrating silencing of USP25. (c) Tc1 oocyte with an asynapsed 
h21 chromosome (H2AFX domain-positive) and an RNA FISH signal 
(arrow), demonstrating expression of USP25. (d) Control Tc1 oocyte with a 
self-synapsed h21 chromosome (H2AFX domain-negative) with an RNA 
FISH signal (arrow), showing expression of USP25. Scale bar represents 
5μm. (e) The percentage of Tc1 oocytes expressing USP25, NRIP1, and TPTE 
at 17.5, 18.5, 19.5, and 20.5 dpc. Tc1 oocytes were subdivided into those 
with a H2AFX domain (red bars) and those without a H2AFX domain (gray 
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bars). (f) Raw data showing number of Tc1 oocytes expressing USP25, 
NRIP1, and TPTE at 17.5, 18.5, 19.5, and 20.5 dpc. 
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5.2.3 Mosaic gene silencing of the h21 chromosome in Tc1 oocytes 
Next, I examined whether meiotic silencing in Tc1 oocytes leads to 
stochastic inactivation of genes, as observed in XO oocytes. I performed 
triple RNA FISH for the genes USP25, NRIP1, and TPTE in oocytes from 19.5 
dpc Tc1 ovaries. Importantly, of the H2AFX domain-negative Tc1 oocytes 
(Figure 4.5a), 89% had RNA FISH signals for all three genes (Figure 4.5c). 
This confirms that in the absence of meiotic silencing the h21 is highly 
transcriptionally active.  
By contrast, a much smaller percentage of H2AFX domain-positive 
Tc1 oocytes (21%) had RNA FISH signals for all three genes simultaneous 
(Figure 4.5c). Importantly, while only a subset (23%) of H2AFX domain-
positive oocytes had no RNA FISH signals (i.e. no genes expressed), the 
majority (79%) had at least one RNA FISH signal missing (i.e. ≥1 gene 
silenced) (Figure 4.5b-c). Therefore, the silencing response in Tc1 oocytes 
results in mosaic gene inactivation.  
In summary, in contrast to the situation in spermatocytes, where 
silencing is robust and complete, meiotic silencing in oocytes leads to an 
incomplete and mosaic pattern of gene inactivation. 
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Figure 4.5. Mosaic silencing of the h21 chromosome in Tc1 
oocytes. 
(a,b) Representative images of 19.5 dpc Tc1 oocyte nuclei (DAPI, blue) 
subject to three-gene RNA FISH for USP25 (yellow), NRIP1 (red), and TPTE 
(green), and H2AFX immunostaining (inset, red) to identify the asynapsed 
h21 chromosome. (a) Tc1 oocyte with a self-synapsed h21 chromosome 
(H2AFX-negative) showing RNA FISH signals for all three genes, indicative 
of an active h21 chromosome. (b) Tc1 oocyte with an asynapsed h21 
chromosome (H2AFX-positive) showing only an RNA FISH signal for TPTE 
(green, arrow), indicating that two of three genes are silenced. (c) 
Quantitation of three-gene RNA FISH. Pie chart: the percentage of Tc1 
oocytes with an asynapsed h21 chromosome (H2AFX-positive) that have at 
least one gene silenced (79%). Bar chart: breakdown of the percentage of 
oocytes with one, two and three genes silenced. n is the number of oocytes 
analyzed. 
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5.3 Characterization of the sexually dimorphic silencing response 
5.3.1 The Y chromosome does not improve X silencing in oocytes 
After establishing that meiotic silencing is sexually dimorphic, I 
examined potential factors that may contribute to this sex-based difference. 
A fundamental difference between males and females is the contribution of 
the Y chromosome in males. It is possible, therefore, that the Y chromosome 
encodes certain factors necessary for a robust silencing response. To 
address this hypothesis, I examined whether the efficiency of silencing in 
oocytes improves in the presence of a mouse Y chromosome.  
To examine this possibility, I analyzed silencing in XYd1 females, 
which contain a mouse Y chromosome variant that does not express the 
male-determining factor Sry (Capel et al., 1993; Mahadevaiah et al., 1998). 
Unlike in XY spermatocytes, where the X and Y chromosomes synapse at the 
PAR in >90% of cases (Kauppi et al., 2011), in the majority of XY oocytes the 
X and Y chromosomes remain asynapsed (Mahadevaiah et al., 1993). 
To address whether the Yd1 chromosome improves X chromosome 
meiotic silencing, I performed RNA FISH for the X-linked gene Scml2 on XYd1 
oocytes from 18.5 dpc females. As done previously, I identified oocytes with 
an asynapsed X chromosome using H2AFX. The majority of XYd1 oocytes 
with a H2AFX domain had an asynapsed X chromosome, but a small 
fraction had an asynapsed Y chromosome and a self-synapsed X 
chromosome. Since the self-synapsed X chromosome is highly 
transcriptionally active, I was able to identify these oocytes because they 
contained an Scml2 RNA FISH signal outside of a H2AFX domain (not 
shown). I excluded these oocytes from my analysis, since these oocytes had 
a self-synapsed X chromosome.  
As expected, 91% of the H2AFX domain-negative XYd1 oocytes 
expressed Scml2 (Figure 4.6). This is consistent with the percentage of XO 
oocytes with a self-synapsed X chromosome that expresses Scml2 at 18.5 
dpc (see Figure 4.2d-e). Based on my earlier analysis of XO females, 71% of 
XO oocytes with an H2AFX domain expressed Scml2 at 18.5 dpc (Figure 
4.2d-e). If the Y chromosome is important for an efficient meiotic silencing 
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response, then the percentage of XYd1 oocytes that express Scml2 would be 
dramatically reduced. Contrary to this, the majority (57%) of XYd1 oocytes 
with an asynapsed X chromosome expressed Scml2 (Figure 4.6). This is 
much higher than the percentage early pachytene XY spermatocytes that 
express Scml2 (15%) (Figure 4.6). Therefore, the degree of Scml2 silencing 
in oocytes is not dramatically improved in the presence of the Yd1 
chromosome. 
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Figure 4.6. RNA FISH analysis of XYd1 oocytes. 
The percentage of XYd1 oocytes at 18.5 dpc with an RNA FISH signal for the 
X-linked gene Scml2. XYd1 oocytes were subdivided into H2AFX domain-
positive and –negative oocytes. n is the number of oocytes analyzed from 
one ovary.  
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5.3.2 H2AFX domain intensity in XO spermatocytes and oocytes. 
I next looked for differences in the epigenetics of asynapsed 
chromatin between male and female germ cells. A critical factor in the 
initiation of meiotic silencing in mammals is H2AFX (Fernandez-Capetillo 
et al., 2003; Ichijima et al., 2011). To determine whether H2AFX is sexually 
dimorphic, I measured the H2AFX signal on the asynapsed X chromosome 
in oocytes and spermatocytes. 
With assistance from Dr. Shantha Mahadevaiah, I measured the 
intensity of the H2AFX domain associated with an asynapsed X 
chromosome on surface spread XO oocytes and spermatocytes. To control 
for the amount of sex chromosome asynapsis, I compared XO oocytes to 
spermatocytes lacking a Y chromosome (i.e. XO males). These particular XO 
mice differentiate into males because they have a copy of Sry on the X 
chromosome (Mazeyrat et al., 2001).  
To evaluate H2AFX domain intensity, I compared H2AFX domain 
intensity in surface spread XO oocytes and XO diplotene spermatocytes 
(Figure 4.7a-b). I analyzed diplotene germ cells because this is the stage 
when silencing is well established and when oocyte losses occur in XO 
females (see Figure 1). Germ cells were substaged based up the 
characteristic staining of SYCP3 at diplonema (see Figure 1).  
Notably, there was no significant difference in the integrated 
intensity of the H2AFX domain in XO oocytes compared to XO 
spermatocytes (unpaired T test, P=0.5376) (Figure 4.7c). This indicates 
that H2AFX signalling/intensity in response to X chromosome asynapsis is 
not different between the sexes, and that it unlikely accounts for the 
sexually-dimorphic silencing phenotype.  
5.3.3 X chromatin compaction in XO spermatocytes and oocytes 
As part of the previous analysis on H2AFX domain intensity, I also 
measured the area of the H2AFX domains. This area corresponds to the 
degree of chromatin compaction of the asynapsed X chromosome, since 
H2AFX marks the chromatin domain. As described above, I compared the 
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normalized size of the H2AFX domains between XO diplotene oocytes and 
XO diplotene spermatocytes. Notably, the mean H2AFX domain area, 
normalized to total cell area, was significantly smaller in XO spermatocytes 
compared to XO oocytes (T test, P<0.0001) (Figure 4.7d). The greater 
normalized H2AFX domain size in oocytes suggests reduced chromatin 
compaction of the asynapsed X chromosome in oocytes compared to 
spermatocytes. Therefore, there is a significant difference in asynapsed X 
chromosome compaction between XO oocytes and spermatocytes.  
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Figure 4.7. H2AFX domains in XO oocytes versus spermatocytes.  
(a) Diplotene XO oocyte stained with SYCP3 (blue) and H2AFX (red), 
showing a typical H2AFX domain. (b) Diplotene XO spermatocyte showing 
a typical H2AFX domain. XO males are also known as XO Eif2s3y tg, Sry tg 
males (Vernet et al., 2011), and were chosen because they have the same 
amount of sex chromosome material as XO females. Scale bar = 10m. (c) 
Quantitation of H2AFX domain integrated intensity in XO diplotene oocytes 
and XO diplotene spermatocytes. (d) Quantitation of H2AFX domain area 
normalized to germ cell area in XO diplotene oocytes and XO diplotene 
spermatocytes, revealing increased compaction of asynapsed X chromosome 
in males compared to females. n is the number of germ cells analyzed. 
Unpaired t test were performed to compare means, and P values are 
reported. 
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5.4 Discussion 
Chromosome abnormalities confer greater germ cell losses in males 
than females (Burgoyne et al., 2009). This is due in part to the reduced 
stringency of the metaphase I spindle checkpoint in females (LeMaire-
Adkins et al., 1997; Nagaoka et al., 2011), but is also thought to reflect ill-
defined sex differences in the efficiency of the prophase I response to 
asynapsis (Hunt and Hassold, 2002; Morelli and Cohen, 2005; Nagaoka et al., 
2012). In this chapter, I explored the mechanistic basis for the sex-specific 
differences in the meiotic prophase I surveillance response.  
I provide evidence that meiotic silencing is less efficient/robust in 
oocytes compared to spermatocytes. A significant number of XO oocytes that 
have an asynapsed X chromosome still had active X-linked genes, despite the 
presence of a H2AFX domain. This is in stark contrast to the situation in 
males, whereby silencing causes the complete inactivation of all sex-linked 
protein-coding genes by mid-pachynema (Turner et al., 2006).  
 Using simultaneous triple-gene RNA FISH, I showed that meiotic 
silencing in oocytes leads to the stochastic inactivation of genes, in which 
some X-linked genes are inactivated, while others remain active. Given that 
the mouse X chromosome has ~940 genes and is enriched for genes 
involved in oogenesis (Khil et al., 2004), including one gene that I analyzed, 
namely Zfx (Luoh et al., 1997), mosaic silencing of the X chromosome is 
expected to cause the inactivation of a large number of essential genes, 
which would presumably be deleterious for XO oocyte survival.     
My conclusion that silencing is more heterogeneous in oocytes 
compared to spermatocytes is further supported by analysis of Tc1 oocytes, 
and also a recent published analysis of sex-reversed XY oocytes (Taketo and 
Naumova, 2013). In this independent study, the efficiency of silencing of the 
X and Y chromosomes in XY oocytes was estimated indirectly by 
measurement of sex-linked gene products. They found a lower percentage of 
XY oocytes with staining for the protein ATRX in the presence of silencing; 
however, the level of staining was not completely abolished, suggesting 
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leaky gene expression. These results are consistent with my observations 
that meiotic silencing is sexually dimorphic. 
 This mosaic nature of silencing in oocytes may have several 
important implications. First, the impact of silencing on oocyte survival is 
expected to be dependent on the kind and combinations of genes that are 
inactivated in each oocyte. For example, oocytes with many critical genes 
inactivated would be starved of important cellular factors and thus subject 
to elimination sooner than oocytes that have no or few important genes 
silenced. Overall, this stochastic nature of silencing may lead to oocyte 
elimination occurring over a more extended period than predicted by a 
traditional checkpoint model (Barchi et al., 2005).   
 Second, mosaic silencing could lead to inability to eliminate all 
oocytes that have asynapsed chromosomes, especially if silencing fails to 
inactivate sufficient numbers of critical genes to be deleterious. This could 
explain why there remained a fraction of late diplotene oocytes with 
H2AFX domains in the XO, In(X)1H, T(16;17)43H, and XX mouse models. 
Based on my current data, however, it is difficult to determine whether 
these remaining oocytes are subject to elimination by the end of late 
diplonema, or whether they will survive and continue to metaphase I. 
Additional studies are required to make this distinction. 
In addition to identifying a sexual dimorphism in the degree of 
silencing, I also observed differences in the degree of compaction of the 
asynapsed X chromosome between XO oocytes and spermatocytes. This 
result suggests that the chromatin of asynapsed chromosomes is less 
heterochromatic in oocytes, which may contribute to weaker silencing 
response. Less condensed chromatin in oocytes is also consistent with a 
previous study of chromosome length in oocytes, which revealed that SC is 
twice as long in oocytes compared to spermatocytes (Wallace and Hultén, 
1985). In summary, the sexual dimorphism in the efficiency of meiotic 
silencing is associated with sex-specific chromatin features.    
 It is possible that there are also sex-specific epigenetic features that 
contribute to the differential efficiency of silencing in oocytes vs. 
spermatocytes. Many silencing components have been shown to be localize 
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to asynapsed chromosomes in oocytes, including H2AFX (Turner et al., 
2005), BRCA1 (Turner et al., 2005), ATR (Turner et al., 2005), HORMAD1 
(Wojtasz et al., 2009), HORMAD2 (Wojtasz et al., 2009), and ubi-H2A 
(Baarends et al., 2005).  
Other important silencing factors that operate in spermatocytes 
include MDC1 (Ichijima et al., 2011), SUMO-1 (Rogers et al., 2004), and 
H3K9me3 (van der Heijden et al., 2007). Notably, a recent study of silencing-
related epigenetic marks in sex-reversed XY oocytes, reported that 
H3K9me3 is not enriched on the asynapsed X chromosome in XY oocytes 
(Taketo and Naumova, 2013). This result has also been confirmed by 
members of the Turner laboratory (unpublished data). This suggests that 
accumulation of H3K9me3 on asynapsed chromatin may be important for 
establishing a fully inactive chromatin domain, and that its absence in 
oocytes contributes to leaky silencing. 
The sex-specific H3K9me3 staining pattern in mammalian germ cells 
may be indicative of a spermatocyte-specific histone methyltransferase. One 
potential methytransferase involved in meiotic silencing is Suppressor Of 
Variegation 3-9 Homolog 2 (SUV39-h2) (O'Carroll et al., 2000). SUV39-h2 is 
preferentially expressed in the testis and localizes to the sex body in 
pachytene spermatocytes (O'Carroll et al., 2000). Whether this 
methyltransferase is present on the asynapsed X chromosome in XO oocytes 
is unclear.  
Another candidate silencing methyltransferase is Set Domain 
Bifurcated 1 (SETDB1), which has recently been implicated in the 
maintenance of X chromosome inactivation (XCI) in female somatic cells 
(Minkovsky et al., 2014). It is possible that SETDB1 is not expressed in 
oocytes to owning to reactivation of the X chromosome in oocytes (Monk 
and McLaren, 1981). Future work should address the putative roles of 
methyltransferases, and other silencing-related epigenetic marks, as they 
relate to the sexually dimorphic meiotic silencing response. 
Chromosome abnormalities cause prophase I loss in both males and 
females, but the effects are usually less severe in females (Nagaoka et al., 
2012). Based on the results from this chapter, I suspect that the sexually 
 200 
dimorphism in prophase I surveillance may also be associated with 
fundamental differences in meiotic silencing in the sexes. In spermatocytes, 
meiotic silencing normally results in robust inactivation of the asynapsed X 
and Y chromosomes, called MSCI (Turner, 2007). In the presence of small 
levels of asynapsis, such as the accessory human chromosome 21 in Tc1 
spermatocytes, meiotic silencing also affects non-XY asynapsis 
(Mahadevaiah et al., 2008). If this segment of asynapsis contains critical 
spermatogenesis genes, then silencing would be expected to cause 
spermatocyte losses. Therefore, meiotic silencing likely also function to 
eliminate male germ cells with autosomal asynapsis.  
However, in the context autosomal asynapsis, meiotic silencing of the 
asynapsed X-Y (i.e. MSCI) in spermatocytes typically breaks down 
(Mahadevaiah et al., 2008). Silencing factors are titrated away from the XY 
bivalent, which leads to defective MSCI and subsequent mis-expression of a 
small number of sex-linked genes that are pachytene-lethal (Mahadevaiah et 
al., 2008; Royo et al., 2010). In summary, meiotic silencing in males may lead 
to spermatocyte arrest via two pathways: (1) inactivation of critical genes 
on asynapsed autosomes, (2) titration of silencing factors from the X and Y, 
leading to MSCI failure.  
By contrast, in oocytes, only the first pathway, the inactivation of 
critical genes on asynapsed autosomes, is active. Furthermore, I have shown 
that this pathway is leaky, such that oocytes are not fully capable of 
inactivating all genes associated with asynapsis.  As in spermatocytes, more 
extensive levels of asynapsis in oocytes (>2-3 pairs of asynapsed 
chromosomes) leads to aberrant accumulation of silencing factors ATR, 
BRCA1 and H2AFX, and disrupted meiotic silencing (Kouznetsova et al., 
2009). In these situations of extensive asynapsis, therefore, the abrogated 
silencing response may result in the inability to eliminate these defective 
germ cells. Consistent with this prediction, I observed a high percentage of 
PWD x C57BL/6 F1 oocytes with multiple asynapsed chromosomes from 
pachynema to late diplonema (see Figure 2.2). Since oocytes with extensive 
asynapsis persist into diplonema, there may not be safeguard mechanisms 
outside of meiotic silencing to eliminate cells with defective asynapsis.  
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In summary, I predict that the decreased efficiency of the prophase I 
meiotic surveillance mechanism in oocytes is due to a combination of 
factors, which may involve the inefficiency of the meiotic silencing response 
in oocytes, and the absence of additional surveillance mechanisms to deal 
with high levels of asynapsis. Importantly, these sex-specific differences in 
the prophase I asynapsis surveillance mechanism may contribute the high 
prevalence of human aneuploidies that arise from maternal meiotic errors 
(Hunt and Hassold, 2002; Morelli and Cohen, 2005; Nagaoka et al., 2012).   
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6 Results: Examination of factors involved in meiotic 
silencing 
The last objective of this thesis was to better characterize the role of 
BRCA1 and HORMAD2 during meiosis, and in particular, in meiotic silencing. 
First, I will focus on BRCA1. The role of BRCA1 in mammalian meiosis is not 
well understood, but it is thought to be involved in DNA DSB repair events 
(Xu et al., 2003) and meiotic silencing (Turner et al., 2004).  
In this section, I will first look into the putative role of BRCA1 in 
meiotic DNA DSB repair. Specifically, I will examine the localization of 
BRCA1 during normal and DNA DSB-defective meiosis. I will then study the 
localization of the DNA repair factor RAD51 in Brca1 mutant spermatocytes. 
An early study of Brca1p53+/- mutant mice reported disrupted 
localization of RAD51 (Xu et al., 2003), however this finding was disputed by 
a more recent study (Broering et al., 2014). It is important to clarify this 
discrepancy. I also will present data from anti-BRCA1 ChIP-seq in normal 
and DNA DSB-defective germ cells, with the goal of understanding the 
meiotic localization of BRCA1 on a genome-wide scale.  
Subsequently, I will address the role of BRCA1 in the meiotic 
silencing cascade. Previous work implicating BRCA1 in meiotic silencing 
were based off of studies of Brca111/11 p53+/- mutants, which express a 
shortened BRCA1 isoform that is still capable of binding to asynapsed 
chromosomes in spermatocytes (Turner et al., 2004). I wished to evaluate 
the meiotic silencing phenotype in a Brca1 null mutant. I will therefore 
study a recently described Brca1 null mutant mouse model (Bunting et al., 
2012), which harbors a deletion of exon 2 that encodes the conserved ring 
finger motif (Ludwig et al., 1997). Brca1 nullizygosity has a much more 
severe phenotype compared to Brca111/11 mutants, resulting in earlier 
embryonic lethality (Ludwig et al., 1997), which can be overcome by 
additional deletion of 53BP1 (Bunting et al., 2012). These Brca1-/- 53bp1-/- 
males are sterile (Bunting et al., 2012), but the meiotic phenotype has not 
yet been characterized. In this chapter, I will describe the localization of the 
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silencing factor ATR, and relate it to an RNA FISH analysis of X gene 
transcription, in Brca1-/- 53bp1-/- mutant spermatocytes.  
In the second part of this chapter, I will study meiotic silencing in a 
recently generated Hormad2-/- mouse model (Wojtasz et al., 2012). Recent 
expression profiling has shown that the HORMA-domain genes Hormad1 
and Hormad2 are expressed highly during meiosis (Wojtasz et al., 2009). 
Two independent groups reported that Hormad1-/- mice have defects in 
meiotic silencing (Daniel et al., 2011; Shin et al., 2010). MSCI failure in 
Hormad1-/- mice is associated with failed recruitment and/or accumulation 
of the silencing factors BRCA1, ATR, and H2AFX to the asynapsed X and Y 
chromosomes (Daniel et al., 2011; Shin et al., 2010). Since both HORMAD1 
and HORMAD2 accumulate along the cores of the asynapsed X-Y 
chromosomes in spermatocytes (Wojtasz et al., 2009), I wished to analyze 
whether HORMAD2 also functions in meiotic silencing pathway.  
I therefore characterized the meiotic silencing response in Hormad2-
/- mice, developed by Attila Tóth’s group (Dresden, Germany). I will 
examine the localization of three critical meiotic silencing factors, namely 
BRCA1, HORMAD1, and H2AFX, in Hormad2-/- spermatocytes. Finally, I will 
study meiotic silencing in Hormad2-/- spermatocytes at the transcriptional 
level using gene-specific RNA FISH.  These results on Hormad2-/- are 
published as part of a recent Hormad2-/- characterization study (Wojtasz et 
al., 2012), and shed new light on the meiotic silencing pathway in mammals.  
6.1 Role of BRCA1 during meiotic prophase I 6.1.1 BRCA1 localization 
during male meiotic prophase I 
Before analyzing Brca1 mutant mice, I first wanted to assess the 
localization of BRCA1 in wildtype spermatocytes. I performed meiotic 
chromosome spreads on wildtype spermatocytes and double-
immunostained for SYCP3, to identify chromosome axes, and BRCA1. At 
leptonema and zygonema, BRCA1 localized to SYCP3 axes as foci (Figure 
5.1a, arrow), in a manner reminiscent of DNA DSB repair foci, such as 
RAD51, DMC1, and RPA. BRCA1 foci were restricted to the asynapsed 
segments of chromosomes, i.e. were absent on synapsed regions of 
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chromosomes (Figure 5.1a, arrowheads). This indicates that BRCA1 is lost 
from meiotic chromosome axes upon synapsis.  
At pachynema and diplonema, BRCA1 was restricted to the 
asynapsed cores of the X-Y chromosomes, but not at regions of X-Y synapsis 
(i.e. at the PAR) (Figure 5.1b, arrow). These meiotic prophase I staining 
patterns of BRCA1 are consistent with previous BRCA1 localization studies 
(Mahadevaiah et al., 2008; Turner et al., 2004). 
Given the putative role for BRCA1 in meiotic DNA DSB repair (Xu et 
al., 2003), I next analyzed the spatial relationship between BRCA1 and DNA 
repair factors during meiosis. Previously, it was shown that BRCA1 co-
localizes with RAD51 on asynapsed chromosome axes in spermatocytes 
lacking the gene Dnmt3l (Mahadevaiah et al., 2008). I therefore examined 
whether BRCA1 co-localizes with another DNA repair protein, namely 
DMC1.  
Wildtype chromosome spreads were triple-immunostained with 
SYCP3, BRCA1, and DMC1. Notably, BRCA1 and DMC1 foci were observed in 
close proximity on asynapsed chromosome axes at leptonema and 
zygonema (Figure 5.1c). Interestingly, while most BRCA1 foci were 
localized on SYCP3-labeled chromosome axes, DMC1 foci were spatially 
distinct, oftentimes localizing slightly off the axes (Figure 5.1c, arrow). This 
spatial difference suggests that BRCA1 and DMC1 may bind different 
structural elements of chromosomes.   
At DNA DSB sites, DMC1 binds ssDNA to facilitate strand exchange in 
concert with RAD51 (Bishop et al., 1992; Cloud et al., 2012). It is unclear 
whether BRCA1 binds DNA directly, like DMC1 and RAD51, or binds the 
proteinaceous synaptonemal complex core. Given the spatial offset between 
DMC1 and BRCA1, and the fact that BRCA1 co-localizes over the SYCP3 
signal, it is possible that BRCA1 associates with the SC .  
In addition to their distinct spatial relationships, I observed two 
distinct types of foci observed in spermatocytes stained for BRCA1 and 
DMC1. The majority of foci were mixed, containing both BRCA1 and DMC1 in 
close proximity (Figure 5.1d, arrows). However, a subset of foci contained 
only BRCA1 (Figure 5.1d, arrowheads). These BRCA1 foci may represent 
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functional or structurally distinct regions on chromosomes, or they could 
represent foci that have yet to recruit DMC1. This could also indicate that 
BRCA1 foci are in excess of DMC1 foci. 
6.1.2 Localization of BRCA1 in meiotic mutant spermatocytes 
Given that BRCA1 foci occur in close proximity to DMC1 foci, it is 
possible that DMC1 recruits BRCA1 to DNA DSB sites. If this is true, BRCA1 
foci should be abolished in Dmc1-/- germ cells. To test this hypothesis, I 
performed meiotic chromosome spreads in Dmc1-/- spermatocytes and 
analyzed the localization of BRCA1. Dmc1-/- spermatocytes fail to 
successfully repair meiotic DNA DSBs, and DNA repair proteins such as 
RAD51 persist and chromosomes fail to synapse (Pittman et al., 1998; 
Yoshida et al., 1998). Contrary to a role for DMC1 in recruiting DMC1 to 
chromosomes, I found that BRCA1 foci localized normally to pre-synaptic 
chromosomes in Dmc1-/- spermatocytes (Figure 5.1e). Therefore, Dmc1 is 
not required for recruiting BRCA1 to asynapsed chromosome axes as foci.  
If BRCA1 indeed localizes to meiotic DNA DSB sites, as suggested by 
it’s localization pattern, then BRCA1 foci should disappear in Spo11-/- germ 
cells, which do not initiate programmed DNA DSBs (Mahadevaiah et al., 
2001). Contrary to this expectation, a study reported that BRCA1 foci occur 
in Spo11-/- spermatocytes (Mahadevaiah et al., 2008). To confirm this 
puzzling finding, I repeated this experiment and assessed BRCA1 
localization in Spo11-/- spermatocytes (Baudat et al., 2000; Romanienko 
and Camerini-Otero, 2000).  
Consistent with the previous study (Mahadevaiah et al., 2008), I also 
observed BRCA1 foci along pre-synaptic axes in Spo11-/- zygotene-like 
spermatocytes (Figure 5.1f). Therefore, despite the fact that BRCA1 foci are 
located in close proximity DNA DSBs in wildtype germ cells, they do not 
disappear in the absence of DNA DSBs.  
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Figure 5.1. BRCA1 localization in wildtype, Dmc1-/-, and Spo11-/- 
spermatocytes.  
(a) Leptotene wildtype spermatocyte immunostained for SYCP3 (magenta) 
and BRCA1 (green), showing abundant BRCA1 foci associated with pre-
synaptic axes. Inset shows magnification of region indicated by arrow. 
Arrowheads show synapsed chromosomes from nearby nucleus. There are 
no BRCA1 foci on these synapsed axes. (b) Pachytene wildtype 
spermatocyte showing BRCA1 staining restricted to the non-homologous 
asynapsed regions of the X and Y chromosomes (inset). The synapsed 
psuedoautosomal region (arrow) is devoid of BRCA1, as are synapsed 
autosomes. (c) Zygotene wildtype spermatocyte immunostained for SYCP3 
(cyan), DMC1 (red), and BRCA1 (green), showing the close proximity of 
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DMC1 and BRCA1 foci. Inset shows magnification of region indicated by 
arrow. (d) More magnified image of a zygotene wildtype spermatocyte 
immunostained for SYCP3, DMC1, and BRCA1. Two types of protein 
complexes are visible: the first type shows co-existence of DMC1 foci and 
BRCA1 foci (arrows), and the second type contains only BRCA1 foci 
(arrowhead). (e) Dmc1-/- zygotene-like spermatocyte immunostained for 
SYCP3 (magenta) and BRCA1 (green), showing normal BRCA1 foci on 
asynapsed chromosome axes. Inset shows magnification of region indicated 
by arrow. (f) Spo11-/- zygotene-like spermatocyte immunostained for 
SYCP3 and DMC1, showing BRCA1 foci along DNA DSB-deficient asynaptic 
cores.  
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6.1.3 RAD51 localization in Brca1 mutants 
A previous study (Xu et al., 2003) showed impaired loading of RAD51 
in Brca111/11 mutants, which suggests that BRCA1 might be required 
for proficient meiotic DNA DSB repair. A more recent analysis (Broering et 
al., 2014), however, showed that RAD51 localizes normally in several 
different Brca1 mutants. To address these contradictory findings, I assessed 
the localization of RAD51, using the same antibody used by Xu and 
colleagues (Xu et al., 2003), in different Brca1 mutants.  
I first examined RAD51 staining in control Brca111/ p53+/- 
spermatocytes. As expected, RAD51 foci were visible on pre-synaptic 
chromosomes at zygonema in Brca111/ p53+/- spermatocytes (Figure 
5.2a).  Contrary to the initial report (Xu et al., 2003), RAD51 foci were also 
visible in Brca111/11 p53+/- mutants (Figure 5.2b). I verified this 
finding using a different RAD51 antibody, which has been used in previous 
meiotic studies (Cole et al., 2012). Using this second antibody, RAD51 foci 
were also detected in both controls and Brca111/11 p53+/- mutants 
(Figure 5.2c,d).  
For further verification, I also examined RAD51 staining in a different 
Brca111 double mutant, namely Brca111/11 53bp1-/- males. Using 
both RAD51 antibodies, RAD51 foci were observed in Brca111/11 53bp1-
/- spermatocytes (Figure 5.2e,f). These data support the more recent 
report (Becherel et al., 2013) indicating Brca1 mutation does not affect the 
loading of RAD51 on pre-synaptic chromosomes during meiotic prophase I.  
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Figure 5.2. RAD51 localization in Brca111/11 mutant 
spermatocytes.  
(a) Control Brca111/+ p53+/- zygotene spermatocyte immunostained for 
SYCP3 (magenta) and RAD51 (ab#1, SC-8349, 1:100) (green), showing 
normal localization of RAD51 on asynapsed chromosome axes. (b) 
Brca111/11 p53+/- zygotene spermatocyte immunostained for SYCP3 
and RAD51 (ab#1) showing unimpaired localization of RAD51. (c) Control 
Brca111/+ p53+/- zygotene spermatocyte immunostained for SYCP3 
(magenta) and RAD51, using a second antibody (ab#2, EMD PC130, 1:250) 
(green), showing normal localization of RAD51 on asynapsed chromosome 
axes. (d) Brca111/11 p53+/- zygotene spermatocyte immunostained for 
SYCP3 and RAD51 (ab#2) showing unimpaired localization of RAD51. (e) 
Brca111/11 53bp1-/- zygotene spermatocyte, showing RAD51 foci 
(ab#1). (f) Brca111/11 53bp1-/- zygotene spermatocyte, showing 
RAD51 foci (ab#2).  
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6.1.4 ChIP-seq in wildtype spermatocytes  
The above data involving the role for BRCA1 in meiotic DNA DSB 
repair are somewhat paradoxical. I showed that BRCA1 foci are not 
dependent upon Spo11, and that Brca1 mutants load RAD51 or DMC1 
normally. This suggests that BRCA1 is dispensable for DNA DSB repair. This 
begs the question as to why then BRCA1 localize to meiotic DNA DSB sites.  
Given these observations, I wished to examine more closely the 
location of BRCA1 relative to meiotic DNA DSBs. To address this, I 
performed anti-BRCA1 chromatin immunoprecipitation followed by deep 
sequencing (ChIP-seq). This approach has been used previously to generate 
a detailed map of meiotic DNA DSB hotspots in mice (Smagulova et al., 
2011).  
As a positive control, I first performed anti-DMC1 ChIP-seq on 
chromatin from C57Bl/6 wildtype mice testes. A similar experiment was 
done previously to define hotspots in wildtype spermatocytes (Smagulova et 
al., 2011). My sequencing data was analyzed by computational biologist Dr. 
Kevin Brick (National Institutes of Health, USA). In confirmation that my 
anti-DMC1 ChIP-seq experiment was successful, there was significant 
enrichment of DMC1 sequencing reads at previously map hotspots in the 
genome (Figure 5.3). Quantitative analysis revealed 19,488 “peaks” of 
statistically significant DMC1 enrichment, which is similar to the 18,735 
hotspots previously identified in the mouse genome (Brick et al., 2012). 
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Figure 5.3. Control anti-DMC1 ChIP-seq in wildtype 
spermatocytes.  
Image from Integrative Genome Viewer (IGV) showing representative peaks 
of DMC1 enrichment within a representative genomic region (a 290kb 
region on chromosome X) containing several DNA DSB hotspots (blue boxes 
in “hotspots” row) defined by (Smagulova et al., 2011).  
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After verifying the efficacy of this approach, I then performed ChIP-
seq on C57Bl/6 wildtype spermatocytes using two different anti-BRCA1 
antibodies. First, I tested the rabbit polyclonal BRCA1 antibody that I used 
for chromosome spread experiments, used three different 
dilutions/conditions (Figure 5.4a). I also tested a second BRCA1 antibody 
that has been used in unpublished ChIP-seq experiments in somatic cells by 
members of Dr. Andre Nussenzweig’s laboratory (NIH) (Figure 5.4a).  
Compared to my anti-DMC1 ChIP-seq results,  enrichment peaks 
were not as obvious in my anti-BRCA1 ChIP-seq data (Figure 5.4b). 
However, upon comparing the BRCA1 ChIP-seq data to published hotspot 
data I noticed small peaks of BRCA1 enrichments near a subset of the 
strongest DMC1-defined hotspots (Figure 5.4b). Based on quantitative 
analysis, BRCA1 enrichment shows positive correlations with hotspot 
strength, defined by my DMC1 ChIP-seq data (Figure 5.4c). For example, 
anti-BRCA1 sample 3 showed a Pearson’s correlation coefficient of 0.70 
when compared to C57BL/6 hotspot strength (Figure 5.4c). This positive 
correlation suggests that BRCA1 is enriched at DNA DSB hotpsots, especially 
at the strongest ones in the genome. 
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Figure 5.4. Anti-BRCA1 ChIP-seq in wildtype spermatocytes.   
(a) Summary of anti-BRCA1 ChIP-seq experimental conditions and 
sequencing results. The standard protocol (Smagulova et al., 2011) and 
kinetic enrichment (KE) protocol (Khil et al., 2012) was followed as 
described previously. PF = post filter clusters. (b) Representative image 
showing anti-BRCA1 sequencing reads across the same 290kb region on 
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chromosome X as shown in Figure 5.3. There is some anti-BRCA1 
enrichment compared to background in a minority of DMC1-defined 
hotspots (arrows, samples #1-3), however the degree of enrichment is small 
compared to that observed by DMC1 ChIP-seq. (c) Correlation plots of anti-
BRCA1 read enrichment across the genome between samples compared to 
hotspot strength (defined by DMC1 enrichment). Number in top left corner 
of each box is the Pearson’s correlation coefficient, where 1.0 indicates a 
perfect positive linear correlation. Red signifies relatively high positive 
correlations.   
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6.1.5 Anti-BRCA1 ChIP-seq in Spo11-/- mice 
If BRCA1 localizes to meiotic DNA DSB sites, as indicated by my 
cytological data (Figure 5.1) and ChIP-seq data (Figure 5.4), then why are 
BRCA1 foci present in DNA DSB-deficient Spo11-/- spermatocytes? One 
possibility is that BRCA1 localizes to chromosomes prior to the formation of 
DNA DSBs. Under this model, BRCA1 could serve to recruit SPO11 or other 
DNA DSB machinery to generate DNA DSBs at specific sites. This would 
predict that BRCA1 would be enriched at hotspots Spo11-/- spermatocytes, 
like in wildtype spermatocytes.  
To test this possibility, I performed anti-BRCA1 ChIP-seq on Spo11-/- 
spermatocytes (Figure 5.5a). Spo11-/- male mice arrest at the mid-
pachytene stage of prophase I (Baudat et al., 2000), and are therefore 
enriched in spermatocytes in early prophase I. To control for this arrest 
effect, I also performed anti-BRCA1 ChIP-seq using Dmc1-/- spermatocytes 
(Figure 5.5a), which also arrest at mid-pachytene (Pittman et al., 1998). I 
verified earlier that BRCA1 foci are present in Dmc1-/- spermatocytes using 
chromosome spreads (see Figure 5.1e). For these ChIP-seq experiments, I 
used the same ChIP conditions that were used for sample 3 in the previous 
experiment (anti-BRCA1, pRb, 0.75ul), since they provided the best results 
in wildtype spermatocytes (Figure 5.5a). 
For both Spo11-/- and Dmc1-/- genotypes, I generated negative 
control “input” samples. Input samples are made from an aliquot of the 
sample chromatin before it is subject to immunoprecipitation. Comparing 
input samples to anti-BRCA1 ChIP samples allow for identification of true 
peaks of BRCA1 enrichment (Smagulova et al., 2011). 
In the control anti-BRCA1 Dmc1-/- sample, I observed BRCA1 
enrichment at hotspot locations (Figure 5.5b). I measured this 
quantitatively using a metric called Fraction of sequencing Reads In 
Hotspots (FRIP), which estimates enrichment within hotspots. Importantly, 
FRIP was significantly higher in the Dmc1-/- sample (2.8%) compared to the 
input sample (1.6%) (Figure 5.5b). Furthermore, the FRIP for the Dmc1-/- 
sample was similar to that for the anti-BRCA1 wildtype ChIP sample 
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produced in my previous experiment (Figure 5.5b). These data confirm that 
BRCA1 is enriched at DNA DSB sites in the Dmc1-/- control. 
By contrast, there was no significant BRCA1 enrichment at hotspots 
in the Spo11-/- sample (Figure 5.5b). The FRIP for the Spo11-/- ChIP 
sample (1.6%) and the Spo11-/- input negative control (1.5%) were not 
significantly different (Figure 5.5b). Furthermore, there was no detectable 
correlation between BRCA1 reads in the Spo11-/- sample and hotspot 
strength (Figure 5.5c). This suggests that BRCA1 is not enriched at hotspots 
in Spo11-/- spermatocytes. 
To determine if there are any locations in the genome with BRCA1 
enrichment, I then looked for BRCA1 peaks outside of hotspot sites. Based 
on peak calling algorithms, there were only 71 BRCA1 peaks in the Spo11-/- 
ChIP sample, and only three (4%) localized to existing hotspot sites (Figure 
5.5d). This is in contrast to the Dmc1-/- sample, in which 67% of the 79 
identified peaks were located within hotspots (Figure 5.5d).  
Notably, the majority of the 71 peaks identified in the Spo11-/- 
sample were also found in the input control, and thus likely represented 
mapping artifacts (not shown). Only four peaks in the Spo11-/- samples 
were not in the input negative control, and of these, all were located at 
transcription start sites (Figure 5.5e). This is consistent with a report that 
suggests a putative role for BRCA1 in transcriptional regulation (Mullan et 
al., 2006). I confirmed these results with replicate experiments (not shown). 
In summary, based on my anti-BRCA1 ChIP-seq data, BRCA1 does not 
localize to meiotic DNA DSB hotspots in Spo11-/- spermatocytes. These data 
are not consistent with a model whereby BRCA1 is upstream of SPO11 in the 
meiotic DNA DSB pathway.  
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Figure 5.5. Anti-BRCA1 ChIP-seq in Spo11-/- spermatocytes.  
(a) Summary of anti-BRCA1 ChIP-seq experimental conditions and 
sequencing results. For the two anti-BRCA1 samples (#1,3), I used 0.75ul of 
pRb antibody, which produced the best results in wildtype spermatocytes 
(Figure 5.4c). (b) Fraction of sequencing reads within hotspot peaks for 
each sample. If BRCA1 associates with DNA DSBs, anti-BRCA1 ChIP-seq 
samples should be enriched for DNA fragments (i.e. ssDNA) within hotspots. 
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The fraction of reads in peaks (i.e. hotspots) (FRIP) is a measure of the 
percentage of sequencing tags/reads mapping to hotspots. There is 
enrichment of ssDNA fragments within hotspots in wildtype and Dmc1-/- 
ChIP samples compared to input (negative control), but no significant 
enrichment of ssDNA fragments within hotspots in the Spo11-/- sample 
compared to input. (c) No detectable correlation between anti-BRCA1 ChIP 
reads and hotspot strength in the absence of Spo11. (d) Total number of 
peaks in samples, and the number/percentage of those peaks located within 
known hotspots. Darker color indicates a higher number/percentage. (e) 
Representative IGV snapshot showing one of four significant peaks of 
BRCA1 enrichment in the Spo11-/- sample (arrow). The peak is located 
within the promoter region of a gene on chromosome 2, called Trp53rk, 
which encodes a p53 kinase (Abe et al., 2001).  
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6.1.6 Anti-DMC1 ChIP-seq in Brca1-/- spermatocytes 
Based on the above results, it seems unlikely that BRCA1 is critical 
for the designation and/or repair of meiotic DNA DSBs. However, they do 
not discount the possibility that BRCA1 is involved in positioning/location, 
or strength of meiotic DNA DSBs. In mammals, PRDM9 is a major 
determinant of meiotic DNA DSB hotspot location in the genome (Baudat et 
al., 2010; Brick et al., 2012). However, other currently undefined factors 
could also be involved in the designation of meiotic DNA DSB hotspot 
location. If BRCA1 is involved in regulating DNA DSB positioning, then I 
would expect hotspot locations to be altered in Brca1 mutant mice, as 
observed in Prdm9-/- mice (Brick et al., 2012).   
To test this possibility, I mapped hotspots by anti-DMC1 ChIP-seq in 
Brca1-/- 53bp1-/- mutants. First, I assessed whether 53bp1 deletion affects 
hotspot location and strength. There was a strong positive correlation 
between DMC1 enrichment at hotspots between Brca1+/+ 53bp1-/- controls 
and wildtype controls (Figure 5.6a), suggesting that hotspot location and 
strength are unaffected on the 53bp1-/- background.  
Next, I analyzed whether hotspot location and strength differed 
between Brca1-/- 53bp1-/- and littermate Brca1+/+ 53bp1-/- controls. 
Notably, there was a strong positive correlation in DMC1 enrichment at 
hotspots between Brca1-/- 53bp1-/- and Brca1+/+ 53bp1-/- littermate 
controls (Pearson, R=0.8997) (Figure 5.6b), and also between Brca1-/- 
53bp1-/- and wildtype controls (Pearson, R=0.9228) (Figure 5.6c). Based 
on peak calling algorithms, the number of hotspots in each of our samples 
ranged from 12,441 to 19,488 depending on the genotype (Figure 5.6d). 
Notably, the vast majority of hotspots overlapped between Brca1-/- 53bp1-
/-, Brca1+/+ 53bp1-/-, and wildtype samples (Figure 5.6e). This indicates 
that Brca1 deletion does not significantly affect hotspot strength or location.  
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Figure 5.6. Anti-DMC1 ChIP-seq in Brca1-/- spermatocytes. 
(a) Correlation of DMC1 enrichment (i.e. strength) at known DNA DSB 
hotspot locations between DMC1 ChIP-seq samples. The R value represents 
the Pearson’s correlation coefficient for each comparison. All comparisons 
showed a significant positive correlation, suggesting that hotspot strength 
across the genome is largely unchanged by deletion of Brca1. (b) Number of 
peaks in DMC1 ChIP-seq samples determined by peak calling algorithms. (c) 
Venn diagram showing the number/percentage of peaks that overlaps 
between wildtype, 53bp1-/-, and Brca1-/- 53bp1-/- samples. Only overlaps 
in the central 400bp of hotspots were counted, as described previously 
(Brick et al., 2012).  
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6.1.7 ATR localization in Brca1-/- spermatocytes 
The above analyses suggest that BRCA1 is dispensable for meiotic 
DNA DSB events. A non-essential role for BRCA1 in meiotic DNA DSB repair 
is also consistent with the observation that Brca1 mutant females are fertile 
(Xu et al., 2003). The Brca1-/- male infertility phenotype is therefore due to 
BRCA1’s role in a male-specific process, namely MSCI. This is supported by 
earlier work on Brca111/11 p53+/- mutants, which have defective 
targeting of ATR to the X and Y chromosome and failed MSCI (Turner et al., 
2004).  
ATR shows two distinct localization patterns in spermatocytes. In 
wildtype mice, ATR forms foci on chromosome cores during leptonema and 
zygonema (Keegan et al., 1996; Moens et al., 1999; Perera et al., 2004) 
(Figure 5.7a-b). At pachynema and diplonema, by contrast, ATR labels the 
axis and chromatin of the asynapsed X and Y chromosomes (Figure 5.7c-d).  
While there is evidence that BRCA1 is necessary for recruiting ATR to 
the sex chromosomes at pachynema (Turner et al., 2004), it is not clear 
whether BRCA1 is required for targeting of ATR foci to chromosome cores 
during early meiotic prophase I. To address this, I examined ATR 
localization at zygonema in Brca1 mutant spermatocytes. I observed ATR 
foci on pre-synaptic axes in zygotene spermatocytes in both the control and 
Brca1-/- 53bp1-/- males (Figure 5.7e,f). This indicates that BRCA1 is not 
required for targeting of ATR foci to chromosomes during early meiotic 
prophase I.  
Next, I studied the localization of ATR at pachynema in the Brca1-/- 
53bp1-/- mutant mouse. Previous studies reported failed targeting of ATR to 
the asynapsed sex chromosomes in the Brca111/11 p53+/- mutant 
(Turner et al., 2004). As expected, ATR localized normally to the asynapsed 
X-Y chromosomes during pachynema in Brca1+/+ 53bp1-/- control 
spermatocytes (Figure 5.7g). By contrast, in Brca1-/- 53bp1-/- pachytene 
spermatocytes, I observed disrupted localization of ATR on the asynapsed X-
Y (Figure 5.7h-l).  
There were several different abnormal ATR staining patterns in 
Brca1-/- 53bp1-/- mutants (Figure 5.7h-l). In the majority of mutant 
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spermatocytes (70%, n=100 cells), ATR localized to the asynapsed sex 
chromosomes as several foci (Figure 5.7h), sometimes involving a large 
focus near the PAR (Figure 5.7i). These ATR foci are reminiscent of the 
pattern of DNA DSBs proteins on the asynapsed sex chromosomes. In a 
small percentage of pachytene spermatocytes (10%), ATR accumulated 
along the length of the asynapsed X-Y chromosomes, but not within the 
chromatin (Figure 5.7j). In another subset of spermatocytes (15%), ATR 
localized only as a very large and intense focus at the PAR of the X-Y 
chromosomes (Figure 5.7k). In the remaining spermatocytes (5%), ATR 
was seen within the chromatin of the X-Y chromosomes, but rarely 
encompassed the entire chromatin domain of the sex chromosomes (Figure 
5.7l). I also noticed that X-Y pairing was disrupted in a subset of mutant 
spermatocytes (Figure 5.7h,j).  
This Brca1 mutant phenotype is consistent with previously published 
work on the Brca111/11 mutant (Turner et al., 2004). In conclusion, 
BRCA1 is dispensable for DNA DSB events during meiosis, but is essential 
for proper targeting of ATR to the sex chromosomes for meiotic silencing.  
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Figure 5.7. ATR localization in wildtype and Brca1-/- 
spermatocytes.  
(a-d) Wildtype spermatocytes double-immunostained for ATR and SYCP3. 
(a,b) ATR foci are present along presynaptic chromosome cores at 
leptonema and zygonema. Arrows point to representative regions magnified 
in inset. (c,d) ATR labels the XY axis and sex chromatin (arrows) at 
pachynema and diplonema. (e) Control Brca1+/+ 53bp1-/- zygotene 
spermatocyte, normal ATR foci. (f) Brca1-/- 53bp1-/- zygotene 
spermatocyte, normal ATR foci. (g) Control Brca1+/+ 53bp1-/- pachytene 
spermatocyte, normal ATR staining within the sex chromatin. (h-l) Mutant 
Brca1-/- 53bp1-/- pachytene spermatocytes, showing abnormalities in ATR 
staining on the X and Y chromosomes. Abnormal XY ATR staining patterns 
observed include: (h) multiple ATR foci (arrows); (i) multiple ATR foci with 
a large ATR signal near the PAR (arrow); (j) partial axial ATR staining 
(arrow); (k) a single large ATR focus near the PAR (arrow); (l) abnormal 
chromatin ATR staining (arrow), not encompassing the entire chromatin 
region of asynapsis (arrowhead).  
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6.2. Role of Hormad2 in meiotic silencing  
6.2.1 Localization of silencing factors in Hormad2-/- mice 
To understand the impact of Hormad2-deficiency on meiotic 
silencing, I first examined the localization of several important silencing 
factors in Hormad2-/- mutants, including BRCA1, ATR, and H2AFX. In 
Hormad1-/- mice, the level of HORMAD2 and BRCA1 and the asynapsed X 
and Y chromosomes is greatly reduced, suggesting that HORMAD1 is 
upstream of HORMAD2 and BRCA1 (Daniel et al., 2011). However, the 
relationship between HORMAD2, BRCA1, and H2AFX has not been studied.  
To address this, I examined Hormad2-/- and control wildtype 
spermatocytes triple-immunstained for SYCP3, BRCA1, and H2AFX (Figure 
5.8). As expected, in early pachytene control spermatocytes, BRCA1 
localized to the asynapsed X-Y axes and H2AFX accumulated in the X-Y 
chromatin (Figure 5.8a,b). By contrast, in early pachytene spermatocytes 
from Hormad2-/- mice, X-Y BRCA1 staining was not linear, but foci-like, and 
did encompass the entire X-Y axes length (Figure 5.8c). While H2AFX was 
present within the sex chromatin of Hormad2-/- spermatocytes, the staining 
pattern was aberrant, oftentimes not involving all the chromatin (Figure 
5.8d, arrow). Furthermore, in a subset of Hormad2-/- spermatocytes, only a 
few faint BRCA1 foci were visible on the asynapsed sex chromosomes 
(Figure 5.8e), and this was associated with a drastic reduction in H2AFX 
staining (Figure 5.8f).  
I also noticed that in general that BRCA1 and H2AFX in Hormad2-/- 
spermatocytes was more prominent near the distal region of the X-Y 
chromosomes (i.e. near the PAR) (Figure 5.8g,h, arrows). In other words, 
the centromeric region of the X chromosome was not frequently labeled 
with BRCA1 or H2AFX (Figure 5.8g,h, arrowheads). In summary, 
targeting and/or accumulation of the silencing factors BRCA1 and H2AFX is 
disrupted in the absence of Hormad2.  
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Figure 5.8. Abnormal BRCA1 and H2AFX staining in Hormad2-/- 
spermatocytes.  
(a,b) Wildtype pachytene spermatocyte with normal linear localization of 
BRCA1 along the asynapsed cores of the XY chromosomes. (b) Same 
wildtype spermatocyte showing normal accumulation of H2AFX within the 
sex chromatin. (c) Hormad2-/- pachytene spermatocyte with abnormal 
BRCA1 staining, characterized by BRCA1 foci, rather than linear BRCA1 
staining. (d) Same Hormad2-/- spermatocyte with diffuse staining of 
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H2AFX on the asynapsed sex chromosomes. Arrowhead points to an 
asynapsed region not labeled with H2AFX. (e) Hormad2-/- pachytene 
spermatocyte with only a few faint BRCA1 foci. (f) Same Hormad2-/- 
spermatocyte with drastic reduction in H2AFX staining. (g) Hormad2-/- 
pachytene spermatocyte with few BRCA1 foci near the PAR end of the 
chromosome (arrow), but none near the centromeric end (arrowhead). (h) 
Same Hormad2-/- spermatocyte with H2AFX staining near the PAR 
(arrow), but not near the centromeric end (arrowhead).  
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6.2.2 RNA FISH analysis of X gene transcription in Hormad2-/- mice 
 The above data suggests that HORMAD2, like HORMAD1, is an 
important component of the meiotic silencing response. Specifically, 
HORMAD2 is required for recruiting and/or stabilizing BRCA1. To formally 
verify a role for HORMAD2 in silencing, I next assessed X chromosome gene 
transcription in Hormad2-/- spermatocytes. If HORMAD2 is a bona fide 
silencing factor, than Hormad2-/- spermatocytes should exhibit de-
repression of the sex chromosomes, as found in other silencing mutants 
such as H2afx-/- and Mdc1-/- mice (Fernandez-Capetillo et al., 2003; 
Ichijima et al., 2011; Turner et al., 2004).  
I assessed X-linked gene transcription in Hormad2 spermatocytes by 
gene-specific RNA FISH. I probed for the same three X-linked genes that I 
studied in my analysis of silencing in XO oocytes and XY spermatocytes, 
namely Scml2, Utx, and Zfx (see Figure 4.1). I first assessed transcription of 
Scml2, Utx, and Zfx by RNA FISH in Hormad2-/- spermatocytes compared to 
wildtype spermatocytes (Figure 5.9a-d). Using this approach, I found that 
Utx and Zfx were expressed in a significantly higher percentage of early 
pachytene spermatocytes in Hormad2-/- mice compared to wildtype 
controls (Figure 5.9e,f). This indicates a silencing defect in Hormad2-/- 
spermatocytes. Interestingly, the frequency of escape from silencing for 
Scml2 was not significantly different between wildtype and Hormad2-/- 
mice (Figure 5.9e,f).  
Next, I compared the level of X de-repression in Hormad2-/- mutants 
to that of H2afx-/- mutants, which do not undergo silencing (Fernandez-
Capetillo et al., 2003). While the frequency of escape from silencing for Zfx 
was similar between Hormad2-/- and H2afx-/- mice, the level of escape in 
H2afx-/- compared to Hormad2-/- spermatocytes was higher for Utx and 
Scml2 (Figure 5.9d,e). This suggests that a regional disruption of MSCI 
occurs in Hormad2-/- spermatocytes, whereby the centromeric end of the X 
(i.e. near Zfx) is more disrupted than the PAR end (i.e. near Smcl2). This is 
consistent with my earlier observation that H2AFX in Hormad2-/- 
spermatocytes is more often associated with the PAR end of the X-Y 
chromosomes. 
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In summary, Hormad2-deficiency leads to at least partial de-
repression of the X chromosome. Further characterization of the Hormad2-
/- mouse, by Attila Tóth and colleagues (Wojtasz et al., 2012), highlighted 
that MSCI defects are the predominant meiotic phenotype in Hormad2-/- 
mice. This work has revealed that HORMAD2 is an important component of 
the meiotic silencing pathway in mammals.  
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Figure 5.9. RNA FISH analysis of Hormad2-/- spermatocytes.  
(a) Wildtype early pachytene spermatocyte nucleus subject to RNA FISH for 
Utx (no signal = not expressed), and immunostaining for HORMAD1 and 
H2AFX, to identify the asynapsed X chromosome. (b) Hormad2-/- early 
pachytene nucleus with an RNA FISH signal for Utx (arrow), indicating 
expression of Utx from the asynapsed X chromosome. The region that X 
chromosome adjacent to the Utx RNA FISH signal is devoid of H2AFX. (c) 
Hormad2-/- early pachytene nucleus showing a Zfx RNA FISH signal in a 
region adjacent to an abnormal H2AFX domain. (d) Two Hormad2-/- early 
pachytene nuclei with abnormal H2AFX domains. The top nucleus is 
negative for Scml2 RNA FISH signal, while the bottom nucleus has an Scml2 
RNA FISH signal. (e) Percentage of early pachytene spermatocytes with an 
RNA FISH signal for Utx, Zfx, and Scml2 in wildtype, Hormad2-/-, and H2afx-
/- mice. Tukey multiple comparison tests were performed. Red P values are 
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significant. (e) Raw data showing number of early pachytene spermatocytes 
with an RNA FISH signal for Utx, Zfx, and Scml2 in wildtype, Hormad2-/-, and 
H2afx-/- mice. 
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6.3 Discussion 
In the final result chapter of my thesis, I provide several lines of 
evidence that both BRCA1 and HORMAD2 have important roles in the 
establishment of meiotic silencing in spermatocytes. Furthermore, I showed 
that BRCA1 is unlikely to be a critical component of the meiotic DNA DSB 
repair system. 
BRCA1 is a multifunctional protein that is important for maintenance 
of genomic stability in somatic cells (Huen et al., 2010). BRCA1’s role as a 
tumor suppressor its thought to be related to its critical functions in cell 
cycle checkpoint control and the DNA damage response (Huen et al., 2010). 
The Brca1 gene encodes a protein with a RING finger domain, which confers 
E3 ubiquitin ligase activity to BRCA1, and tandem BRCT domains, which are 
involved in binding phosphorylated proteins that facilitate the DNA damage 
response (Huen et al., 2010). Early work revealed that BRCA1 localizes at 
DNA DSBs in both mitotic and meiotic cells, implicating BRCA1 in the DDR in 
germ cells (Scully et al., 1997).  
A role for BRCA1 in the meiotic DNA DSB repair pathway was 
supported by meiotic analysis of Brca111/11 mutant mice, which encode 
a truncated allele of Brca1 (Xu et al., 2003). This study reported aberrant 
localization of the DNA repair protein RAD51 in the absence of wildtype 
BRCA1 (Xu et al., 2003). A subsequent meiotic analysis of Brca111/11 
mutant mice uncovered a distinct role for BRCA1 in the meiotic silencing 
pathway (Turner et al., 2004). In the Brca111/11 spermatocytes, ATR 
and H2AFX do not accumulate on the asynapsed X and Y chromosomes at 
pachynema, leading to failed silencing of the sex chromosomes (Turner et 
al., 2004). In summary, BRCA1 is thought to have two major functions 
during meiosis: (1) DNA DSB repair and (2) meiotic silencing.    
 In wildtype spermatocytes, BRCA1 foci were located on pre-synaptic 
chromosome axes in leptonema and zygonema and overlapped DMC1 foci. 
Using ChIP-seq, I showed that the majority of BRCA1 peaks in wildtype 
spermatocytes are located at sites meiotic DNA DSB hotspots. Furthermore, 
the level of BRCA1 enrichment at hotspots was positively correlated with 
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hotspot strength. Together, these data support that BRCA1 associates at 
DNA DSBs in normal meiosis.  
 Paradoxically, BRCA1 foci were also observed in programmed DNA 
DSB-deficient Spo11-/- spermatocytes, in agreement with a previous report 
(Mahadevaiah et al., 2008). This confirms that the initial recruitment of 
BRCA1 foci onto pre-synaptic chromosome axes is not dependent on DNA 
DSB formation per se. Based on my anti-BRCA1 ChIP-seq data, there was no 
obvious pattern of BRCA1 enrichment in Spo11-/- spermatocytes. This 
indicates that BRCA1 foci in Spo11-/- spermatocytes are not located at 
hotspot sites, but rather likely bind stochastically to pre-synaptic 
chromosome axes when DNA DSBs are not present to target BRCA1 to 
specific sites.  
I conclude that BRCA1 does not pre-designate sites of DNA DSBs, and 
suspect that BRCA1 is actively recruited to DNA DSB sites once formed by 
SPO11. Like in somatic cells, BRCA1 may be recruited to DNA DSB sites by 
some early DNA damage response factor, like H2AFX and/or MDC1 (Lou et 
al., 2003). Addressing this will involve additional studies of BRCA1 foci 
localization in other meiotic mutants, e.g. H2afx-/-, Mdc1-/-, etc. 
 Impaired loading of RAD51 in Brca111/11 p53+/- spermatocytes 
suggests an important role for RAD51 in meiotic DNA repair events (Xu et 
al., 2003). However, in my analysis, I observed normal localization of RAD51 
in Brca111/11 mutant spermatocytes, which is consistent with a more 
recent analysis (Broering et al., 2014). This studied also reported normal 
localization of other homologous recombination factors, such as MSH4 and 
MLH1 (Broering et al., 2014). Therefore, Brca1 deficiency has little effect on 
DNA DSB repair events in spermatocytes.  
 My subsequent analysis of BRCA1 revolved around the putative role 
for BRCA1 in meiotic silencing. ATR normally localizes to unrepaired DNA 
DSBs as foci during early meiotic prophase I (Burgoyne et al., 2007), and 
spreads along asynapsed axes by pachynema (Turner et al., 2004). 
Consistent with this early analysis of Brca111/11 mutants (Turner et al., 
2004), I observed defective ATR chromatin accumulation in Brca1-/- 53bp1-
/- spermatocytes. In this mutant, ATR localized only partially to the 
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asynapsed X and Y chromosome axes as foci or short stretches, suggesting 
failure to spread beyond sites of DNA DSBs.  
 Based on these observations, it is tempting to speculate that BRCA1 
is a key factor linking DNA DSBs to meiotic silencing. Historically it has been 
thought that meiotic silencing occurs independent of DNA DSBs, because 
H2AFX domains form in Spo11-/- germ cells (Mahadevaiah et al., 2001). 
However, subsequent experiments showed that meiotic silencing is not 
correctly targeted to the X and Y chromosomes in Spo11-/- spermatocytes 
(Bellani et al., 2005). My results, and a recently published analysis 
(Carofiglio et al., 2013)(Carofiglio et al., 2013)(Carofiglio et al., 
2013)(Carofiglio et al., 2013)(Carofiglio et al., 2013)(Carofiglio et al., 
2013)(Carofiglio et al., 2013)(Carofiglio et al., 2013)(Carofiglio et al., 
2013)(Carofiglio et al., 2013)(Carofiglio et al., 2013), reveal the presence of 
DNA DSB repair foci within H2AFX domains of Spo11-/- germ cells (Figure 
3.5), suggesting a potential link between DNA DSBs and meiotic silencing.  
 Taken together, my BRCA1 results inform an updated model of the 
meiotic silencing pathway (Figure 5.10a-b). During normal meiosis, BRCA1 
and ATR localize first to DNA DSBs during early prophase I, and then by 
pachynema, BRCA1 and ATR spread along the length of the asynapsed axes 
(Turner et al., 2004). In the absence of BRCA1, ATR cannot efficiently spread 
between DNA DSBs along the axes or within the chromatin, but is retained 
at unrepaired DNA DSBs (Figure 5.10a-b). Under this model, BRCA1’s main 
meiotic role is to facilitate the spreading of ATR between DNA DSBs on 
asynapsed chromosomes. This new model places BRCA1 as an important 
intermediary connecting the DNA DSBs to meiotic silencing (Figure 5.10a-
b). 
 The HORMA-domain containing protein HORMAD1 has been 
implicated in several meiotic processes, including the DNA DSB formation 
and repair, chromosome synapsis, meiotic silencing, and meiotic 
surveillance (Daniel et al., 2011; Kogo et al., 2012b; Shin et al., 2010; Shin et 
al., 2013). Another HORMAD-domain protein, HORMAD2, was recently 
identified in mammals (Wojtasz et al., 2009). Given that HORMAD1 and 
HORMAD2 have a similar localization pattern along asynapsed 
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chromosomes in mammalian germ cells (Fukuda et al., 2009), HORMAD2 
may also play a role in meiotic silencing. Consistent with this, I found that 
BRCA1 accumulation on asynapsed axes is dependent on Hormad2.  
Aberrant BRCA1 staining was also a feature of Hormad1-/- 
spermatocytes (Daniel et al., 2011), suggesting a potential interdependence 
between HORMAD1 and HORMAD2. However, HORMAD1 staining was 
normal in Hormad2-/- spermatocytes, indicating that HORMAD1 is 
upstream of HORMAD2. Indeed, there is reduced HORMAD2 staining in 
Hormad1-/- spermatocytes (Wojtasz et al., 2012), indicating that HORMAD1 
recruits HORMAD2 to asynapsed chromosomes. Taken together, these 
results place HORMAD2 downstream of HORMAD1 and upstream of BRCA1 
in the mammalian response to asynapsis (Figure 5.10a).   
Given that BRCA1 was disrupted by Hormad2 deletion, I expected 
downstream silencing factors to also be abnormal. Notably, H2AFX rarely 
encompassed the full sex chromatin area in Hormad2-/- spermatocytes, and 
was more frequently associated with the PAR regions of the X-Y 
chromosomes than the centromeric regions. Hormad2-/- spermatocytes 
therefore show regional disruption of H2AFX.  
Additional work by the Tóth group revealed that Hormad2 is also 
required for efficient ATR accumulation on asynapsed chromosomes 
(Wojtasz et al., 2012). By gene-specific RNA FISH, I observed regional 
disruption of meiotic silencing, with silencing at the PAR end being 
relatively intact compared to silencing near the centromere pole. I conclude 
that efficient meiotic silencing requires Hormad2.  
Results from my Brca1 and Hormad2 mutant analyses, combined 
with other recent studies (Daniel et al., 2011; Ichijima et al., 2011; Royo et 
al., 2013), suggest a more detailed model for the meiotic silencing pathway. 
First, the DNA damage response is activated upon introduction of 
programmed (i.e. Spo11-dependent) or non-programmed (i.e. Spo11-
independent) DNA DSBs during early meiotic prophase I, resulting in the 
accumulation of BRCA1, ATR, H2AFX, and other DDR factors at DNA DSBs 
(Figure 5.10b). Concomitantly, HORMAD1 recruits HORMAD2 to pre-
synaptic chromosome axes. Chromosome synapsis during the zygotene-
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pachytene transition period facilitates homology-driven repair of DNA DSBs, 
and the subsequent displacement of BRCA1, ATR, H2AFX, HORMAD1, and 
HORMAD2 from chromosomes.  
In the absence of a pairing partner, as in the case of the heterologous 
regions of the X and Y chromosomes, unrepaired DNA DSBs persist into 
early pachynema, as do their associated DDR factors. At this stage, BRCA1 
spreads between DNA DSB sites in a manner that depends upon HORMAD1 
(Daniel et al., 2011), HORMAD2 (Wojtasz et al., 2012), and ATR (Royo et al., 
2013). Similarly, ATR subsequently accumulates along the length of the 
asynapsed axes in a HORMAD1/2- and BRCA1-dependent fashion. Finally, 
ATR spreads from the chromosome axes into the chromatin loops, in a 
manner that requires MDC1 (Ichijima et al., 2011). Within the chromatin, 
ATR phosphorylates H2AFX at serine-139 to form H2AFX (Royo et al., 
2013), one of the important effectors of meiotic silencing (Fernandez-
Capetillo et al., 2003). Recent work has also revealed that phosphorylation 
of various chromosome axes components, including HORMAD1, may be 
important for the silencing (Fukuda et al., 2012).  
Similar to the role I ascribed for H2AFX as a meiotic surveillance 
factor, subsequent work has revealed that Hormad2 is required for the 
elimination of Spo11-/- oocytes (Kogo et al., 2012a; Wojtasz et al., 2012). 
Given the importance of HORMAD2 in the establishment of meiotic 
silencing, it is possible that HORMAD2’s meiotic surveillance function is 
achieved through meiotic silencing. Alternatively, HORMAD2 could exert its 
quality control function via ATR, though an otherwise undefined synaptic 
checkpoint.  
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Figure 5.10. Model for mechanism of meiotic silencing in 
wildtype and mutant meiosis. 
(a) Proposed sequence of events in meiotic silencing pathway. HORMAD1 
binds asynapsed chromosome axes and recruits HORMAD2, which is 
required for the axial accumulation of BRCA1. BRCA1 then mediates 
amplification/spreading of ATR throughout the chromatin of the asynapsed 
chromosome. ATR then phosphorylates H2AFX, forming a H2AFX silencing 
domain. (b) Proposed events on the asynapsed X chromosome in wildtype 
spermatocytes. DDR/meiotic silencing factors accumulate as foci near DNA 
DSBs on asynapsed chromosome axes. These foci are lost once 
chromosomes synapse, such as on autosomes (A). DDR/meiotic silencing 
factors, including BRCA1 and ATR, then spread from these DNA DSB-
associated foci along the length of the asynapsed chromosome axes. This 
axial spreading is dependent upon HORMAD1, HORMAD2, BRCA1, and ATR. 
By mid-pachynema, silencing factors, including MDC1, ATR, and H2AFX 
have spread throughout the chromatin, creating a stable silencing state. This 
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process requires HORMAD1, HORMAD2, BRCA1, ATR, MDC1, and H2AFX. (c) 
Proposed events in Hormad2-/- and Brca1-/- mice: DDR/meiotic silencing 
factors do not spread efficiently along the axes, which results in failed 
chromatin accumulation of silencing factions. Failure to establish a silenced 
X chromosome in these mutants results in spermatocyte arrest.  
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7 General discussion 
7.1 Overall summary  
The prophase I surveillance mechanisms that operate in germ cells 
have been a topic of considerable interest for decades. In mammals, these 
mechanisms serve to prevent aneuploidy in embryos by eliminating germ 
cells with defects. In doing this, however, these mechanisms can also lead to 
infertility. Despite their clinical importance, limited progress has been made 
toward understanding the molecular pathways of these surveillance 
mechanisms. In this thesis, I described and characterized a novel H2AFX-
dependent mechanism of meiotic surveillance of asynapsis.  
The findings in this thesis challenge the more classical models of 
meiotic surveillance, which are based on DNA damage and an asynapsis 
checkpoint, and in doing so they alter the way we think about the pathways 
that drive germ cell arrest and infertility in mammals. The H2AFX/meiotic 
silencing-based model is all-encompassing – it unifies existing data in both 
the male and female germ lines. Importantly, it can easily explain why an 
asynapsed X chromosome evokes oocyte arrest but not spermatocyte arrest. 
This paradox of mammalian meiosis is explained by the fact that silencing of 
important genes on the X chromosome in spermatocytes is compensated for 
by X-derived autosomal retrogenes, which is not active in oocytes. 
In addition, I described a meiotic characterization of two targeted 
mutant mouse models, Hormad2-/- and Brca1-/- 53bp1-/- mice, and in 
doing so identify new components of the meiotic silencing cascade. My 
results help clarify the role of BRCA1 in meiosis, and lead us to a simplified 
model of BRCA1 function in mammalian germ cells, in which BRCA1 
functions mainly to facilitate the spreading of ATR along asynapsed 
chromosomes for silencing. Together, these findings help advance our 
understanding of mammalian meiosis and fertility. In the following sections, 
I will discuss outstanding questions and future directions of my work. 
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7.2 H2AFX-dependent meiotic surveillance 
A major finding of this thesis is the role for H2AFX in the diplotene 
elimination of asynaptic oocytes in mice with chromosome abnormalities. 
My non-phosphorylatable H2AFX transgene study revealed that serine 
phosphorylation of H2AFX is the critical epigenetic event responsible for 
oocyte losses at diplonema. However, these data do not reveal the precise 
mechanism by which H2AFX accumulation on asynapsed chromosomes 
drives oocyte losses. 
Evidence that meiotic silencing is the mechanism by which H2AFX 
triggers oocyte losses comes from my analysis of accessory chromosome 
mouse models (i.e. XXY and Tc1). In these models, accumulation of H2AFX 
on the accessory asynapsed chromosomes was not associated with oocyte 
losses. These findings are consistent with the meiotic silencing model of 
oocyte arrest, but not the checkpoint model.  These accessory chromosome 
results suggest that H2AFX-dependent oocyte losses are dependent on the 
gene content of asynapsed chromosomes, supporting the meiotic silencing 
model.   
Nevertheless, it is important to acknowledge potential caveats of 
these experiments. First, it is possible that accessory chromosomes do not 
mount the same asynapsis response as endogenous chromosomes, and 
therefore do not trigger a checkpoint. However, I failed to identify any 
differences in the accumulation of meiotic silencing factors and DNA damage 
response factors, including BRCA1, ATR, H2AFX, HORMAD1, and 
HORMAD2, between accessory and endogenous asynapsed chromosomes. 
While I cannot discount the possibility that there are unidentified epigenetic 
differences in the molecular response to asynapsed accessory chromosome, 
the available data suggests that accessory chromosomes trigger a normal 
response to asynapsis.  
Another potential caveat is that the accessory chromosomes studied 
are appreciably smaller than the X chromosome in XO oocytes and therefore 
may not be sufficiently large to trigger oocyte arrest by a putative asynapsis 
checkpoint. The 171Mb mouse X chromosome is significantly larger than the 
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42Mb h21 Tc1 chromosome (O'Doherty et al., 2005) and the 91Mb mouse Y 
chromosome (Ensembl.org). Despite this size difference, however, I 
measured no significant difference in the intensity of the H2AFX domain 
between XO and Tc1 oocytes. This suggests that differences in chromatin 
H2AFX signaling are unlikely to contribute to the differential outcome of 
asynapsis in Tc1 and XO mouse models.  
However, it is still possible that there are quantitative differences in 
other chromatin asynapsis factors, such as ATR, or some axial factors, such 
as HORMAD1 and HORMAD2, that contribute to oocyte elimination in XO 
females but not Tc1 females. Additionally, there may be some variations in 
epigenetic modifications that contribute to the different fates of these 
oocytes. Future studies should focus on further characterizing the proteins 
and modifications associated with asynapsed accessory chromosome. 
Precisely how meiotic silencing of endogenous asynapsed 
chromosomes leads to arrest is unclear. The most parsimonious explanation 
is that the silencing of critical genes starves germ cells of necessary factors, 
thus leading to oocyte death. Alternatively, it could cause arrest through 
silencing of non-coding genes or transposons, or through changes in 
transcription factor binding profiles on asynapsed chromosomes. My data 
do not allow us to discriminate between these possibilities.  
During male meiosis, accumulation of silencing factors, such as 
HORMAD1, HORMAD2, BRCA1, ATR, MDC1 and H2AFX, on asynapsed 
autosomes causes prophase I arrest (Turner et al., 2005), but localization of 
the same proteins to the asynapsed X chromosome does not. Importantly, 
the X chromosome does not possess unique properties preventing it from 
triggering arrest. This is demonstrated by the fact that asynapsed accessory 
chromosomes, such as in Tc1 males, also fail to trigger prophase I arrest 
(Mahadevaiah et al., 2008) (unpublished results, Turner lab).  
In contrast to the autosomes, however, the X chromosome is 
dramatically depleted in genes required for male meiosis (Khil et al., 2004; 
Wang, 2004). Interestingly, silencing of X-linked housekeeping genes is also 
compensated for by a unique backup system of autosomally-located, X-
derived retrogenes that are essential for spermatogenesis (Bradley et al., 
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2004; McCarrey and Thomas, 1987; Wang, 2004). The fact that both the X 
chromosome and accessory chromosomes are deficient in male meiotic 
genes could explain why H2AFX-induced silencing of these chromosomes 
does not induce prophase I arrest.  
Silencing of the X chromosome in the female, by contrast, is expected 
to be deleterious, because the X chromosome is enriched for oogenesis 
genes (Khil et al., 2004), and the autosomal retrogene system that in males 
compensates for MSCI is not active in the female germ line. In theory, one 
could test this hypothesis by inserting transgenes for critical X-linked 
meiotic genes onto autosomes in XO mice and assessing for rescue of 
oocytes. However, this would be experimentally unrealistic given that the 
mouse X chromosome contains 940 coding genes, many of which are 
involved in oogenesis (Khil et al., 2004) such as Zfx (Luoh et al., 1997), and 
180 long non-coding genes (ensemble.org).  
Another important question that should be addressed is whether the 
rescue in XO H2afx-/- oocytes persists into adulthood. While H2afx ablation 
reverses XO perinatal oocyte losses, it is unclear whether the rescue is still 
evident after prophase I, or whether other surveillance mechanisms act 
later in development to eliminate those defective oocytes. To examine this, 
one can count oocytes in wildtype, XO, and XO H2afx-/- oocytes at later time 
points, including several weeks post-partum.  
If oocyte numbers are lower in XO H2afx-/- females compared to 
wildtype females at these time points, it is possible that additional quality 
control mechanisms operate in response to asynapsis. If oocyte numbers 
remain similar to those found in wildtype females, then it is unlikely that 
other asynapsis safeguarding mechanisms exist.   
7.3 Limitations of an H2AFX-based surveillance mechanism 
Based on the work from this thesis, oocytes with an asynapsed X 
chromosome or an asynapsed autosome are eliminated during diplonema 
by an H2AFX-dependent mechanism. The limitations of this mechanism are 
not yet defined. For example, it is unclear whether this surveillance 
mechanism can function when challenged with larger amounts of asynapsis.  
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Two independent studies have shown that meiotic silencing breaks 
down in the presence of more than three pairs of asynapsed chromosomes 
(Kouznetsova et al., 2009; Mahadevaiah et al., 2008).  It has been 
hypothesized that with more extensive asynapsis, important meiotic 
silencing factors, such as BRCA1 and ATR, are titrated to unrepaired DNA 
DSBs, and thus are not available to efficiently facilitate silencing 
(Kouznetsova et al., 2009; Mahadevaiah et al., 2008).  Based upon this 
observation, I would expect that oocytes with significant levels of asynapsis 
(>4) would not be eliminated as efficiently as oocytes with fewer asynapsed 
chromosomes.  
Indeed, based on preliminary findings from the Turner laboratory, F1 
PWDxB6 oocytes with >4 asynapsed chromosomes show reduced H2AFX 
staining and are not eliminated by late diplonema (unpublished results). By 
contrast, F1 PWDxB6 oocytes with ≤4 asynapsed chromosomes within the 
same ovaries show normal H2AFX accumulation and are eliminated by late 
diplonema (unpublished results). This indicates that the H2AFX-dependent 
surveillance mechanism breaks down in the face of extensive asynapsis. 
Furthermore, it suggests that there is not an alternative or compensatory 
surveillance mechanism to deal with high levels of asynapsis.   
To better characterize the limitations of the H2AFX surveillance 
mechanism, it will be important to determine the total length of asynapsed 
chromosome axes that causes H2AFX localization to be disrupted. It will 
also be of interest to evaluate whether the disruption of meiotic silencing 
factors is in fact related to titrated at DNA DSBs, as others have suggested 
(Mahadevaiah et al., 2008).  
Interestingly, I showed that DNA repair proteins do not persist on 
multiple asynapsed chromosomes in PWDxB6 F1 oocytes. To reconcile this, 
future work should characterize the localization of BRCA1 and ATR, and 
other factors with a shared role in the DNA damage response and meiotic 
silencing, on multiple asynapsed chromosomes in PWDxB6 F1 oocytes. 
Furthermore, it should be examined whether PWDxB6 F1 oocytes give rise 
to a high proportion of aneuploidy embryos as a result of a 
relaxed/disrupted prophase I surveillance mechanism.  
 244 
7.4 DNA DSB repair and the DNA damage checkpoint in mice 
Classically, the DNA damage checkpoint has been invoked to explain 
the elimination of oocytes with persistent DNA damage (Bolcun-Filas et al., 
2014; Di Giacomo et al., 2005). In this thesis, I showed that markers of DNA 
DSB repair, such as RPA/RAD51/DMC1, do not persist on asynapsed 
chromosomes in chromosomally abnormal mice with competent DNA repair 
systems. Strikingly, this holds true even when several chromosomes are 
asynapsed, as in F1 PWDxB6 females, indicating that this repair system is 
robust. This also suggests that persistent DNA damage is unlikely to be a 
trigger of oocyte arrest in mice with chromosome abnormalities. 
This is in contrast to mice with mutations in DNA repair enzymes, 
such as Dmc1-/- mice, which show signs of persistent DNA damage repair 
foci. My data question the contribution of the DNA damage checkpoint in 
normal biology, i.e. outside of situations in which mice have specific 
mutations or exogenously induced DNA damage. This also emphasises the 
importance of studying both targeted and non-targeted mouse models to 
gain a full understanding of the pathways causing prophase oocyte I 
elimination 
My findings of DNA repair on asynapsed chromosomes in oocytes is 
also consistent with previous work in the male germ line, which showed 
that DNA DSB markers disappear from the asynapsed X chromosome by 
mid-late pachynema (Plug et al., 1998). This highlights that DNA repair on 
asynapsed chromosome is conserved between the sexes.  
Mechanistically, it is unclear how DNA DSBs are repaired efficiently 
on asynapsed chromosomes. RPA turnover on the asynapsed X chromosome 
occurred with normal kinetics in XO H2afx-/- females, indicating that DNA 
DSB repair on asynapsed chromosomes does not require H2AFX. Additional 
research is needed to identify the mechanism of DNA DSB repair on 
asynapsed chromosomes in oocytes. 
Studies in yeast have revealed that in addition to the canonical 
interhomolog (IH) repair pathway, meiotic DNA DSBs can be repaired via 
alternative pathways, such as intersister (IS) repair (Goldfarb and Lichten, 
2010). Normally, to ensure that crossovers are generated during meiosis, 
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there is a “barrier” that suppresses recombination between sister 
chromatids to favor repair using homologs (Niu et al., 2005). In yeast 
meiosis, despite the IH repair bias, IS repair still occurs at substantial levels 
(Goldfarb and Lichten, 2010; Schwacha and Kleckner, 1997). Recent work 
suggests that IS repair also occurs in mammals (Li et al., 2011). I suspect 
that IS recombination is a likely mechanism for the repair of DNA DSBs on 
asynapsed chromosomes in chromosome variant mice.  
Another putative mechanism of DNA DSB repair in the absence of a 
homologous chromosome is non-homologous end joining (NHEJ), which is a 
major repair mechanism in somatic cells. Unlike IH and IS repair pathways, 
which require a homolog (either a homologous chromosome or sister 
chromatid) for repair, NHEJ does not require any sequence homology. NHEJ 
involves the direct ligation of broken DNA ends together (Davis and Chen, 
2013). NHEJ does not depend upon break resection and 3’ ssDNA overhangs, 
which instead is a feature of HR (Mimitou and Symington, 2009). Since 
asynapsed chromosomes contained RPA/RAD51/DMC1, which are all 
proteins that recognize ssDNA, these DNA DSBs have already undergone 
resection and would no longer be a template for NHEJ. Therefore, NHEJ 
likely does not contribute to the repair of breaks on asynapsed 
chromosomes. 
Notably, I found that DNA DSB repair takes longer on asynapsed 
chromosomes compared to synapsed chromosomes in oocytes. This is also 
consistent with the delayed repaired observed on the asynapsed X 
chromosome in spermatocytes (Plug et al., 1998). Therefore, the mechanism 
of repair on asynapsed chromosomes either takes longer or is somewhat 
delayed in mammalian germ cells. Characterizing this DNA repair 
mechanism, especially the molecular players involved in it, will be an 
important area of research for future studies.  
7.5 Other factors involved in meiotic silencing and surveillance  
In this thesis, I have shown that both BRCA1 and HORMAD2 are 
essential components of the meiotic silencing pathway in mice. Using a 
recently generated Brca1-/- mutant (Bunting et al., 2012), I verified that 
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BRCA1 is essential for the accumulation of the silencing factor ATR, 
consistent with previous reports (Broering et al., 2014; Turner et al., 2004). 
I also found that HORMAD2 is necessary for the proper axial 
loading/accumulation of BRCA1 on asynapsed axes. This places HORMAD2 
upstream of BRCA1 in the cascade of events leading to silencing.    
Recently, the kinase ATR was also shown to be important for meiotic 
silencing (Royo et al., 2013) and meiotic surveillance in mammals (Wojtasz 
et al., 2012). In a conditional mouse mutant of Atr, the localization of many 
meiotic silencing components, including BRCA1, ATRIP, TOPBP1, MDC1, 
H2AFX, SUMO, and uH2A, is disrupted (Royo et al., 2013). Similarly, H2afx-
/- mutants show improper loading of ATR and MDC1 (Royo et al., 2013). 
This indicates an ATR is a critical component of meiotic silencing, and that 
there is an interdependent relationship between many of the silencing 
factors.  
ATR accumulation at unrepaired DNA DSBs and/or within the 
chromatin of asynapsed chromatin has been proposed to be a proximal 
trigger of oocyte arrest in mice with asynapsed chromosomes (e.g. Spo11-/-) 
(Wojtasz et al., 2012). Ablation of Hormad2 in mice, which results in 
improper loading of chromatin ATR on asynapsed chromosomes (this 
thesis), rescues oocyte losses in asynaptic Spo11-/- oocytes (Wojtasz et al., 
2012). This suggests that chromatin ATR is involved in meiotic surveillance 
of asynapsis. This is consistent with my model of meiotic surveillance based 
on meiotic silencing factors. However, these data could also be interpreted 
as an ATR-dependent checkpoint that functions independent of silencing.  
In my XO H2afx-/- experiments, the most parsimonious explanation 
for the rescue of XO oocyte losses is ablation of silencing. However, it is also 
possible that an ATR-dependent checkpoint was disrupted, and that this 
contributes to the oocyte rescue phenotype. Indeed, ATR chromatin staining 
is disrupted in H2afx-/- spermatocytes. This possibility of an ATR-
dependent checkpoint seems less likely, however, given my accessory 
chromosome results. In these mouse models, ATR signaling is active but not 
sufficient to trigger oocyte arrest. If an ATR-dependent checkpoint 
mechanism operates in mice, then ATR accumulation on asynapsed 
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accessory chromosomes should induce oocyte losses. Therefore, I favor the 
model whereby ATR-dependent oocyte losses occur via ATR’s direct role in 
meiotic silencing (Royo et al., 2013).  
It is also possible that ATR plays an important role in a DNA DSB 
dependent checkpoint. To assess for a potential role for ATR in a meiotic 
DNA DSB checkpoint, it will be important to examine oocyte numbers in Atr 
mutant females. The effect of Atr ablation should be studied in the context of 
mouse models with persistent unrepaired DNA DSBs (i.e. Dmc1-/-). If ATR is 
involved in a DNA DSB checkpoint pathway, Atr ablation should increase 
oocyte numbers in Dmc1-/- mutants, and other mutants with persistent 
unrepaired DNA DSBs phenotypes (Di Giacomo et al., 2005).  
Whether any other downstream effectors are involved in H2AFX-
mediated oocyte losses remains unclear. A recent study reported a role for 
the checkpoint kinase protein CHK2 in the DNA damage checkpoint in 
oocytes (Bolcun-Filas et al., 2014). While Chk2 ablation reversed oocyte 
losses in DNA DSB repair defective oocytes (i.e. Dmc1-/- and Trip13 
mutants), it is unknown whether it has a role in regulating the elimination of 
oocytes with asynapsed chromosomes. It seems unlikely that CHK2 would 
be directly involved in H2AFX-dependent oocyte losses because they seem 
to be involved in distinct pathways. CHK2 seems to function predominately 
in DNA damage-induced oocyte losses (Bolcun-Filas et al., 2014; Livera et al., 
2008), whereas H2AFX is not involved in the DNA damage checkpoint (this 
thesis).  
It is will also be important to test for a role for apoptosis in H2AFX-
dependent oocyte losses. This can be assessed by genetically ablating the 
apoptosis pathway in mice with chromosome abnormalities (e.g. XO mice). 
For example, oocyte numbers can be counted in XO mice with a mutation in 
key apoptosis regulators, such as p53 or its paralog p63, both of which have 
been shown to be involved in DNA damage-induced apoptosis in oocytes 
(Bolcun-Filas et al., 2014). XO oocyte rescue by p53/63 deletion would 
implicate a role for apoptotic cell death in XO oocyte losses. Another way to 
examine for a role for apoptosis is to examine the localization of apoptotic 
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pathway proteins (e.g. cleaved caspases, p53, p63, etc.) by 
immunofluorescence in XO ovary sections.   
In summary, much remains to be discovered about the downstream 
effectors involved in the elimination of oocytes with asynapsis. 
Characterizing this pathway is important because it may provide targets 
with which to interfere with oocyte elimination  
7.6 Sexual dimorphism in meiotic silencing  
 Another important conclusion from my thesis is that silencing is 
sexually dimorphic in mammals. Numerous previous studies have shown 
that meiotic silencing in spermatocytes is very robust, leading to the 
complete inactivation of X-linked coding genes at pachynema (Khil et al., 
2004; Turner et al., 2005). While there have been reports that X-linked 
miRNAs escape meiotic silencing in spermatocytes, new work is challenging 
these results, showing that miRNAs are also subject to silencing (Turner lab, 
unpublished results).   
 Previous studies in the female germ line have shown that the major 
silencing factors BRCA1, ATR, H2AFX, and ubi-H2A all localize to asynapsed 
chromosomes (Baarends et al., 2005; Turner et al., 2005). These marks 
coincided with an absence of Cot1 RNA and RNA polymerase II 
immunostaining, indicative of silencing (Baarends et al., 2005; Turner et al., 
2005).  Based on these studies, meiotic silencing was expected to be 
proficient in oocytes, similar to spermatocytes. However, until now, studies 
of gene specific RNA FISH studies, the gold standard for analyzing nascent 
transcription in germ cells, were lacking.  
 My RNA FISH analyses have unequivocally shown that meiotic 
silencing is less robust in oocytes compared to spermatocytes. Furthermore, 
simultaneous three-gene RNA FISH showed that within individual oocytes, 
genes on asynapsed chromosomes are silenced in a stochastic manner. In 
other words, the combination of genes that are silenced on a given 
asynapsed chromosome differs between individual oocytes. This mosaicism 
could create distinct gene expression profiles that disturb different 
biological pathways. Thus, in XO females, and other chromosomally 
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abnormal mouse models exhibiting prophase I germ cell losses, the precise 
cause of arrest could differ from oocyte to oocyte depending on the suite of 
genes that are silenced, as discussed above. 
 Why is meiotic silencing more robust in males than in females? While 
most major components of silencing (e.g. BRCA1, ATR, H2AFX) are present 
on asynapsed chromosomes in oocytes, it is possible that other contributors 
of meiotic silencing are absent or not expressed appropriately in oocytes. 
Consistent with this idea, a recent study (Taketo and Naumova, 2013) 
revealed that the repressive histone modification H3K9me3 is not present 
on asynapsed chromosomes in oocytes like it is in spermatocytes. The 
Turner lab has also independently verified this finding (unpublished). This 
indicates that there are epigenetic differences in the response to asynapsed 
chromosome in oocytes. Furthermore, this suggests that H3K9me3 is 
required for stable and complete silencing of meiotic chromosomes. 
Identification of the histone methyltransferases that catalyze H3K9 
methylation on asynapsed chromosomes represents an important challenge 
in the future for understanding sex differences in the prophase I response to 
asynapsis. 
 There are likely important clinical implications of the reduced 
efficiency of silencing in the female germ line. In general, chromosome 
abnormalities confer greater germ cell losses in males than in females 
(Burgoyne et al., 2009). This is due in part to the reduced stringency of the 
metaphase I spindle checkpoint in females (LeMaire-Adkins et al., 1997; 
Nagaoka et al., 2011), but is also thought to reflect ill-defined sex differences 
in the efficacy of the prophase I response to asynapsis (Hunt and Hassold, 
2002; Morelli and Cohen, 2005; Nagaoka et al., 2012). A decreased efficiency 
of meiotic silencing may help explain the reduced efficiency of the prophase 
I surveillance response.  
For example, it is possible that oocytes with prophase I defects are 
able to avoid elimination if its asynapsed chromosome are replete of 
essential genes or if not enough critical genes are silenced. Therefore, the 
sexual dimorphism in silencing may provide an explanation to why 
chromosome abnormalities cause more severe germ cell loss in males than 
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in females, and also why most cases of human aneuploidy arise from 
maternal meiotic errors (Morelli and Cohen, 2005). 
Evolutionarily, is there a reason for the sexual dimorphism in 
silencing efficiency? Insight into this intriguing question may come from the 
recent confirmation that robust XY silencing in spermatocytes is critical for 
spermatocyte survival (Royo et al., 2010). Defects in silencing of the X and Y 
chromosomes in spermatocytes (i.e. MSCI) cause midpachytene arrest, and 
this has been linked to the misexpression of toxic sex-linked genes (Royo et 
al., 2010). It is therefore possible that meiotic silencing in males must be 
highly efficient in order to prevent the mis-expression of these “toxic” XY-
encoded genes during normal male meiosis. In the female germ line, by 
contrast, there is little selective pressure for a robust meiotic silencing 
response, since incomplete silencing does not negatively impact oocyte 
survival. 
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